BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 013636
(439 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 194 bits (494), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 105/283 (37%), Positives = 167/283 (59%), Gaps = 7/283 (2%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
L+ A++NF N++G GG G VYK R + L AVKR+ ++ E +F EV ++
Sbjct: 33 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMA 92
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGL 265
H+N++ L G+C+ R LVY M NGS+ L P L W R +IA+ ARGL
Sbjct: 93 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 152
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGYVAP 323
YLH+HC+ ++HRD+K++NILLD F A + DFGL+ + +V + GT+G++AP
Sbjct: 153 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAP 212
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE--KMSPTQCQSMVTWAMPQLTDRSKLPN 381
EYL GK ++K+DV+ +GV+LLEL+ G+R + +++ ++ W L ++ KL
Sbjct: 213 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEA 271
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+VD ++ + + Q+ VA+LC Q P RP +++V+ L
Sbjct: 272 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 193 bits (490), Expect = 2e-49, Method: Compositional matrix adjust.
Identities = 104/283 (36%), Positives = 166/283 (58%), Gaps = 7/283 (2%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
L+ A++NF N++G GG G VYK R + L AVKR+ ++ E +F EV ++
Sbjct: 25 LQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMA 84
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGL 265
H+N++ L G+C+ R LVY M NGS+ L P L W R +IA+ ARGL
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK--ISGTLGYVAP 323
YLH+HC+ ++HRD+K++NILLD F A + DFGL+ + +V + G +G++AP
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAP 204
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE--KMSPTQCQSMVTWAMPQLTDRSKLPN 381
EYL GK ++K+DV+ +GV+LLEL+ G+R + +++ ++ W L ++ KL
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEA 263
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+VD ++ + + Q+ VA+LC Q P RP +++V+ L
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 182 bits (462), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 107/283 (37%), Positives = 160/283 (56%), Gaps = 12/283 (4%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
LE ATNNF +IG G G VYK + A+KR EF E+ L+ R
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG---PTHGSNLTWHLRMKIAVDVARG 264
H +++SL+G+C L+Y+ M+NG+L++ L+G PT +++W R++I + ARG
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSRNVKISGTLGYV 321
L YLH ++HRD+KS NILLD +F K++DFG+S G + GTLGY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
PEY ++G+LT+KSDVY+FGVVL E+L R + + P + ++ WA+ + + +L
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQLEQ 267
Query: 382 IVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
IVDP + D + + L + AV C+ RP + DVL L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 182 bits (461), Expect = 5e-46, Method: Compositional matrix adjust.
Identities = 108/284 (38%), Positives = 162/284 (57%), Gaps = 14/284 (4%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
LE ATNNF +IG G G VYK + A+KR EF E+ L+ R
Sbjct: 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG---PTHGSNLTWHLRMKIAVDVARG 264
H +++SL+G+C L+Y+ M+NG+L++ L+G PT +++W R++I + ARG
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARG 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK----ISGTLGY 320
L YLH ++HRD+KS NILLD +F K++DFG+S GT+ + GTLGY
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS-KKGTELDQTHLXXVVKGTLGY 207
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
+ PEY ++G+LT+KSDVY+FGVVL E+L R + + P + ++ WA+ + + +L
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQLE 266
Query: 381 NIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
IVDP + D + + L + AV C+ RP + DVL L
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 159 bits (402), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
YEL + TNNF E N +GEGG G VYK N +A K +D + +++
Sbjct: 18 YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
F+ E+ + K +H+N++ LLG+ + LVY M NGSL +L L+WH+R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
KIA A G+ +LHE NH +HRD+KS+NILLD +F AK+SDFGL+ + ++ V
Sbjct: 137 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXX 193
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
+I GT Y+APE L G++T KSD+Y+FGVVLLE++ G V++ Q ++
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 250
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+ + + +D + D D + + +VA C+ + + RP I V
Sbjct: 251 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 159 bits (402), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
YEL + TNNF E N +GEGG G VYK N +A K +D + +++
Sbjct: 18 YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 76
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
F+ E+ + K +H+N++ LLG+ + LVY M NGSL +L L+WH+R
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
KIA A G+ +LHE NH +HRD+KS+NILLD +F AK+SDFGL+ + ++ V
Sbjct: 137 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXS 193
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
+I GT Y+APE L G++T KSD+Y+FGVVLLE++ G V++ Q ++
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 250
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+ + + +D + D D + + +VA C+ + + RP I V
Sbjct: 251 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 158 bits (400), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 105/288 (36%), Positives = 159/288 (55%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
YEL + TNNF E N +GEGG G VYK N +A K +D + +++
Sbjct: 12 YEL-KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 70
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
F+ E+ + K +H+N++ LLG+ + LVY M NGSL +L L+WH+R
Sbjct: 71 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 130
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
KIA A G+ +LHE NH +HRD+KS+NILLD +F AK+SDFGL+ + ++ V
Sbjct: 131 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXX 187
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
+I GT Y+APE L G++T KSD+Y+FGVVLLE++ G V++ Q ++
Sbjct: 188 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+ + + +D + D D + + +VA C+ + + RP I V
Sbjct: 245 EDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKV 291
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 150 bits (379), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 104/288 (36%), Positives = 152/288 (52%), Gaps = 20/288 (6%)
Query: 145 YELLEAATNNFQE------SNVIGEGGRGHVYKARFNEKLLAAVK---RIDDAGHDAERE 195
YEL + TNNF E N GEGG G VYK N +A K +D + +++
Sbjct: 9 YEL-KNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ 67
Query: 196 FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
F+ E+ K +H+N++ LLG+ + LVY NGSL +L L+WH R
Sbjct: 68 FDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRC 127
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV--- 312
KIA A G+ +LHE NH +HRD+KS+NILLD +F AK+SDFGL+ + ++ V
Sbjct: 128 KIAQGAANGINFLHE--NHH-IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXS 184
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
+I GT Y APE L G++T KSD+Y+FGVVLLE++ G V++ Q ++
Sbjct: 185 RIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEI 241
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+ + + +D D D + +VA C+ + + RP I V
Sbjct: 242 EDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKV 288
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 93/271 (34%), Positives = 142/271 (52%), Gaps = 21/271 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYC 218
IG G G V++A ++ +A VK + + AER EF EV + ++RH NI+ +G
Sbjct: 45 IGAGSFGTVHRAEWHGSDVA-VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+V E + GSL + LH L R+ +A DVA+G+ YLH N P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
R+LKS N+L+D + K+ DFGLS + A T + +GT ++APE L + +KSDV
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
Y+FGV+L EL ++P ++P Q + V + +L ++P ++P
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP------------ 266
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
QVAA+ C EP RP ++ L PL+
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 136 bits (342), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 93/271 (34%), Positives = 141/271 (52%), Gaps = 21/271 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRHQNIISLLGYC 218
IG G G V++A ++ +A VK + + AER EF EV + ++RH NI+ +G
Sbjct: 45 IGAGSFGTVHRAEWHGSDVA-VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+V E + GSL + LH L R+ +A DVA+G+ YLH N P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
RDLKS N+L+D + K+ DFGLS + A + +GT ++APE L + +KSDV
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
Y+FGV+L EL ++P ++P Q + V + +L ++P ++P
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----EIPRNLNP------------ 266
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
QVAA+ C EP RP ++ L PL+
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 109 bits (273), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 86/291 (29%), Positives = 123/291 (42%), Gaps = 36/291 (12%)
Query: 147 LLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWL 203
LLE +IG GG G VY+A + +A D D + N E
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
++H NII+L G C+ LV E + G L + L G + + + AV +AR
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIAR 116
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFN--------AKLSDFGLSVTAGTQSRNVKIS 315
G+ YLH+ P++HRDLKSSNIL+ K++DFGL A R K+S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL---AREWHRTTKMS 173
Query: 316 --GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL 373
G ++APE + + SDV+++GV+L ELL G P + V L
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
S P ++ D C P+P RP T++L L
Sbjct: 234 PIPSTCPEPFAKLMED----------------CWNPDPHSRPSFTNILDQL 268
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 86/292 (29%), Positives = 141/292 (48%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
A N + IG+GG G V+K R +K + A+K + + E +EF EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
++ + H NI+ L G +H R +V E + G L +L H + W +++++ +D+A
Sbjct: 77 MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
G+EY+ N P+VHRDL+S NI L S AK++DFGLS Q +SG
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
LG ++APE + E T+K+D Y+F ++L +L G P ++ S + + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L R +P P +R+ ++ LC +P RP + ++ L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 37/306 (12%)
Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
N +R G++D+ E E E S IG G G VYK +++ + + ++ D
Sbjct: 17 NKIRPRGQRDSSYYWEIEASEVML-----STRIGSGSFGTVYKGKWHGDVAVKILKVVDP 71
Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
+ + F NEV L K RH NI+ +GY + + +V + + SL K LH +
Sbjct: 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLH--VQETK 128
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
+ IA A+G++YLH ++HRD+KS+NI L K+ DFGL+
Sbjct: 129 FQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185
Query: 309 SRNVKI---SGTLGYVAPEYLL---EGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SPTQ 361
S + ++ +G++ ++APE + + +SDVY++G+VL EL+ G P + + Q
Sbjct: 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245
Query: 362 CQSMV--TWAMPQLTDRSK-LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLIT 418
MV +A P L+ K P + ++ D C++ RPL
Sbjct: 246 IIFMVGRGYASPDLSKLYKNCPKAMKRLVAD----------------CVKKVKEERPLFP 289
Query: 419 DVLHSL 424
+L S+
Sbjct: 290 QILSSI 295
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
A N + IG+GG G V+K R +K + A+K + + E +EF EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
++ + H NI+ L G +H R +V E + G L +L H + W +++++ +D+A
Sbjct: 77 MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
G+EY+ N P+VHRDL+S NI L S AK++DFG S Q +SG
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
LG ++APE + E T+K+D Y+F ++L +L G P ++ S + + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L R +P P +R+ ++ LC +P RP + ++ L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V+ A +K+L AVK + DA +A ++F+ E LT ++H++I+
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP--------THGSNLTWHLRMKIAVDVARG 264
G C+ + +V+E M++G L K L HGP + LT + IA +A G
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TLGY 320
+ YL + VHRDL + N L+ + K+ DFG+S + + ++ G + +
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIRW 196
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVT 367
+ PE ++ K T +SDV++ GVVL E+ G++P ++S + +T
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 102 bits (255), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 92/333 (27%), Positives = 149/333 (44%), Gaps = 54/333 (16%)
Query: 116 GKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVI-----GEGGRGHVY 170
G G SLSP + + L + + +Y +A ++ + +++ GEG G V+
Sbjct: 4 GSGSSLSPTEGKGSGL----QGHIIENPQY-FSDACVHHIKRRDIVLKWELGEGAFGKVF 58
Query: 171 KARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
A + +K+L AVK + +A A ++F E LT ++HQ+I+ G C
Sbjct: 59 LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 225 FLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVARGLEYLHEHC 272
+V+E M++G L + L HGP G + L + +A VA G+ YL
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---A 175
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TLGYVAPEYLLE 328
VHRDL + N L+ K+ DFG+S + ++ G + ++ PE +L
Sbjct: 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLPIRWMPPESILY 234
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
K T +SDV++FGVVL E+ G++P ++S T+ +T R+ P
Sbjct: 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPP------- 287
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+V A+ C Q EP R I DV
Sbjct: 288 ----------EVYAIMRGCWQREPQQRHSIKDV 310
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 102 bits (255), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 92/296 (31%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKI-R 207
N+ + +VIGEG G V KAR + ++ AA+KR+ + A D R+F E+ L K+
Sbjct: 15 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
H NII+LLG C H +L E +G+L L + S L+
Sbjct: 75 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+ A DVARG++YL + +HRDL + NIL+ ++ AK++DFGLS + + V +
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYV 186
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
T+G ++A E L T SDV+++GV+L E++ +G P M+ C +
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 242
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+PQ R + P D + D M C + +P RP +L SL
Sbjct: 243 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 285
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 102 bits (254), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 85/292 (29%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAE-------REFNNEVNW 202
A N + IG+GG G V+K R +K + A+K + + E +EF EV
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 203 LTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
++ + H NI+ L G +H R +V E + G L +L H + W +++++ +D+A
Sbjct: 77 MSNLNHPNIVKLYG-LMHNPPR-MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIA 132
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDS-----SFNAKLSDFGLSVTAGTQSRNVKISGT 317
G+EY+ N P+VHRDL+S NI L S AK++DF LS Q +SG
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGL 186
Query: 318 LG---YVAPEYL--LEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ 372
LG ++APE + E T+K+D Y+F ++L +L G P ++ S + + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L R +P P +R+ ++ LC +P RP + ++ L
Sbjct: 247 L--RPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKEL 284
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 102 bits (254), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 92/296 (31%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRH 208
N+ + +VIGEG G V KAR + ++ AA+KR+ + A D R+F E+ L K+ H
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 209 Q-NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
NII+LLG C H +L E +G+L L + S L+
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+ A DVARG++YL + +HRDL + NIL+ ++ AK++DFGLS + + V +
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEVYV 196
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
T+G ++A E L T SDV+++GV+L E++ +G P M+ C +
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 252
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+PQ R + P D + D M C + +P RP +L SL
Sbjct: 253 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 295
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G + K+L S ++A
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQ---KLSKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 161 IGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V+ A + +K+L AVK + +A A ++F E LT ++HQ+I+
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVA 262
G C +V+E M++G L + L HGP G + L + +A VA
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TL 318
G+ YL VHRDL + N L+ K+ DFG+S + + ++ G +
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPI 195
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
++ PE +L K T +SDV++FGVVL E+ G++P ++S T+ +T R+
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 255
Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
P +V A+ C Q EP R I DV
Sbjct: 256 CPP-----------------EVYAIMRGCWQREPQQRHSIKDV 281
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 102 bits (253), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FN 197
++ +I+Y+ +E V+G G G V KA++ K +A +K+I+ ++ER+ F
Sbjct: 1 SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVA-IKQIES---ESERKAFI 49
Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
E+ L+++ H NI+ L G C++ LV E + GSL LHG T M
Sbjct: 50 VELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
+ ++G+ YLH ++HRDLK N+LL + K+ DFG + T N K G
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--G 165
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
+ ++APE ++K DV+++G++L E++ R+P +++ + M WA+ T
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRP 223
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+ N+ P + ++ C +PS RP + +++
Sbjct: 224 PLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIV 255
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 102 bits (253), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 44/283 (15%)
Query: 161 IGEGGRGHVYKARFN------EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V+ A + +K+L AVK + +A A ++F E LT ++HQ+I+
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----THGSN-----LTWHLRMKIAVDVA 262
G C +V+E M++G L + L HGP G + L + +A VA
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----TL 318
G+ YL VHRDL + N L+ K+ DFG+S + + ++ G +
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLPI 201
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
++ PE +L K T +SDV++FGVVL E+ G++P ++S T+ +T R+
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA 261
Query: 378 KLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
P +V A+ C Q EP R I DV
Sbjct: 262 CPP-----------------EVYAIMRGCWQREPQQRHSIKDV 287
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 102 bits (253), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 85/280 (30%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G + K+L S ++A
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLXGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 102 bits (253), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 78/285 (27%), Positives = 140/285 (49%), Gaps = 32/285 (11%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FN 197
++ +I+Y+ +E V+G G G V KA++ K +A +K+I+ ++ER+ F
Sbjct: 2 SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVA-IKQIES---ESERKAFI 50
Query: 198 NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
E+ L+++ H NI+ L G C++ LV E + GSL LHG T M
Sbjct: 51 VELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
+ ++G+ YLH ++HRDLK N+LL + K+ DFG + T N K G
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--G 166
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
+ ++APE ++K DV+++G++L E++ R+P +++ + M WA+ T
Sbjct: 167 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRP 224
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+ N+ P + ++ C +PS RP + +++
Sbjct: 225 PLIKNLPKP-------------IESLMTRCWSKDPSQRPSMEEIV 256
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 101 bits (251), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 87/281 (30%), Positives = 138/281 (49%), Gaps = 41/281 (14%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR N K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+RH NI+ L GY H TR +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGY-FHDSTRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELAN 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ P
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPP 175
Query: 324 EYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
E ++EG++ D K D+++ GV+ E L+G+ P E + ++ + T P+
Sbjct: 176 E-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV--EFT----FPDF 228
Query: 383 VDPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
V RD + LKH PS RP++ +VL
Sbjct: 229 VTEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 101 bits (251), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 138/280 (49%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR ++ GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTELCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTXLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 67
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 124
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 125 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 180
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 181 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 233
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 234 TEGARDLISRLLKH--------------NPSQRPMLREVL 259
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 60
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 61 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 117
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 118 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 173
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 174 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 226
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 227 TEGARDLISRLLKH--------------NPSQRPMLREVL 252
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 62
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 63 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 119
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 120 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 175
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 176 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 228
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 229 TEGARDLISRLLKH--------------NPSQRPMLREVL 254
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG S A + SR +SGTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPS-SRRTTLSGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 91/296 (30%), Positives = 142/296 (47%), Gaps = 49/296 (16%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE---KLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRH 208
N+ + +VIGEG G V KAR + ++ AA+KR+ + A D R+F E+ L K+ H
Sbjct: 22 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 209 Q-NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-------------GPTHGSNLTWHLR 254
NII+LLG C H +L E +G+L L + S L+
Sbjct: 82 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+ A DVARG++YL + +HR+L + NIL+ ++ AK++DFGLS + + V +
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLS-----RGQEVYV 193
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTW 368
T+G ++A E L T SDV+++GV+L E++ +G P M+ C +
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE- 249
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+PQ R + P D + D M C + +P RP +L SL
Sbjct: 250 KLPQ-GYRLEKPLNCDDEVYDLMR------------QCWREKPYERPSFAQILVSL 292
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRAALCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPMLREVL 260
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 63
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 120
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 121 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 176
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 229
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 230 TEGARDLISRLLKH--------------NPSQRPMLREVL 255
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 80
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 81 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 137
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 138 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 193
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 194 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 246
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 247 TEGARDLISRLLKH--------------NPSQRPMLREVL 272
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 89
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 90 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 146
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 147 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 202
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 203 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 255
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 256 TEGARDLISRLLKH--------------NPSQRPMLREVL 281
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 65
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 66 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 122
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 123 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRXXLCGTLDYLPPE 178
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 231
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 232 TEGARDLISRLLKH--------------NPSQRPMLREVL 257
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 99.8 bits (247), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 64
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 121
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + R+ + GTL Y+ PE
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE 177
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 230
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 231 TEGARDLISRLLKH--------------NPSQRPMLREVL 256
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 99.4 bits (246), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 99.4 bits (246), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 89
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 90 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 146
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 147 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRDDLCGTLDYLPPE 202
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 203 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 255
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 256 TEGARDLISRLLKH--------------NPSQRPMLREVL 281
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 98.6 bits (244), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 66
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---LSKFDEQRTATYITELANA 123
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K+++FG SV A + SR + GTL Y+ PE
Sbjct: 124 LSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 179
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 232
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 233 TEGARDLISRLLKH--------------NPSQRPMLREVL 258
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 98.6 bits (244), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 83/280 (29%), Positives = 137/280 (48%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 65
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 66 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANA 122
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K+++FG SV A + SR + GTL Y+ PE
Sbjct: 123 LSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPS-SRRTTLCGTLDYLPPE 178
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
++EG++ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 231
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP++ +VL
Sbjct: 232 TEGARDLISRLLKH--------------NPSQRPMLREVL 257
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 98.2 bits (243), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 48/296 (16%)
Query: 161 IGEGGRGHVYKARF------NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V+ A +K+L AVK + D A ++F E LT ++H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDV 261
G C + +V+E M++G L K L HGP L + IA +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG----T 317
A G+ YL + VHRDL + N L+ ++ K+ DFG+S + + ++ G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS-TDYYRVGGHTMLP 198
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
+ ++ PE ++ K T +SDV++FGV+L E+ G++P ++S T+ +T ++ +R
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--RVLER 256
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD---VLHSLIPLVP 429
P + + D M + C Q EP R I + +LH+L P
Sbjct: 257 ---PRVCPKEVYDVM------------LGCWQREPQQRLNIKEIYKILHALGKATP 297
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
E N ++ G++D+ ++E+ + Q IG G G VYK +++ + + +
Sbjct: 14 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 68
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
+ F NEV L K RH NI+ +GY + +V + + SL LH
Sbjct: 69 TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 125
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
+ + IA A+G++YLH ++HRDLKS+NI L K+ DFGL+
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 182
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
S + ++SG++ ++APE + ++ DK SDVYAFG+VL EL+ G+ P
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
+ + Q MV + P L+ RS P + ++ + C++ +
Sbjct: 240 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 283
Query: 413 YRPLITDVLHSL 424
RPL +L S+
Sbjct: 284 ERPLFPQILASI 295
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 20 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
+ +V + + SL L H S + ++ + IA ARG++YLH ++H
Sbjct: 80 PQLA-IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
RDLKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ D
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 188
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
+SDVYAFG+VL EL+ G+ P
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLP 212
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
E N ++ G++D+ ++E+ + Q IG G G VYK +++ + + +
Sbjct: 13 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 67
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
+ F NEV L K RH NI+ +GY + +V + + SL LH
Sbjct: 68 TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 124
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
+ + IA A+G++YLH ++HRDLKS+NI L K+ DFGL+
Sbjct: 125 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 181
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
S + ++SG++ ++APE + ++ DK SDVYAFG+VL EL+ G+ P
Sbjct: 182 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 238
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
+ + Q MV + P L+ RS P + ++ + C++ +
Sbjct: 239 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 282
Query: 413 YRPLITDVLHSL 424
RPL +L S+
Sbjct: 283 ERPLFPQILASI 294
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 97.1 bits (240), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
A +V + + SL L H S + ++ + IA ARG++YLH ++H
Sbjct: 91 APQLAIVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
RDLKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ D
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 200
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
+SDVYAFG+VL EL+ G+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 85/309 (27%), Positives = 143/309 (46%), Gaps = 43/309 (13%)
Query: 129 NSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDA 188
N ++ G++D+ ++E+ + Q IG G G VYK +++ + + +
Sbjct: 9 NRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNVTAP 63
Query: 189 GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSN 248
+ F NEV L K RH NI+ +GY + +V + + SL LH +
Sbjct: 64 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--IIETK 120
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
+ IA A+G++YLH ++HRDLKS+NI L K+ DFGL+
Sbjct: 121 FEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 177
Query: 309 SRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEKM-S 358
S + ++SG++ ++APE + ++ DK SDVYAFG+VL EL+ G+ P + +
Sbjct: 178 SGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234
Query: 359 PTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRP 415
Q MV + P L+ RS P + ++ + C++ + RP
Sbjct: 235 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRDERP 278
Query: 416 LITDVLHSL 424
L +L S+
Sbjct: 279 LFPQILASI 287
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 86/312 (27%), Positives = 144/312 (46%), Gaps = 43/312 (13%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
E N ++ G++D+ ++E+ + Q IG G G VYK +++ + + +
Sbjct: 14 EDRNRMKTLGRRDSSD--DWEIPDGQITVGQR---IGSGSFGTVYKGKWHGDVAVKMLNV 68
Query: 186 DDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH 245
+ F NEV L K RH NI+ +GY + +V + + SL LH
Sbjct: 69 TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA-IVTQWCEGSSLYHHLH--II 125
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
+ + IA A+G++YLH ++HRDLKS+NI L K+ DFGL+
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEK 182
Query: 306 GTQSRN---VKISGTLGYVAPEYLLEGKLTDK------SDVYAFGVVLLELLMGRRPVEK 356
S + ++SG++ ++APE + ++ DK SDVYAFG+VL EL+ G+ P
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239
Query: 357 M-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
+ + Q MV + P L+ RS P + ++ + C++ +
Sbjct: 240 INNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAE----------------CLKKKRD 283
Query: 413 YRPLITDVLHSL 424
RPL +L S+
Sbjct: 284 ERPLFPQILASI 295
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 39/280 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLT 204
A +F+ +G+G G+VY AR + K + A+K +++ AG E + EV +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQS 68
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+RH NI+ L GY A +L+ E G++ ++L S ++A
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANA 125
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE
Sbjct: 126 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE 181
Query: 325 YLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
+EG+ D K D+++ GV+ E L+G+ P E + + ++ + T P+ V
Sbjct: 182 -XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFT----FPDFV 234
Query: 384 DPVIRDTMD--LKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
RD + LKH PS RP + +VL
Sbjct: 235 TEGARDLISRLLKH--------------NPSQRPXLREVL 260
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHPVVH 278
+ +V + + SL L H S + ++ + IA ARG++YLH ++H
Sbjct: 92 PQLA-IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTD-- 333
RDLKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ D
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDSN 200
Query: 334 ----KSDVYAFGVVLLELLMGRRP 353
+SDVYAFG+VL EL+ G+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
A +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 75 APQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
SDVYAFG+VL EL+ G+ P + + Q MV + P L+ RS P + ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ C++ + RPL +L S+
Sbjct: 247 AE----------------CLKKKRDERPLFPQILASI 267
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
+ +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 76 PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRP 353
SDVYAFG+VL EL+ G+ P
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP 208
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
+ +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 81 PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 191
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
SDVYAFG+VL EL+ G+ P + + Q MV + P L+ RS P + ++
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ C++ + RPL +L S+
Sbjct: 252 AE----------------CLKKKRDERPLFPQILASI 272
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
+ +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 81 PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 191
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
SDVYAFG+VL EL+ G+ P + + Q MV + P L+ RS P + ++
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 251
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ C++ + RPL +L S+
Sbjct: 252 AE----------------CLKKKRDERPLFPQILASI 272
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 18 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
+ +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 78 PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 188
Query: 335 ---SDVYAFGVVLLELLMGRRP 353
SDVYAFG+VL EL+ G+ P
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLP 210
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 38/277 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G VYK +++ + + + + F NEV L K RH NI+ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
+ +V + + SL LH + + IA A+G++YLH ++HRD
Sbjct: 76 PQLA-IVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRN---VKISGTLGYVAPEYLLEGKLTDK--- 334
LKS+NI L K+ DFGL+ S + ++SG++ ++APE + ++ DK
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPY 186
Query: 335 ---SDVYAFGVVLLELLMGRRPVEKM-SPTQCQSMV--TWAMPQLTD-RSKLPNIVDPVI 387
SDVYAFG+VL EL+ G+ P + + Q MV + P L+ RS P + ++
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ C++ + RPL +L S+
Sbjct: 247 AE----------------CLKKKRDERPLFPQILASI 267
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG G G V+ R + L AVK + D + +F E L + H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+ ++V E++Q G L T G+ L +++ D A G+EYL C +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
RDL + N L+ K+SDFG+S A R V + + APE L G+
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----WTAPEALNYGRY 292
Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
+ +SDV++FG++L E +G P +S Q + V
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDA-GHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG G G V+ R + L AVK + D + +F E L + H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+ ++V E++Q G L T G+ L +++ D A G+EYL C +H
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIH 236
Query: 279 RDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
RDL + N L+ K+SDFG+S A R V + + APE L G+
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK----WTAPEALNYGRY 292
Query: 332 TDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
+ +SDV++FG++L E +G P +S Q + V
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + + APE + G T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
+F +G+G G+VY AR + K + A+K +++ AG E + EV + +
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHL 69
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
RH NI+ L GY A +L+ E G++ ++L S ++A L
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALS 126
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y H + V+HRD+K N+LL S+ K++DFG SV A + SR + GTL Y+ PE +
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPE-M 181
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVE 355
+EG++ D K D+++ GV+ E L+G P E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 87
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 88 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 143
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + + APE + G T KSDV+
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 204 SFGILLTEIVTHGRIPYPGMT 224
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
L S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 40 LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+
Sbjct: 96 PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
M G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N
Sbjct: 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 212
Query: 287 LLDSSFN---AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
LL AK+ DFG++ AG + + ++ PE +EG T K+D ++F
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
GV+L E+ +G P S + VT
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 140
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 201 SFGILLTEIVTHGRIPYPGMT 221
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
L S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 17 LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 72
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+
Sbjct: 73 PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 132
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
M G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N
Sbjct: 133 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 189
Query: 287 LLDSSFN---AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
LL AK+ DFG++ AG + + ++ PE +EG T K+D ++F
Sbjct: 190 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 249
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
GV+L E+ +G P S + VT
Sbjct: 250 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 277
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 81 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 197 SFGILLTEIVTHGRIPYPGMT 217
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 86
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 87 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 142
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 203 SFGILLTEIVTHGRIPYPGMT 223
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + + APE + G T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
+F +G+G G+VY AR + K + A+K +++ AG E + EV + +
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAG--VEHQLRREVEIQSHL 69
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
RH NI+ L GY A +L+ E G++ ++L S ++A L
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELANALS 126
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y H + V+HRD+K N+LL S+ K++DFG SV A + R+ + GTL Y+ PE +
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-LCGTLDYLPPE-M 181
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVE 355
+EG++ D K D+++ GV+ E L+G P E
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 159 NVIGEGGRGHVYKARFN-----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNII 212
VIG G G VYK +++ A+K + + +R +F E + + H NII
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLH 269
L G + ++ E M+NG+L+K L G L LR +A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR-----GIAAGMKYL- 163
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISG---TLGYVAPEY 325
N VHRDL + NIL++S+ K+SDFGLS V SG + + APE
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 326 LLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
+ K T SDV++FG+V+ E++ G RP ++S + M + D +LP +D
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPTPMD 274
Query: 385 PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
+YQ + + C Q E + RP D++ L L+
Sbjct: 275 CP-------SAIYQ---LMMQCWQQERARRPKFADIVSILDKLI 308
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 80 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 135
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 196 SFGILLTEIVTHGRIPYPGMT 216
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 140
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 201 SFGILLTEIVTHGRIPYPGMT 221
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 84 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 200 SFGILLTEIVTHGRIPYPGMT 220
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 92.4 bits (228), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT 215
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 74 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 190 SFGILLTEIVTHGRIPYPGMT 210
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 88
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HRD
Sbjct: 89 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRD 144
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 205 SFGILLTEIVTHGRIPYPGMT 225
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV+E M++G L L T + + +DV G+ YL E C V+HRD
Sbjct: 77 QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 131
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 192 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 237
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 238 QIMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 269
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV+E M++G L L T + + +DV G+ YL E C V+HRD
Sbjct: 72 QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 126
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 232
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 233 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 264
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
L S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 6 LRTSTIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 61
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+
Sbjct: 62 PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 121
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
M G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N
Sbjct: 122 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 178
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
LL AK+ DFG++ S K + ++ PE +EG T K+D ++F
Sbjct: 179 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 238
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
GV+L E+ +G P S + VT
Sbjct: 239 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 266
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 91.7 bits (226), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV+E M++G L L T + + +DV G+ YL E C V+HRD
Sbjct: 74 QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 234
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 235 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 266
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKE-GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV+E M++G L L T + + +DV G+ YL E C V+HRD
Sbjct: 94 QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 148
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 209 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 254
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 255 QIMN---HCWKERPEDRPAFSRLLRQLAEIAESGL 286
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 29 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 89 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 146
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 147 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 201
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 261
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 262 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 310
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 3 STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
L AVK + + E +F E ++K+ HQNI+ +G + + RF++ E+M
Sbjct: 59 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N LL
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
AK+ DFG++ S K + ++ PE +EG T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
L E+ +G P S + VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
L S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 26 LRTSTIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 81
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+
Sbjct: 82 PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 141
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
M G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N
Sbjct: 142 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 198
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
LL AK+ DFG++ S K + ++ PE +EG T K+D ++F
Sbjct: 199 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 258
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
GV+L E+ +G P S + VT
Sbjct: 259 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 286
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 72 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 130 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 184
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 244
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 72 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 129
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 130 GMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 184
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 244
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 293
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 78/268 (29%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 119 LSLSPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN-- 175
L S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 16 LRTSTIMTDYNPNYCFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 71
Query: 176 ----EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEM 230
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+
Sbjct: 72 PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 131
Query: 231 MQNGSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNI 286
M G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N
Sbjct: 132 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNC 188
Query: 287 LLDSSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAF 340
LL AK+ DFG++ S K + ++ PE +EG T K+D ++F
Sbjct: 189 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 248
Query: 341 GVVLLELL-MGRRPVEKMSPTQCQSMVT 367
GV+L E+ +G P S + VT
Sbjct: 249 GVLLWEIFSLGYMPYPSKSNQEVLEFVT 276
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 3 STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+M
Sbjct: 59 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N LL
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
AK+ DFG++ S K + ++ PE +EG T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
L E+ +G P S + VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 14 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 70 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 129
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 247 PSKSNQEVLEFVT 259
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 26/265 (9%)
Query: 122 SPILERFN-SLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN----- 175
S I+ +N + AGK ++S +L E N +G G G VY+ + +
Sbjct: 3 STIMTDYNPNYSFAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPND 58
Query: 176 -EKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQN 233
L AVK + + E +F E ++K HQNI+ +G + + RF++ E+M
Sbjct: 59 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 118
Query: 234 GSLEKQLHG----PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
G L+ L P+ S+L + +A D+A G +YL E NH +HRD+ + N LL
Sbjct: 119 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLT 175
Query: 290 SSFN---AKLSDFGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVV 343
AK+ DFG++ S K + ++ PE +EG T K+D ++FGV+
Sbjct: 176 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 344 LLELL-MGRRPVEKMSPTQCQSMVT 367
L E+ +G P S + VT
Sbjct: 236 LWEIFSLGYMPYPSKSNQEVLEFVT 260
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 29 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K+ HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 85 EVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 262 PSKSNQEVLEFVT 274
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 14 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 70 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 129
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 186
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 247 PSKSNQEVLEFVT 259
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 6 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 61
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 62 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 121
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 122 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 178
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 179 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 238
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 239 PSKSNQEVLEFVT 251
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 39 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 99 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 157 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 211
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 271
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 272 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 320
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 26/274 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + AVK I + G +E EF E + K+ H ++ G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
++V E + NG L L +HG L +++ DV G+ +L +H +HRD
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+D K+SDFG++ V +V + + APE K + KSDV+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
AFG+++ E+ +G+ P + + ++ V+ R P++ I Y
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-----HRLYRPHLASDTI---------Y 235
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTD 431
Q+ C P RP +L S+ PL D
Sbjct: 236 QIMYS---CWHELPEKRPTFQQLLSSIEPLREKD 266
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 84/289 (29%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGLS A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 29 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 D-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 85 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 262 PSKSNQEVLEFVT 274
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + F E N + +++HQ ++ L +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M+NGSL L P+ G LT + + +A +A G+ ++ E N+ +HR+
Sbjct: 75 QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER-NY--IHRN 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + + K++DFGL+ + + + APE + G T KSDV+
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L E++ GR P M+
Sbjct: 191 SFGILLTEIVTHGRIPYPGMT 211
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/238 (31%), Positives = 111/238 (46%), Gaps = 19/238 (7%)
Query: 139 TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFN 197
++ I+ L F+ ++G G G VYK R LAA+K +D G D E E
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIK 68
Query: 198 NEVNWLTKI-RHQNIISLLGYCIHA------ETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
E+N L K H+NI + G I + +LV E GS+ + T G+ L
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLK 127
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG-TQS 309
I ++ RGL +LH+H V+HRD+K N+LL + KL DFG+S T
Sbjct: 128 EEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 310 RNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGRRPVEKMSPTQC 362
R GT ++APE + + D KSD+++ G+ +E+ G P+ M P +
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 25/253 (9%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFN------EKLLAAVKRID 186
AGK ++S +L E N +G G G VY+ + + L AVK +
Sbjct: 29 FAGKTSSIS----DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 84
Query: 187 DA-GHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--- 242
+ E +F E ++K HQNI+ +G + + RF++ E+M G L+ L
Sbjct: 85 EVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 144
Query: 243 -PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSD 298
P+ S+L + +A D+A G +YL E NH +HRD+ + N LL AK+ D
Sbjct: 145 RPSQPSSLAMLDLLHVARDIACGCQYLEE--NH-FIHRDIAARNCLLTCPGPGRVAKIGD 201
Query: 299 FGLSVTAGTQSRNVKISGTL---GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPV 354
FG++ S K + ++ PE +EG T K+D ++FGV+L E+ +G P
Sbjct: 202 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 261
Query: 355 EKMSPTQCQSMVT 367
S + VT
Sbjct: 262 PSKSNQEVLEFVT 274
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGL+ A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 89.7 bits (221), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV E M++G L L T + + +DV G+ YL E C V+HRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 190 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 235
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 236 QIMN---HCWRERPEDRPAFSRLLRQLAEIAESGL 267
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 43/289 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWL 203
E N V+G G G V R +++ A+K + + +R +F E + +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+ H NII L G ++ +V E M+NGSL+ L H + T + + +A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIAS 158
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGT 317
G++YL + VHRDL + NIL++S+ K+SDFGL A +R KI
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP-- 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PT 360
+ + +PE + K T SDV+++G+VL E++ G RP +MS P
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
Query: 361 QC-----QSMVTWAMPQLTDRSKLPNIV---DPVIRDTMDLKHLYQVAA 401
C Q M+ +R K IV D +IR+ LK + AA
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 89.4 bits (220), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + E F E + K+RH+ ++ L +
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 77 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 132
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 193 SFGILLTELTTKGRVPYPGM 212
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 145
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V ++ +V + + PE L+ K + KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSE 229
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G G G VY+ + + L AVK + + + E EF E + +I+H N++ LLG C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
+++ E M G+L L + ++ + + +A ++ +EYL + +HR
Sbjct: 78 REPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
DL + N L+ + K++DFGLS +T T + + + + APE L K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
+AFGV+L E+ G P + P+Q ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 20/237 (8%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG+G G V + +A +DA A F E + +T++RH N++ LLG
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 255
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+ + ++V E M GSL L S L +K ++DV +EYL + V
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
HRDL + N+L+ AK+SDFGL+ A + K+ + + APE L E K + KSDV
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 369
Query: 338 YAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKL--PNIVDPVIRDTM 391
++FG++L E+ GR P ++ +P++ K+ P+ P + D M
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGCPPAVYDVM 419
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 29/285 (10%)
Query: 153 NNFQESNVIGEGGRGHV---YKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRH 208
++++ VIG G V Y A EK+ A+KRI+ + + E E+ +++ H
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKV--AIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR----MKIAVDVAR 263
NI+S + + +LV +++ GS L+ H G + + L I +V
Sbjct: 68 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRN---VKISGT 317
GLEYLH++ +HRD+K+ NILL + +++DFG+S T G +RN GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 318 LGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
++APE + + + D K+D+++FG+ +EL G P K P + + LT +
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLTLQ 236
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+ P++ V M K+ + LC+Q +P RP ++L
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 80/285 (28%), Positives = 138/285 (48%), Gaps = 29/285 (10%)
Query: 153 NNFQESNVIGEGGRGHV---YKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRH 208
++++ VIG G V Y A EK+ A+KRI+ + + E E+ +++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKV--AIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR----MKIAVDVAR 263
NI+S + + +LV +++ GS L+ H G + + L I +V
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRN---VKISGT 317
GLEYLH++ +HRD+K+ NILL + +++DFG+S T G +RN GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 318 LGYVAPEYLLEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR 376
++APE + + + D K+D+++FG+ +EL G P K P + + LT +
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VLMLTLQ 241
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+ P++ V M K+ + LC+Q +P RP ++L
Sbjct: 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 76/246 (30%), Positives = 122/246 (49%), Gaps = 21/246 (8%)
Query: 122 SPILERFNSLRLAG-KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NE 176
SP+L+ + L+ + V +++ ++ ++ + VIG G G VY +
Sbjct: 17 SPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK 76
Query: 177 KLLAAVK---RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQ 232
K+ AVK RI D G ++ F E + H N++SLLG C+ +E + +V M+
Sbjct: 77 KIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 134
Query: 233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF 292
+G L + TH N T + + VA+G++YL + VHRDL + N +LD F
Sbjct: 135 HGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 189
Query: 293 NAKLSDFGLSVTAGTQ---SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
K++DFGL+ + S + K L ++A E L K T KSDV++FGV+L EL
Sbjct: 190 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 249
Query: 348 LMGRRP 353
+ P
Sbjct: 250 MTRGAP 255
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 88.6 bits (218), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 125
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V + +V + + PE L+ K + KSD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSE 209
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V + R ++ A+K + + +R EF +E + + + H NII L
Sbjct: 21 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
G ++ ++ E M+NG+L+ L + T + + +A G+ YL E
Sbjct: 81 EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEYLLE 328
VHRDL + NIL++S+ K+SDFGLS S + + +LG + APE +
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
K T SD +++G+V+ E++ G RP MS P C Q M+
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 255
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLK 394
R + P +V D +IR+ LK
Sbjct: 256 DCWQKDRNARPRFPQVVSALDKMIRNPASLK 286
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 75 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V + +V + + PE L+ K + KSD++
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSE 213
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG G G V+ + K A+K I + G +E +F E + K+ H ++ L G C+
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
LV+E M++G L L T + + +DV G+ YL E V+HRD
Sbjct: 74 QAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L+ + K+SDFG++ V + + + + +PE + + KSDV+
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FGV++ E+ G+ P E S ++ + D S + P + T H+Y
Sbjct: 189 SFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKPRLAST----HVY 234
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLIPLVPTDL 432
Q+ C + P RP + +L L + + L
Sbjct: 235 QIMN---HCWKERPEDRPAFSRLLRQLAAIAASGL 266
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V + +V + + PE L+ K + KSD++
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSE 214
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG+G G V + +A +DA A F E + +T++RH N++ LLG
Sbjct: 12 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+ + ++V E M GSL L S L +K ++DV +EYL + V
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 124
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
HRDL + N+L+ AK+SDFGL+ A + K+ + + APE L E K + KSDV
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
++FG++L E+ GR P ++
Sbjct: 183 WSFGILLWEIYSFGRVPYPRI 203
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + KIRH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G G G VY+ + + L AVK + + + E EF E + +I+H N++ LLG C
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
+++ E M G+L L + ++ + + +A ++ +EYL +HR
Sbjct: 78 REPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
DL + N L+ + K++DFGLS +T T + + + + APE L K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
+AFGV+L E+ G P + P+Q ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTA----GTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
L + N L++ K+SDFGLS T SR K + + PE L+ K + KSD
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP--VRWSPPEVLMYSKFSSKSD 188
Query: 337 VYAFGVVLLELL-MGRRPVEKMSPTQ 361
++AFGV++ E+ +G+ P E+ + ++
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSE 214
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 76/246 (30%), Positives = 122/246 (49%), Gaps = 21/246 (8%)
Query: 122 SPILERFNSLRLAG-KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NE 176
SP+L+ + L+ + V +++ ++ ++ + VIG G G VY +
Sbjct: 16 SPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK 75
Query: 177 KLLAAVK---RIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQ 232
K+ AVK RI D G ++ F E + H N++SLLG C+ +E + +V M+
Sbjct: 76 KIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 133
Query: 233 NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF 292
+G L + TH N T + + VA+G++YL + VHRDL + N +LD F
Sbjct: 134 HGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKF 188
Query: 293 NAKLSDFGLSVTAGTQ---SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
K++DFGL+ + S + K L ++A E L K T KSDV++FGV+L EL
Sbjct: 189 TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 248
Query: 348 LMGRRP 353
+ P
Sbjct: 249 MTRGAP 254
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 88.2 bits (217), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG+G G V + +A +DA A F E + +T++RH N++ LLG
Sbjct: 27 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 83
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+ + ++V E M GSL L S L +K ++DV +EYL + V
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
HRDL + N+L+ AK+SDFGL+ A + K+ + + APE L E K + KSDV
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREKKFSTKSDV 197
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
++FG++L E+ GR P ++
Sbjct: 198 WSFGILLWEIYSFGRVPYPRI 218
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDD-AGHDAE--REFNNEVNWLTKIRHQ 209
+F+ N++G+G VY+A + L A+K ID A + A + NEV +++H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH--GSNLTWHLRMKIAVDVARGLEY 267
+I+ L Y + +LV EM NG + + L N H +I G+ Y
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----GMLY 127
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYL 326
LH +H ++HRDL SN+LL + N K++DFGL+ ++ + GT Y++PE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+SDV++ G + LL+GR P +
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + ++ +A G+ Y+ E N+ VHRD
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
L+++NIL+ + K++DFGL+ T + K + + APE L G+ T KSD
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP--IKWTAPEAALYGRFTIKSD 194
Query: 337 VYAFGVVLLELLM-GRRPVEKM 357
V++FG++L EL GR P M
Sbjct: 195 VWSFGILLTELTTKGRVPYPGM 216
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
+ V+G G G VYK + K+ A+K +++ G A EF +E + +
Sbjct: 38 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H +++ LLG C+ + T LV ++M +G L + +H H N+ L + V +A+G+
Sbjct: 98 DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMM 154
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL E +VHRDL + N+L+ S + K++DFGL+ + G + ++A
Sbjct: 155 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
E + K T +SDV+++GV + EL+ G +P + + PT+
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTR 249
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + ++ +A G+ Y+ E N+ VHRD
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYV-ERMNY--VHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 197 SFGILLTELTTKGRVPYPGM 216
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 145
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V + +V + + PE L+ K + KSD++
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSE 229
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V ++ + A+K I + G +E EF E + + H+ ++ L G C
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
F++ E M NG L L H L M DV +EYL + +HRD
Sbjct: 82 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYLE---SKQFLHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
L + N L++ K+SDFGLS V + +V + + PE L+ K + KSD++
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQ 361
AFGV++ E+ +G+ P E+ + ++
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSE 220
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 74 EEPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 129
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 190 SFGILLTELTTKGRVPYPGM 209
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G G G VY+ + + L AVK + + + E EF E + +I+H N++ LLG C
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
+++ E M G+L L + ++ + + +A ++ +EYL +HR
Sbjct: 78 REPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
DL + N L+ + K++DFGLS +T T + + + + APE L K + KSDV
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 338 YAFGVVLLEL-LMGRRPVEKMSPTQCQSMV 366
+AFGV+L E+ G P + P+Q ++
Sbjct: 194 WAFGVLLWEIATYGMSPYPGIDPSQVYELL 223
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
++F +G+G G+VY AR + K + A+K +++ G E + E+ + +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHL 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
RH NI+ + Y + +L+ E G L K+L HG ++A L
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHG-RFDEQRSATFMEELADALH 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y HE V+HRD+K N+L+ K++DFG SV A + R + GTL Y+ PE +
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-MCGTLDYLPPE-M 183
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
+EGK D K D++ GV+ E L+G P + S T+ +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 128
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 189 SFGILLTELTTKGRVPYPGM 208
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V R ++ A+K + D +R +F +E + + + H NII L
Sbjct: 36 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
G + ++ E M+NGSL+ L + T + + + G++YL +
Sbjct: 96 EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLSDMS-- 151
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
VHRDL + NIL++S+ K+SDFG+S A +R KI + + APE +
Sbjct: 152 -AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 208
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
K T SDV+++G+V+ E++ G RP MS P C Q M+
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 268
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
+ +DR K IV D +IR+ LK
Sbjct: 269 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 300
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 305
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 366 SFGILLTELTTKGRVPYPGM 385
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 75 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 130
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 191 SFGILLTELTTKGRVPYPGM 210
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G T G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 388
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 449 SFGILLTELTTKGRVPYPGM 468
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 21/237 (8%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
++F +G+G G+VY AR + K + A+K +++ G E + E+ + +
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHL 72
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
RH NI+ + Y + +L+ E G L K+L HG ++A L
Sbjct: 73 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHG-RFDEQRSATFMEELADALH 129
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y HE V+HRD+K N+L+ K++DFG SV A + R + GTL Y+ PE +
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-MCGTLDYLPPE-M 184
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA----MPQLTDRSK 378
+EGK D K D++ GV+ E L+G P + S T+ + P L+D SK
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 241
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 87.4 bits (215), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V R ++ A+K + D +R +F +E + + + H NII L
Sbjct: 15 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
G + ++ E M+NGSL+ L + T + + + G++YL +
Sbjct: 75 EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
VHRDL + NIL++S+ K+SDFG+S A +R KI + + APE +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 187
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
K T SDV+++G+V+ E++ G RP MS P C Q M+
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 247
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
+ +DR K IV D +IR+ LK
Sbjct: 248 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 279
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 17/219 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
+ V+G G G VYK + K+ A+K +++ G A EF +E + +
Sbjct: 15 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H +++ LLG C+ + T LV ++M +G L + +H H N+ L + V +A+G+
Sbjct: 75 DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVH--EHKDNIGSQLLLNWCVQIAKGMM 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL E +VHRDL + N+L+ S + K++DFGL+ + G + ++A
Sbjct: 132 YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQ 361
E + K T +SDV+++GV + EL+ G +P + + PT+
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTR 226
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V + R ++ A+K + + +R EF +E + + + H NII L
Sbjct: 23 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
G ++ ++ E M+NG+L+ L + T + + +A G+ YL E
Sbjct: 83 EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 138
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEYLLE 328
VHRDL + NIL++S+ K+SDFGLS S + + +LG + APE +
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
K T SD +++G+V+ E++ G RP MS P C Q M+
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 257
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLK 394
R + P +V D +IR+ LK
Sbjct: 258 DCWQKDRNARPRFPQVVSALDKMIRNPASLK 288
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V R ++ A+K + D +R +F +E + + + H NII L
Sbjct: 21 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
G + ++ E M+NGSL+ L + T + + + G++YL +
Sbjct: 81 EGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYLLE 328
VHRDL + NIL++S+ K+SDFG+S A +R KI + + APE +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP--IRWTAPEAIAY 193
Query: 329 GKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQC-----QSMV 366
K T SDV+++G+V+ E++ G RP MS P C Q M+
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLML 253
Query: 367 TWAMPQLTDRSKLPNIV---DPVIRDTMDLKH 395
+ +DR K IV D +IR+ LK
Sbjct: 254 DCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 285
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVCEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 70/242 (28%), Positives = 112/242 (46%), Gaps = 35/242 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR------FNEKLLAAVKRI-DDAGHDAEREFNNEVN 201
E NN + IGEG G V++AR + + AVK + ++A D + +F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-------HGSNLTWHLR 254
+ + + NI+ LLG C + L++E M G L + L + S+L+ R
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 255 MK--------------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFG 300
+ IA VA G+ YL E VHRDL + N L+ + K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 301 LS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
LS +A + + + ++ PE + + T +SDV+A+GVVL E+ G +P
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 357 MS 358
M+
Sbjct: 280 MA 281
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL + L H + ++ + +G+EYL
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 196 KFSVASDVWSFGVVLYELF 214
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 74/242 (30%), Positives = 127/242 (52%), Gaps = 34/242 (14%)
Query: 161 IGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDAE---REFNNEVNWLTKIRHQNIISL 214
+G GG VY A N K+ A+K I + E + F EV+ +++ HQNI+S+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKV--AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQL--HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+ + +LV E ++ +L + + HGP L+ + + G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAH--- 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFG----LSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ +VHRD+K NIL+DS+ K+ DFG LS T+ TQ+ +V GT+ Y +PE +
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV--LGTVQYFSPEQ-AK 185
Query: 329 GKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
G+ TD+ +D+Y+ G+VL E+L+G P ++ V+ A+ + D +PN+ V
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPF------NGETAVSIAIKHIQD--SVPNVTTDVR 237
Query: 388 RD 389
+D
Sbjct: 238 KD 239
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 159 NVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IG+G G V + +A +DA A F E + +T++RH N++ LLG
Sbjct: 18 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 74
Query: 219 IHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+ + ++V E M GSL L S L +K ++DV +EYL + V
Sbjct: 75 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFV 130
Query: 278 HRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
HRDL + N+L+ AK+SDFGL+ A + K+ + + APE L E + KSDV
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTAPEALREAAFSTKSDV 188
Query: 338 YAFGVVLLELL-MGRRPVEKM 357
++FG++L E+ GR P ++
Sbjct: 189 WSFGILLWEIYSFGRVPYPRI 209
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 17/222 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
++F +G+G G+VY AR + K + A+K +++ G E + E+ + +
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHL 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
RH NI+ + Y + +L+ E G L K+L HG ++A L
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHG-RFDEQRSATFMEELADALH 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y HE V+HRD+K N+L+ K++DFG SV A + R + GTL Y+ PE +
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRX-MCGTLDYLPPE-M 183
Query: 327 LEGKLTD-KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVT 367
+EGK D K D++ GV+ E L+G P + S T+ +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQA--HAERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 196 KFSVASDVWSFGVVLYELF 214
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 14 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 74 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 129
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAG 306
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+
Sbjct: 130 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 307 TQSRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 187 XXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
+F+E +IG GG G V+KA+ + +KR+ AERE V L K+ H NI+
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 213 SL----LGYCIHAETR------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
G+ ET F+ E G+LE+ + G L L ++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALE 126
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
+ + +G++Y+H + +++RDLK SNI L + K+ DFGL + + + G
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKG 183
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
TL Y++PE + + D+YA G++L ELL
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 7 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 67 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 122
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 123 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 179
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 180 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 72 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 127
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 128 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 185 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G+ + F E + K+RH+ ++ L +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 306
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL + + + APE L G+ T KSDV+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 367 SFGILLTELTTKGRVPYPGM 386
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 15 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 75 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 131 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 136
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ K+ + + APE L E
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 197 KFSVASDVWSFGVVLYELF 215
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 163
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 224 KFSVASDVWSFGVVLYELF 242
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 131
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ K+ + + APE L E
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 192 KFSVASDVWSFGVVLYELF 210
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 130
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 191 KFSVASDVWSFGVVLYELF 209
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 15 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 75 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 131 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 188 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M GSL L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L ++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 13 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 73 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 128
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 129 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 186 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 193 KFSVASDVWSFGVVLYELF 211
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 14 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 74 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 129
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 130 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 187 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 70 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 125
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ- 308
T + + VA+G++YL + VHRDL + N +LD F K++DFGL+ +
Sbjct: 126 TVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 309 --SRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 193 KFSVASDVWSFGVVLYELF 211
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 139
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 200 KFSVASDVWSFGVVLYELF 218
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 85.9 bits (211), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 137
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 198 KFSVASDVWSFGVVLYELF 216
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 85.9 bits (211), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 211 KFSVASDVWSFGVVLYELF 229
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M G L L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVMEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V R+ N AVK + ++G + + E+ L + H+NI+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 215 LGYCIH--AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
G C L+ E + +GSL++ L P + + + ++K AV + +G++YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG--- 131
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLE 328
+ VHRDL + N+L++S K+ DFGL+ T + + + APE L++
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 329 GKLTDKSDVYAFGVVLLELLM----GRRP----VEKMSPTQCQSMVTWAMPQLTDRSKLP 380
K SDV++FGV L ELL P ++ + PT Q VT + L + +LP
Sbjct: 192 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 251
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 135
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 196 KFSVASDVWSFGVVLYELF 214
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 64
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 65 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 123
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 180
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEI 206
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 138
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 199 KFSVASDVWSFGVVLYELF 217
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 69/240 (28%), Positives = 114/240 (47%), Gaps = 25/240 (10%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISL 214
+GEG G V R+ N AVK + ++G + + E+ L + H+NI+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 215 LGYCIH--AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
G C L+ E + +GSL++ L P + + + ++K AV + +G++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLE 328
+ VHRDL + N+L++S K+ DFGL+ T + + + APE L++
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 329 GKLTDKSDVYAFGVVLLELLM----GRRPV----EKMSPTQCQSMVTWAMPQLTDRSKLP 380
K SDV++FGV L ELL P+ + + PT Q VT + L + +LP
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 128 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G+G G V+ +N A+K + G + F E + K+RH+ ++ L +
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E ++V E M G L L G G L + +A +A G+ Y+ E N+ VHRD
Sbjct: 84 EEPIYIVTEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYV-ERMNY--VHRD 139
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ + K++DFGL+ + + + APE L G+ T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 339 AFGVVLLELLM-GRRPVEKM 357
+FG++L EL GR P M
Sbjct: 200 SFGILLTELTTKGRVPYPGM 219
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ K+ + + APE L E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 193 KFSVASDVWSFGVVLYELF 211
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 150
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
+HRDL + NIL+++ K+ DFGL+ + + VK G + + APE L E
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 211 KFSVASDVWSFGVVLYELF 229
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 126
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 127 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEI 209
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 85.5 bits (210), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 63
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 122
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 123 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEI 205
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
V+G+G G VY R + ++ A+K I + + + E+ ++H+NI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 219 IHAETRFL--VYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
+E F+ E + GSL L GP + T K + GL+YLH +
Sbjct: 88 -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK---QILEGLKYLH---D 140
Query: 274 HPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK- 330
+ +VHRD+K N+L+++ S K+SDFG S AG +GTL Y+APE + +G
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 331 -LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
+D+++ G ++E+ G+ P ++ Q +M M + V P I +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFK----------VHPEIPE 249
Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+M + A + C +P+P R D+L
Sbjct: 250 SMSA----EAKAFILKCFEPDPDKRACANDLL 277
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 16 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 76 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 131
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAG 306
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 132 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE 188
Query: 307 TQSRNVKISGTL--GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
S + K L ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
V+G+G G VY R + ++ A+K I + + + E+ ++H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 219 IHAETRFL--VYEMMQNGSLEKQLH---GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
+E F+ E + GSL L GP + T K + GL+YLH +
Sbjct: 74 -FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK---QILEGLKYLH---D 126
Query: 274 HPVVHRDLKSSNILLDS-SFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK- 330
+ +VHRD+K N+L+++ S K+SDFG S AG +GTL Y+APE + +G
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 331 -LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRD 389
+D+++ G ++E+ G+ P ++ Q +M M + V P I +
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFK----------VHPEIPE 235
Query: 390 TMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+M + A + C +P+P R D+L
Sbjct: 236 SMSA----EAKAFILKCFEPDPDKRACANDLL 263
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 85.1 bits (209), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 10 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 68
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 69 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 127
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 128 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 184
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEI 210
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNII 212
+IG G G V R + A+K + AG+ R+F +E + + + H NII
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
L G +V E M+NGSL+ L TH T + + V G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYL 326
+ VHRDL + N+L+DS+ K+SDFGLS A + KI + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP--IRWTAPEAI 226
Query: 327 LEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
+ SDV++FGVV+ E+L G RP M+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 18 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 76
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 77 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 136 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 192
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEI 218
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + + +
Sbjct: 125 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 20 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 80 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 135
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 136 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 192
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 193 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 15 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 75 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 131 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 84.7 bits (208), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 134 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 189
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 190 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 15 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 75 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 130
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 131 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 188 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 16 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 76 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 131
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 132 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 188
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 189 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 138 DTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVK---RIDDAGH 190
+ V +++ ++ ++ + VIG G G VY +K+ AVK RI D G
Sbjct: 13 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNL 249
++ F E + H N++SLLG C+ +E + +V M++G L + TH N
Sbjct: 73 VSQ--FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NP 128
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
T + + VA+G+++L + VHRDL + N +LD F K++DFGL+ +
Sbjct: 129 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 310 RNVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + T + ++A E L K T KSDV++FGV+L EL+ P
Sbjct: 186 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 159 NVIGEGGRGHVYKARFNEK----LLAAVK--RIDDAGHDAEREFNNEVNWLTKIRHQNII 212
++GEG G V + ++ L AVK ++D++ EF +E + H N+I
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 213 SLLGYCIHAETR-----FLVYEMMQNGSLEKQL------HGPTHGSNLTWHLRMKIAVDV 261
LLG CI ++ ++ M+ G L L GP H + +K VD+
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH---IPLQTLLKFMVDI 156
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT-L 318
A G+EYL N +HRDL + N +L ++DFGLS + +G R +I+ +
Sbjct: 157 ALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
++A E L + T KSDV+AFGV + E+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEI 242
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 36/244 (14%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-----FNNEVNW 202
+ +Q+ +GEG G VYKA+ ++ + A+KRI DAE E E++
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISL 72
Query: 203 LTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV-D 260
L ++ H NI+SL+ IH+E LV+E M+ L+K L G + ++KI +
Sbjct: 73 LKELHHPNIVSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQ 127
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLG 319
+ RG+ + H+H ++HRDLK N+L++S KL+DFGL+ G R+ TL
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
Y AP+ L+ K S D+++ G + E++ G +P+ P +TD +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL---------------FPGVTDDDQ 228
Query: 379 LPNI 382
LP I
Sbjct: 229 LPKI 232
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 76/244 (31%), Positives = 123/244 (50%), Gaps = 36/244 (14%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE-----FNNEVNW 202
+ +Q+ +GEG G VYKA+ ++ + A+KRI DAE E E++
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISL 72
Query: 203 LTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV-D 260
L ++ H NI+SL+ IH+E LV+E M+ L+K L G + ++KI +
Sbjct: 73 LKELHHPNIVSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQ 127
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLG 319
+ RG+ + H+H ++HRDLK N+L++S KL+DFGL+ G R+ TL
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 320 YVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
Y AP+ L+ K S D+++ G + E++ G +P+ P +TD +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL---------------FPGVTDDDQ 228
Query: 379 LPNI 382
LP I
Sbjct: 229 LPKI 232
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 6 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 64
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 65 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 123
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + +
Sbjct: 124 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 180
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEI 206
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 159 NVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNII 212
+IG G G V R + A+K + AG+ R+F +E + + + H NII
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
L G +V E M+NGSL+ L TH T + + V G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEYL 326
+ VHRDL + N+L+DS+ K+SDFGLS A + KI + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP--IRWTAPEAI 226
Query: 327 LEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS 358
+ SDV++FGVV+ E+L G RP M+
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 7 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 65
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 66 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 124
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HRDL + N L+ + K++DFGLS +T T + + +
Sbjct: 125 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWT 181
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEI 207
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 76 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 132
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 79 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 135
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 68/277 (24%), Positives = 130/277 (46%), Gaps = 29/277 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
E +L T +SDV+++GV + EL+ G +P + + ++ S+ L +LP
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLPQP 241
Query: 383 VDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITD 419
I M ++ + + A P +R LI +
Sbjct: 242 PICTIDVYMIMRKCWMIDA------DSRPKFRELIIE 272
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 78 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 77 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 154 NFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
+F+E +IG GG G V+KA+ + ++R+ AERE V L K+ H NI+
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 213 SL----LGYCIHAETR-------------------------FLVYEMMQNGSLEKQLHGP 243
G+ ET F+ E G+LE+ +
Sbjct: 69 HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-K 127
Query: 244 THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV 303
G L L +++ + +G++Y+H + ++HRDLK SNI L + K+ DFGL
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
+ + + GTL Y++PE + + D+YA G++L ELL
Sbjct: 185 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 80/276 (28%), Positives = 135/276 (48%), Gaps = 29/276 (10%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAE------REFNNEV 200
+++ +++ + +GEG VYKAR N + A+K+I GH +E R E+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREI 63
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTW---HLRMKI 257
L ++ H NII LL H LV++ M E L ++L H++ +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-----ETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-G 316
+ + +GLEYLH+H ++HRDLK +N+LLD + KL+DFGL+ + G+ +R
Sbjct: 119 LMTL-QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174
Query: 317 TLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLM------GRRPVEKMSPTQCQSMVTWA 369
T Y APE L ++ D++A G +L ELL+ G +++++ +++ T
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-FETLGTPT 233
Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVL 405
Q D LP+ V + L H++ A +L
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 269
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 9/216 (4%)
Query: 146 ELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTK 205
++ E + Q +G G G V+ +N A+K + G + F E + K
Sbjct: 2 DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKK 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
++H ++ L + E ++V E M GSL L G L + +A VA G+
Sbjct: 61 LKHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGM 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAP 323
Y+ E N+ +HRDL+S+NIL+ + K++DFGL+ + + + AP
Sbjct: 119 AYI-ERMNY--IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAP 175
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMS 358
E L G+ T KSDV++FG++L EL+ GR P M+
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 25 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 85 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 141
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 142 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 125
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 78 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 77 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 16 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 76 DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 132
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 78 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 78 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 134
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N + AVK++ + + R+F E+ L ++H NI+
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 216 GYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G C A R L+ E + GSL L H + ++ + +G+EYL
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYL---GT 133
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI----SGTLGYVAPEYLLEG 329
+HR+L + NIL+++ K+ DFGL+ K+ + + APE L E
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 330 KLTDKSDVYAFGVVLLELL 348
K + SDV++FGVVL EL
Sbjct: 194 KFSVASDVWSFGVVLYELF 212
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 82 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 21 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 81 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 138 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 40 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 156
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 157 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V ++ A+K + + +R +F +E + + + H N+I L
Sbjct: 40 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + ++ E M+NGSL+ +Q G L LR +A G++YL
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--- 151
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEY 325
+ VHRDL + NIL++S+ K+SDFGLS + + + LG + APE
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQCQSMVTW 368
+ K T SDV+++G+V+ E++ G RP M+ P C S +
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 271
Query: 369 AMPQL--TDRSKLP------NIVDPVIRDTMDLKHLYQVAA 401
M DR+ P N +D +IR+ LK + +++
Sbjct: 272 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS 312
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 24/290 (8%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHD--AEREFNNEVNWLTKIR 207
+ ++ ++GEG G V K R + + A+K+ ++ D ++ E+ L ++R
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
H+N+++LL C + +LV+E + + L+ P + L + + K + G+ +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGF 139
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYL 326
H +H ++HRD+K NIL+ S KL DFG + T T Y APE L
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196
Query: 327 L-EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSK------- 378
+ + K DV+A G ++ E+ MG S + + L R +
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 379 -LPNIVDPVIRDTMDLKHLYQ-----VAAVAVLCIQPEPSYRPLITDVLH 422
+ P I++ L+ Y V +A C+ +P RP ++LH
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ A +N+ AVK + E F E N + ++H ++ L +
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 80
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M GSL L GS + + +A G+ ++ E N+ +HRD
Sbjct: 81 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 136
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ +S K++DFGL+ + + + APE + G T KSDV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L+E++ GR P MS
Sbjct: 197 SFGILLMEIVTYGRIPYPGMS 217
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 83/285 (29%), Positives = 135/285 (47%), Gaps = 44/285 (15%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V R +L A+K + + +R +F E + + + H NII L
Sbjct: 29 VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G ++ +V E M+NGSL+ K+ G L LR ++ G++YL +
Sbjct: 89 EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR-----GISAGMKYLSDM 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------AGTQSRNVKISGTLGYVAPEY 325
VHRDL + NIL++S+ K+SDFGLS A +R KI + + APE
Sbjct: 144 G---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP--IRWTAPEA 198
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
+ K T SDV+++G+V+ E++ G RP +M+ + + + +LP+ +D
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQD-------VIKAVEEGYRLPSPMD 251
Query: 385 -PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
P LYQ + + C Q E + RP ++++ L L+
Sbjct: 252 CPAA--------LYQ---LMLDCWQKERNSRPKFDEIVNMLDKLI 285
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 83.2 bits (204), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 12 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A G+
Sbjct: 72 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAEGMN 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 129 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 69/243 (28%), Positives = 111/243 (45%), Gaps = 28/243 (11%)
Query: 161 IGEGGRGHVYKARFNEKLLA---AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A EK AVK++D NEV + H N++ +
Sbjct: 53 IGEGSTGIVCIA--TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEH 271
+ + ++V E ++ G+L +++ H RM + + V R L YLH
Sbjct: 111 YLVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIATVCLSVLRALSYLH-- 158
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
N V+HRD+KS +ILL S KLSDFG + K + GT ++APE +
Sbjct: 159 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP 217
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
+ D+++ G++++E++ G P P Q + ++P R K + V V+R
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLP---PRVKDLHKVSSVLRGF 274
Query: 391 MDL 393
+DL
Sbjct: 275 LDL 277
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G+G G VYKA+ E +LAA K ID + ++ E++ L H NI+ LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ +++ E G+++ +L P S + + K +D L YLH ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
+HRDLK+ NIL + KL+DFG+S T Q R+ I GT ++APE ++ D
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
K+DV++ G+ L+E+ P +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G+G G VYKA+ E +LAA K ID + ++ E++ L H NI+ LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ +++ E G+++ +L P S + + K +D L YLH ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
+HRDLK+ NIL + KL+DFG+S T Q R+ I GT ++APE ++ D
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
K+DV++ G+ L+E+ P +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 63 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 82.4 bits (202), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G+G G VYKA+ E +LAA K ID + ++ E++ L H NI+ LL
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 220 HAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ +++ E G+++ +L P S + + K +D L YLH ++ +
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DNKI 156
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
+HRDLK+ NIL + KL+DFG+S T Q R+ I GT ++APE ++ D
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDR 215
Query: 334 ----KSDVYAFGVVLLELLMGRRPVEKMSP 359
K+DV++ G+ L+E+ P +++P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ A +N+ AVK + E F E N + ++H ++ L +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M GSL L GS + + +A G+ ++ E N+ +HRD
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 303
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
L+++NIL+ +S K++DFGL+ V + + APE + G T KSDV++F
Sbjct: 304 LRAANILVSASLVCKIADFGLA--------RVGAKFPIKWTAPEAINFGSFTIKSDVWSF 355
Query: 341 GVVLLELLM-GRRPVEKMS 358
G++L+E++ GR P MS
Sbjct: 356 GILLMEIVTYGRIPYPGMS 374
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 4 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 64 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 63 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 62 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 62 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 62 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 119 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 63 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 70 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 63 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 10 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 70 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 183
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR 208
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 82.0 bits (201), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 270
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + ++ + + +A ++
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISS 329
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HR+L + N L+ + K++DFGLS +T T + + + +
Sbjct: 330 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 386
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEI 412
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
++SV +++LE F N++ GEG G V KA F+ K A AVK + +
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
+E R+ +E N L ++ H ++I L G C L+ E + GSL E +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
GP + LT + A +++G++YL E +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
IL+ K+SDFGLS + VK S + ++A E L + T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
+L E++ +G P + P + +++ + R + P+ + +Y+
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
+ + C + EP RP+ D+ L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 82.0 bits (201), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 63 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 11 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 71 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 185
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 245
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 246 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 284
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 8/190 (4%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G G G VY + + L AVK + + + E EF E + +I+H N++ LLG C
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
++V E M G+L L + +T + + +A ++ +EYL + +HR
Sbjct: 99 LEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQISSAMEYLEK---KNFIHR 154
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
DL + N L+ + K++DFGLS +T T + + + + APE L + KSDV
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 338 YAFGVVLLEL 347
+AFGV+L E+
Sbjct: 215 WAFGVLLWEI 224
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 67 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 180
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 81.6 bits (200), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 61 HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 19 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 79 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 135
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 81.6 bits (200), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K+ + + + L + +GL +
Sbjct: 64 NIVKLLD-VIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 195
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 256 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 294
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + + F E N + ++H ++ L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M GSL L G L L + + +A G+ Y+ E N+ +HRD
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYI-ERKNY--IHRD 135
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++N+L+ S K++DFGL+ + + + APE + G T KSDV+
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FG++L E++ G+ P P + + V A+ Q ++ N D LY
Sbjct: 196 SFGILLYEIVTYGKIPY----PGRTNADVMTALSQGYRMPRVENCPD----------ELY 241
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLI 425
+ +C + + RP D L S++
Sbjct: 242 DIMK---MCWKEKAEERPTF-DYLQSVL 265
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
H NI+ LL IH E + +LV+E + S++ K+ + + + L + +G
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
L + H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E LL K + D+++ G + E++ R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIR 207
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 208 HQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ LL IH E + +LV+E + K + + + L + +GL
Sbjct: 61 HPNIVKLLD-VIHTENKLYLVFEFLHQDL--KDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEY 325
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 77 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+ G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 82 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 24/252 (9%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQES---------NVIGEGGRGHVYKARF-- 174
E + + G K + YE A + F + VIG G G V R
Sbjct: 7 ELYFHFKFPGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKL 66
Query: 175 -NEKLLAAVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
++ +A + G+ + R+F E + + + H N++ L G + +V E M
Sbjct: 67 PGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFM 126
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+NG+L+ L H T + + +A G+ YL + VHRDL + NIL++S+
Sbjct: 127 ENGALDAFLR--KHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSN 181
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
K+SDFGLS V + + + APE + K T SDV+++G+V+ E+
Sbjct: 182 LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEV 241
Query: 348 L-MGRRPVEKMS 358
+ G RP MS
Sbjct: 242 MSYGERPYWDMS 253
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K + + + L + +GL
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ A +N+ AVK + E F E N + ++H ++ L +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M GSL L GS + + +A G+ ++ E N+ +HRD
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI-EQRNY--IHRD 309
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++NIL+ +S K++DFGL+ + + + APE + G T KSDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 339 AFGVVLLELLM-GRRPVEKMS 358
+FG++L+E++ GR P MS
Sbjct: 370 SFGILLMEIVTYGRIPYPGMS 390
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 77 DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+ + +A A +E +E + +
Sbjct: 49 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 165
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 166 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIXETDXXR 189
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 250 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 288
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 1 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
H NI+ LL IH E + +LV+E + S++ K+ + + + L + +G
Sbjct: 61 NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
L + H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y AP
Sbjct: 117 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 173
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E LL K + D+++ G + E++ R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+ G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 15 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
++SV +++LE F N++ GEG G V KA F+ K A AVK + +
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
+E R+ +E N L ++ H ++I L G C L+ E + GSL E +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
GP + LT + A +++G++YL E +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
IL+ K+SDFGLS + VK S + ++A E L + T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
+L E++ +G P + P + +++ + R + P+ + +Y+
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
+ + C + EP RP+ D+ L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + + IG+G G VYK N K + A+K ID + D + E+ L++ I
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + + +++ E + GS L+ GP + + LR ++ +GL+YLH
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHSE 135
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL + KL+DFG++ TQ + GT ++APE + +
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P + P + ++ P T
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP-----------------T 235
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
++ +H C+ +P +RP ++L H I
Sbjct: 236 LEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 271
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+ G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 82 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFGL+ G + + G + ++A
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 82 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 138
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDDA-GHDAEREFNNEVNWLTKI 206
F++ V+G G G VYK + K+ A+K + +A A +E +E + +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ ++ LLG C+ + + L+ ++M G L + H N+ + V +A+G+
Sbjct: 77 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ + + K++DFG + G + + G + ++A
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
E +L T +SDV+++GV + EL+ G +P + + ++ S++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 116/244 (47%), Gaps = 38/244 (15%)
Query: 144 EYEL-LEAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE- 195
EY+L E N + V+G G G V A + + AVK + + +ERE
Sbjct: 35 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA 94
Query: 196 FNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL------------------ 236
+E+ +T++ H+NI++LLG C + +L++E G L
Sbjct: 95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 237 --EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
+K+L + LT+ + A VA+G+E+L VHRDL + N+L+
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVV 211
Query: 295 KLSDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-M 349
K+ DFGL+ + S N + G + ++APE L EG T KSDV+++G++L E+ +
Sbjct: 212 KICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 350 GRRP 353
G P
Sbjct: 271 GVNP 274
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 87/323 (26%), Positives = 146/323 (45%), Gaps = 57/323 (17%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVYKAR-FNEKLLA-----AVKRIDD 187
++SV +++LE F N++ GEG G V KA F+ K A AVK + +
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 188 AGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLH 241
+E R+ +E N L ++ H ++I L G C L+ E + GSL E +
Sbjct: 64 NASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 242 GPTH----------------GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSN 285
GP + LT + A +++G++YL E +VHRDL + N
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180
Query: 286 ILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGV 342
IL+ K+SDFGLS + VK S + ++A E L + T +SDV++FGV
Sbjct: 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 VLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAA 401
+L E++ +G P + P + +++ + R + P+ + +Y+
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLL-----KTGHRMERPDNCS---------EEMYR--- 283
Query: 402 VAVLCIQPEPSYRPLITDVLHSL 424
+ + C + EP RP+ D+ L
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDL 306
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 309
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 310 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 368
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HR+L + N L+ + K++DFGLS +T T + + + +
Sbjct: 369 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 425
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEI 451
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 145 YELLEAATNNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWL 203
Y+ E + + +G G G VY+ + + L AVK + + + E EF E +
Sbjct: 209 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 267
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
+I+H N++ LLG C +++ E M G+L L + + + + +A ++
Sbjct: 268 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISS 326
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYV 321
+EYL + +HR+L + N L+ + K++DFGLS +T T + + + +
Sbjct: 327 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 383
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLEL 347
APE L K + KSDV+AFGV+L E+
Sbjct: 384 APESLAYNKFSIKSDVWAFGVLLWEI 409
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 6 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 66 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 126 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIXETDXXR 180
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 240
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 241 G--GLLDKPDNCPDMLLELMR----------------MCWQYNPKMRPSFLEIISSI 279
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 2 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
H NI+ LL IH E + +LV+E + S++ K + + + L + +G
Sbjct: 62 NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
L + H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y AP
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E LL K + D+++ G + E++ R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
N+F +IG GG G VY R + + A+K +D E NE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+ I + Y H + + ++M G L H HG +R A ++ GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
E++H N VV+RDLK +NILLD + ++SD GL+ + + + GT GY+APE
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
L +G D S D ++ G +L +LL G P + + LT +LP+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
P +R ++
Sbjct: 419 PELRSLLE 426
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
N+F +IG GG G VY R + + A+K +D E NE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+ I + Y H + + ++M G L H HG +R A ++ GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
E++H N VV+RDLK +NILLD + ++SD GL+ + + + GT GY+APE
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
L +G D S D ++ G +L +LL G P + + LT +LP+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
P +R ++
Sbjct: 419 PELRSLLE 426
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLE-KQLHGPTHGSNLTWHLRMKIAVDVARG 264
H NI+ LL IH E + +LV+E + S++ K + + + L + +G
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAP 323
L + H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y AP
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAP 175
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E LL K + D+++ G + E++ R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 160 VIGE-GGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+IGE G G VYKA+ E +LAA K ID + ++ E++ L H NI+ LL
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 75
Query: 218 CIHAETRFLVYEMMQNGSLEK---QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+ +++ E G+++ +L P S + + K +D L YLH ++
Sbjct: 76 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQI--QVVCKQTLD---ALNYLH---DN 127
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLSV--TAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
++HRDLK+ NIL + KL+DFG+S T R GT ++APE ++
Sbjct: 128 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWMAPEVVMCETSK 187
Query: 333 D-----KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
D K+DV++ G+ L+E+ P +++P +
Sbjct: 188 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 221
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 82/259 (31%), Positives = 122/259 (47%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYC--IHAETRFLVYEMMQNGS 235
+ AVK + DAG + E++ L + H++II G C A + LV E + GS
Sbjct: 62 MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
L L P H L L A + G+ YLH H +HRDL + N+LLD+ K
Sbjct: 122 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH--AQH-YIHRDLAARNVLLDNDRLVK 174
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
+ DFGL +V G + V+ G + + APE L E K SDV++FGV L ELL
Sbjct: 175 IGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 233
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
+ PT+ ++ A Q+T +L +++ R K +V + C + E
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEA 292
Query: 412 SYRPLITDVLHSLIPLVPT 430
S+RP +LIP++ T
Sbjct: 293 SFRP----TFENLIPILKT 307
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 188
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 249 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 287
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 135 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 189
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 250 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 288
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 12 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 72 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 132 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 186
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 246
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 247 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 285
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKI 206
+ NFQ+ IGEG G VYKAR +++A K R+D E++ L ++
Sbjct: 3 GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H NI+ LL IH E + +LV+E + K+ + + + L + +GL
Sbjct: 63 NHPNIVKLLD-VIHTENKLYLVFEHVDQDL--KKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
+ H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
LL K + D+++ G + E++ R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 17/230 (7%)
Query: 134 AGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDA 192
+GK+ I + +A N+ + +G G G V+K RF + + AVK++ +G+
Sbjct: 6 SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 193 E-REFNNEVNWLTKIRH-QNIISLLGYCIHAETRFLVYEMMQNGS--LEKQLHGPTHGSN 248
E + +++ + K I+ G I F+ E+M + L+K++ GP
Sbjct: 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----- 120
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
+ + K+ V + + L YL E H V+HRD+K SNILLD KL DFG+S
Sbjct: 121 IPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTD-----KSDVYAFGVVLLELLMGRRP 353
+ +G Y+APE + T ++DV++ G+ L+EL G+ P
Sbjct: 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAAGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
N+F +IG GG G VY R + + A+K +D E NE L+ +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+ I + Y H + + ++M G L H HG +R A ++ GL
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 304
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
E++H N VV+RDLK +NILLD + ++SD GL+ + + + GT GY+APE
Sbjct: 305 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 360
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
L +G D S D ++ G +L +LL G P + + LT +LP+
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 417
Query: 385 PVIRDTMD 392
P +R ++
Sbjct: 418 PELRSLLE 425
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 18/248 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAG---HDAEREFNNEVNWLTKIRH 208
N+F +IG GG G VY R + + A+K +D E NE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 QN--IISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+ I + Y H + + ++M G L H HG +R A ++ GL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF-YAAEIILGL 305
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
E++H N VV+RDLK +NILLD + ++SD GL+ + + + GT GY+APE
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEV 361
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD 384
L +G D S D ++ G +L +LL G P + + LT +LP+
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAVELPDSFS 418
Query: 385 PVIRDTMD 392
P +R ++
Sbjct: 419 PELRSLLE 426
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 134 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 188
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 249 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 287
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+GEG G V A R E+ +A VK +D D E+ + H+N++
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G+ ++L E G L E + P + +H M G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+GEG G V A R E+ +A VK +D D E+ + H+N++
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G+ ++L E G L E + P + +H M G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 128 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 182
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 243 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 281
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+GEG G V A R E+ +A VK +D D E+ + H+N++
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 216 GYCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G+ ++L E G L E + P + +H M G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLE 328
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 329 GKL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 123
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 47/276 (17%)
Query: 160 VIGEGGRGHVYKARFN----EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIISL 214
VIG G G V ++ A+K + + +R +F +E + + + H N+I L
Sbjct: 14 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 215 LGYCIHAETRFLVYEMMQNGSLE---KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + ++ E M+NGSL+ +Q G L LR +A G++YL
Sbjct: 74 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--- 125
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG------YVAPEY 325
+ VHR L + NIL++S+ K+SDFGLS + + + LG + APE
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 326 LLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMS----------------PTQCQSMVTW 368
+ K T SDV+++G+V+ E++ G RP M+ P C S +
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 245
Query: 369 AMPQL--TDRSKLP------NIVDPVIRDTMDLKHL 396
M DR+ P N +D +IR+ LK +
Sbjct: 246 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAM 281
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+GEG G V A R E+ +A VK +D D E+ + H+N++ G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+ ++L E G L E + P + +H M G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 120
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 219
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 69/268 (25%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
+G G G V+ +N AVK + G + + F E N + ++H ++ L
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 221 AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRD 280
E +++ E M GSL L G L L + + +A G+ Y+ E N+ +HRD
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYI-ERKNY--IHRD 134
Query: 281 LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVY 338
L+++N+L+ S K++DFGL+ + + + APE + G T KS+V+
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 339 AFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLY 397
+FG++L E++ G+ P P + + V A+ Q ++ N D LY
Sbjct: 195 SFGILLYEIVTYGKIPY----PGRTNADVMSALSQGYRMPRMENCPD----------ELY 240
Query: 398 QVAAVAVLCIQPEPSYRPLITDVLHSLI 425
+ +C + + RP D L S++
Sbjct: 241 DIMK---MCWKEKAEERPTF-DYLQSVL 264
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 141 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 195
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 256 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 294
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 43 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N ++ F K+ DFG+ T +
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--TRDIYETDYYR 217
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 277
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 278 G--GLLDKPDNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 316
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 80.1 bits (196), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 79/302 (26%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHRDL + N ++ F K+ DFG+ T + G G ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P+ RP L+ D LH P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
V
Sbjct: 296 EV 297
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+GEG G V A R E+ +A VK +D D E+ + H+N++ G
Sbjct: 13 TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+ ++L E G L E + P + +H M G+ YLH
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 121
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 122 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 220
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 160 VIGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+GEG G V A R E+ +A VK +D D E+ + H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 217 YCIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+ ++L E G L E + P + +H M G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH--- 122
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEG 329
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 330 KL-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ + DV++ G+VL +L G P ++ S + CQ W
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDW 221
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHRDL + N ++ F K+ DFG+ T + G G ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P RP L+ D LH P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
V
Sbjct: 296 EV 297
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHRDL + N ++ F K+ DFG+ T + G G ++
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIXETDXXRKGGKGLLPVRWM 196
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 237
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P RP L+ D LH P
Sbjct: 238 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 292
Query: 427 LV 428
V
Sbjct: 293 EV 294
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKAR--FNEKLLAAVK-RIDDAGHDAEREFNNEVNWLTKIRHQ 209
NFQ+ IGEG G VYKAR +++A K R+D E++ L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 210 NIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
NI+ LL IH E + +LV+E + K + + + L + +GL +
Sbjct: 62 NIVKLLD-VIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL 327
H +H V+HRDLK N+L+++ KL+DFGL+ G R TL Y APE LL
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K + D+++ G + E++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVK-----RIDDAGHDAEREFNNEVNWLTKI 206
++F+ +G+G G+VY AR + + A+K +I+ G E + E+ +
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG--VEHQLRREIEIQAHL 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NI+ L Y +L+ E G L K+L I ++A L
Sbjct: 81 HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK---SCTFDEQRTATIMEELADALM 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
Y H V+HRD+K N+LL K++DFG SV A + R + GTL Y+ PE +
Sbjct: 138 YCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPE-M 192
Query: 327 LEGKL-TDKSDVYAFGVVLLELLMGRRPVEKMS 358
+EG++ +K D++ GV+ ELL+G P E S
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESAS 225
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + IG+G G V+K N + + A+K ID + D + E+ L++ +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 213 SLLGYCIHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + +++ E + GS L+ GP + L+ ++ +GL+YLH
Sbjct: 85 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSE 139
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL + KL+DFG++ TQ + GT ++APE + +
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P M P + V + +P ++ P +V T
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIP----KNNPPTLVGDF---T 245
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
K C+ +PS+RP ++L H I
Sbjct: 246 KSFKEFIDA------CLNKDPSFRPTAKELLKHKFI 275
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 69/253 (27%), Positives = 113/253 (44%), Gaps = 37/253 (14%)
Query: 130 SLRLAGKKDT---VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KAR 173
+ RL+ DT V EYEL E F + +GEG G V K +
Sbjct: 50 TTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK 109
Query: 174 FNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMM 231
E + AVK + DDA + +E+ + I +H+NII+LLG C +++ E
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169
Query: 232 QNGSLEKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
G+L + L +T+ + +ARG+EYL + +H
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIH 226
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKS 335
RDL + N+L+ + K++DFGL+ K + + ++APE L + T +S
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286
Query: 336 DVYAFGVVLLELL 348
DV++FGV++ E+
Sbjct: 287 DVWSFGVLMWEIF 299
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N L AVK++ +G D +R+F E+ L + I+
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G Y ++ LV E + +G L L H + L + + + +G+EYL +
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 133
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
VHRDL + NIL++S + K++DFGL+ + V+ G + + APE L +
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 330 KLTDKSDVYAFGVVLLELL 348
+ +SDV++FGVVL EL
Sbjct: 194 IFSRQSDVWSFGVVLYELF 212
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 44/297 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAER-EFNNEVN 201
E A S +G+G G VY+ + + A+K +++A ER EF NE +
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLR 254
+ + +++ LLG + ++ E+M G L+ L P +N +
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
+++A ++A G+ YL+ + VHRDL + N + F K+ DFG+ T +
Sbjct: 128 IQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGM--TRDIYETDYYR 182
Query: 315 SGTLG-----YVAPEYLLEGKLTDKSDVYAFGVVLLEL-LMGRRPVEKMSPTQCQSMVTW 368
G G +++PE L +G T SDV++FGVVL E+ + +P + +S Q V
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 369 AMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
L D+ P+++ ++R +C Q P RP +++ S+
Sbjct: 243 G--GLLDKPDNCPDMLLELMR----------------MCWQYNPKMRPSFLEIISSI 281
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N L AVK++ +G D +R+F E+ L + I+
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 216 GYCI---HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
G E R LV E + +G L L H + L + + + +G+EYL
Sbjct: 75 GVSYGPGRPELR-LVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG--- 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLE 328
+ VHRDL + NIL++S + K++DFGL+ + V+ G + + APE L +
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 329 GKLTDKSDVYAFGVVLLELL 348
+ +SDV++FGVVL EL
Sbjct: 189 NIFSRQSDVWSFGVVLYELF 208
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N L AVK++ +G D +R+F E+ L + I+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G Y ++ LV E + +G L L H + L + + + +G+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 145
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
VHRDL + NIL++S + K++DFGL+ + V+ G + + APE L +
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 330 KLTDKSDVYAFGVVLLELL 348
+ +SDV++FGVVL EL
Sbjct: 206 IFSRQSDVWSFGVVLYELF 224
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 79.0 bits (193), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHRDL + N ++ F K+ DFG+ T + G G ++
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P RP L+ D LH P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
V
Sbjct: 296 EV 297
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 161 IGEGGRGHVYKARF-----NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
+G+G G V R+ N L AVK++ +G D +R+F E+ L + I+
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 216 G--YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
G Y ++ LV E + +G L L H + L + + + +G+EYL +
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQICKGMEYLG---S 132
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEG 329
VHRDL + NIL++S + K++DFGL+ + V+ G + + APE L +
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 330 KLTDKSDVYAFGVVLLELL 348
+ +SDV++FGVVL EL
Sbjct: 193 IFSRQSDVWSFGVVLYELF 211
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
F + IG G G VY AR + A+K++ +G + ++ + EV +L K+RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
I G + T +LV E GS L H L + +GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 171
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
+H ++HRD+K+ NILL KL DFG +A + GT ++APE +L
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 226
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
EG+ K DV++ G+ +EL + P+ M+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + IG+G G V+K N + + A+K ID + D + E+ L++ +
Sbjct: 29 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + +++ E + GS L GP + + LR ++ +GL+YLH
Sbjct: 89 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL KL+DFG++ TQ + GT ++APE + +
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P ++ P + V + +P+ + N P
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 251
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
LK + C+ EPS+RP ++L H I
Sbjct: 252 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 279
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 78.6 bits (192), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 59/300 (19%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVKISGTLGYVAP 323
YL+ VHRDL + N ++ F K+ DFG++ + K + ++AP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI 382
E L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------------------- 240
Query: 383 VDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIPLV 428
V++ MD +L Q V + +C Q P RP L+ D LH P V
Sbjct: 241 ---VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 297
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQN 210
F + IG G G VY AR + A+K++ +G + ++ + EV +L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
I G + T +LV E GS L H L + +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL--- 327
+H ++HRD+K+ NILL KL DFG +A + GT ++APE +L
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 187
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
EG+ K DV++ G+ +EL + P+ M+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 78.6 bits (192), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHRDL + N ++ F K+ DFG+ T + G G ++
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 198
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 239
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P RP L+ D LH P
Sbjct: 240 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 294
Query: 427 LV 428
V
Sbjct: 295 EV 296
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 78.2 bits (191), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + IG+G G V+K N + + A+K ID + D + E+ L++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + +++ E + GS L GP + + LR ++ +GL+YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 123
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL KL+DFG++ TQ + GT ++APE + +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P ++ P + V + +P+ + N P
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 231
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
LK + C+ EPS+RP ++L H I
Sbjct: 232 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 259
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + IG+G G V+K N + + A+K ID + D + E+ L++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + +++ E + GS L GP + + LR ++ +GL+YLH
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 123
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL KL+DFG++ TQ + GT ++APE + +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P ++ P + V + +P+ + N P
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 231
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
LK + C+ EPS+RP ++L H I
Sbjct: 232 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 259
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
++G+G G V K + + AVK I+ A + EV L K+ H NI+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ + ++V E+ G L ++ + H +I V G+ Y+H+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
VHRDLK NILL+S + K+ DFGLS ++ GT Y+APE +L G +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
K DV++ GV+L LL G P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 158 SNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNII 212
VIG+G G VY + ++ A+K + + E F E + + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 213 SLLGYCIHAE-TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+L+G + E ++ M +G L + + P N T + + VARG+EYL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-------VTAGTQSRNVKISGTLGYVAPE 324
VHRDL + N +LD SF K++DFGL+ + Q R+ ++ + + A E
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTALE 198
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSP 359
L + T KSDV++FGV+L ELL G P + P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
++G+G G V K + + AVK I+ A + EV L K+ H NI+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ + ++V E+ G L ++ + H +I V G+ Y+H+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
VHRDLK NILL+S + K+ DFGLS ++ GT Y+APE +L G +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
K DV++ GV+L LL G P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 78.2 bits (191), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 30/276 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNE-KLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
F + IG+G G V+K N + + A+K ID + D + E+ L++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLH-GPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
G + +++ E + GS L GP + + LR ++ +GL+YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE 138
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGK 330
+HRD+K++N+LL KL+DFG++ TQ + GT ++APE + +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 331 LTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
K+D+++ G+ +EL G P ++ P + V + +P+ + N P
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKNNPPTLEGNYSKP----- 246
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRPLITDVL-HSLI 425
LK + C+ EPS+RP ++L H I
Sbjct: 247 --LKEFVEA------CLNKEPSFRPTAKELLKHKFI 274
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 160 VIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLG 216
++G+G G V K + + AVK I+ A + EV L K+ H NI+ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ + ++V E+ G L ++ + H +I V G+ Y+H+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 277 VHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
VHRDLK NILL+S + K+ DFGLS ++ GT Y+APE +L G +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDE 201
Query: 334 KSDVYAFGVVLLELLMGRRP 353
K DV++ GV+L LL G P
Sbjct: 202 KCDVWSAGVILYILLSGTPP 221
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 58 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 113
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 169
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 224
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDV 251
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 98 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 148 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ D+++ G++++E++ G P P + M+ +P
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 244
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 87 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ D+++ G++++E++ G P P + M+ +P
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 233
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 62 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 117
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISG 316
V+ G++YL E VHRDL + N+LL + AK+SDFGLS + A + G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 317 T--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
+ + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----EK 229
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 230 GERMGCPAGCPREMYDLMNLCWTYDV 255
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 56 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 111
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 112 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 167
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 222
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 223 KGERMGCPAGCPREMYDLMNLCWTYDV 249
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 96 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 146 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ D+++ G++++E++ G P P + M+ +P
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 242
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 62 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 117
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 173
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 228
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 229 KGERMGCPAGCPREMYDLMNLCWTYDV 255
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
E ++F+ + +G G G V K + L+ A K I A R + E+ L +
Sbjct: 12 ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
I+ G + E M GSL++ L + + K+++ V RGL
Sbjct: 72 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLA 128
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y+APE L
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ +SD+++ G+ L+EL +GR P+
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI 213
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 68 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 123
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 179
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 234
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 235 KGERMGCPAGCPREMYDLMNLCWTYDV 261
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
+E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
L + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
+E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
L + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 78 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 189
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 245 KGERMGCPAGCPREMYDLMNLCWTYDV 271
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 78 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 189
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 244
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 245 KGERMGCPAGCPREMYDLMNLCWTYDV 271
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 76 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---IIELV 131
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 187
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 242
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 243 KGERMGCPAGCPREMYDLMNLCWTYDV 269
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHR+L + N ++ F K+ DFG+ T + G G ++
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 200
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 241
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P+ RP L+ D LH P
Sbjct: 242 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 296
Query: 427 LV 428
V
Sbjct: 297 EV 298
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
+E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
L + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 78/302 (25%), Positives = 130/302 (43%), Gaps = 63/302 (20%)
Query: 161 IGEGGRGHVYKARFNE------KLLAAVKRIDDAGHDAER-EFNNEVNWLTKIRHQNIIS 213
+G+G G VY+ + + AVK ++++ ER EF NE + + +++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHG--PTHGSNL-----TWHLRMKIAVDVARGLE 266
LLG + +V E+M +G L+ L P +N T +++A ++A G+
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG-----YV 321
YL+ VHR+L + N ++ F K+ DFG+ T + G G ++
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGM--TRDIYETDYYRKGGKGLLPVRWM 199
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLP 380
APE L +G T SD+++FGVVL E+ + +P + +S Q
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------------------- 240
Query: 381 NIVDPVIRDTMDLKHLYQ-------VAAVAVLCIQPEPSYRP-------LITDVLHSLIP 426
V++ MD +L Q V + +C Q P+ RP L+ D LH P
Sbjct: 241 -----VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSFP 295
Query: 427 LV 428
V
Sbjct: 296 EV 297
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 141 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ D+++ G++++E++ G P P + M+ +P
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 287
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
+E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
L + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 91 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 141 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ D+++ G++++E++ G P P + M+ +P
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 237
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 8/209 (3%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTK 205
+E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPER 174
Query: 326 LLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
L + +SD+++ G+ L+E+ +GR P+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 33/263 (12%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
IGEG G V A R + KL+A VK++D NEV + +H+N++ +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVA-VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHC 272
+ + ++V E ++ G+L +++ H RM + + V + L LH
Sbjct: 218 LVGDELWVVMEFLEGGAL----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAPEYLLEGKL 331
V+HRD+KS +ILL KLSDFG + R + GT ++APE +
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNI--VDPVIRD 389
+ D+++ G++++E++ G P P + M+ +P +L N+ V P ++
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----PRLKNLHKVSPSLKG 379
Query: 390 TMD---LKHLYQVAAVAVLCIQP 409
+D ++ Q A A L P
Sbjct: 380 FLDRLLVRDPAQRATAAELLKHP 402
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 8/214 (3%)
Query: 147 LLEAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLT 204
L E ++F++ + +G G G V+K L+ A K I A R + E+ L
Sbjct: 3 LGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 62
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+ I+ G + E M GSL++ L + + K+++ V +G
Sbjct: 63 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 119
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L YL E H ++HRD+K SNIL++S KL DFG+S + N + GT Y++PE
Sbjct: 120 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPE 176
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
L + +SD+++ G+ L+E+ +GR P M+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMA 210
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 84/353 (23%), Positives = 144/353 (40%), Gaps = 70/353 (19%)
Query: 98 RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
RWK +++ GNS ID P +N E E NN Q
Sbjct: 15 RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
+G G G V +A + + L AVK + H E+E +E+ ++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-----------HGPTHG--SNLTWHLRMK 256
NI++LLG C H ++ E G L L + P+H L+ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
+ VA+G+ +L + +HRD+ + N+LL + AK+ DFGL+ S N + G
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKG 226
Query: 317 T----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMP 371
+ ++APE + + T +SDV+++G++L E+ +G P P
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YP 270
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ SK +V + + ++ C EP++RP + L
Sbjct: 271 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 166 RGHVYKARFNEKLLAAVKRIDDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
R VY+ R +++ A+K + A+ E E + ++ + I+ L+G C AE
Sbjct: 27 RQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84
Query: 225 FLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL 281
LV EM G L K L G SN+ ++ V+ G++YL E VHRDL
Sbjct: 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYLEEK---NFVHRDL 136
Query: 282 KSSNILLDSSFNAKLSDFGLSVTAGTQSR--NVKISGT--LGYVAPEYLLEGKLTDKSDV 337
+ N+LL + AK+SDFGLS G + +G L + APE + K + +SDV
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 338 YAFGVVLLELL-MGRRPVEKMSPTQCQSMV 366
+++GV + E L G++P +KM + + +
Sbjct: 197 WSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 76.6 bits (187), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 160 VIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLL 215
V+G+G G K E ++ + R D+ + +R F EV + + H N++ +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 216 GYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
G + + E ++ G+L + + S W R+ A D+A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLS---VTAGTQSRNVK------------ISGTLGY 320
++HRDL S N L+ + N ++DFGL+ V TQ ++ + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELL 348
+APE + +K DV++FG+VL E++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
AT+ ++ IG G G VYKAR + A+K R+ + EV L ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
H N++ L+ C + T LV+E + P G L +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
RGL++LH +C +VHRDLK NIL+ S KL+DFGL+ Q + TL
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
Y APE LL+ D+++ G + E+ R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 10 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHG-- 242
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 70 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 243 ---------PTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 130 PPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDXXKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
+
Sbjct: 245 IF 246
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 78/259 (30%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGS 235
+ AVK + D G + E++ L + H++II G C + L V E + GS
Sbjct: 45 MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
L L P H L L A + G+ YLH + +HR+L + N+LLD+ K
Sbjct: 105 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVK 157
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
+ DFGL +V G + V+ G + + APE L E K SDV++FGV L ELL
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
+ PT+ ++ A Q+T +L +++ R K +V + C + E
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEA 275
Query: 412 SYRPLITDVLHSLIPLVPT 430
S+RP +LIP++ T
Sbjct: 276 SFRP----TFENLIPILKT 290
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
AT+ ++ IG G G VYKAR + A+K R+ + EV L ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
H N++ L+ C + T LV+E + P G L +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
RGL++LH +C +VHRDLK NIL+ S KL+DFGL+ Q + TL
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
Y APE LL+ D+++ G + E+ R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 85/350 (24%), Positives = 143/350 (40%), Gaps = 70/350 (20%)
Query: 98 RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
RWK +++ GNS ID P +N E E NN Q
Sbjct: 7 RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 42
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
+G G G V +A + + L AVK + H E+E +E+ ++ + +H+
Sbjct: 43 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 102
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVA 262
NI++LLG C H ++ E G L L G L + + VA
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT----L 318
+G+ +L + +HRD+ + N+LL + AK+ DFGL+ S N + G +
Sbjct: 163 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPV 218
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
++APE + + T +SDV+++G++L E+ +G P P + S
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS 262
Query: 378 KLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
K +V + + K++Y + C EP++RP + L
Sbjct: 263 KFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 309
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 420 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---IELV 475
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 476 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 531
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 586
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 587 KGERMGCPAGCPREMYDLMNLCWTYDV 613
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 68/248 (27%), Positives = 110/248 (44%), Gaps = 37/248 (14%)
Query: 135 GKKDT---VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKL 178
G DT V EYEL E F + +GEG G V K + E +
Sbjct: 1 GAMDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAV 60
Query: 179 LAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL 236
AVK + DDA + +E+ + I +H+NII+LLG C +++ E G+L
Sbjct: 61 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 237 EKQLHGP-------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
+ L +T+ + +ARG+EYL + +HRDL +
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAA 177
Query: 284 SNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAF 340
N+L+ + K++DFGL+ K + + ++APE L + T +SDV++F
Sbjct: 178 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 237
Query: 341 GVVLLELL 348
GV++ E+
Sbjct: 238 GVLMWEIF 245
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 4 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 63
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 64 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 123
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 124 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTEN 180
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 181 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
E N + ++ + I+ ++G C AE+ LV EM + G L K L H + +++
Sbjct: 421 EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---IELV 476
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V+ G++YL E VHRDL + N+LL + AK+SDFGLS A N + T
Sbjct: 477 HQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS-KALRADENYYKAQTH 532
Query: 319 G-----YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQ 372
G + APE + K + KSDV++FGV++ E G++P M ++ +M+ +
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-----E 587
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQV 399
+R P + D M+L Y V
Sbjct: 588 KGERMGCPAGCPREMYDLMNLCWTYDV 614
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 6 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 65
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 66 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 125
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 126 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 182
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 183 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
+++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 85/350 (24%), Positives = 143/350 (40%), Gaps = 70/350 (20%)
Query: 98 RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
RWK +++ GNS ID P +N E E NN Q
Sbjct: 15 RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
+G G G V +A + + L AVK + H E+E +E+ ++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-------GSNLTWHLRMKIAVDVA 262
NI++LLG C H ++ E G L L G L + + VA
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT----L 318
+G+ +L + +HRD+ + N+LL + AK+ DFGL+ S N + G +
Sbjct: 171 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPV 226
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRS 377
++APE + + T +SDV+++G++L E+ +G P P + S
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGILVNS 270
Query: 378 KLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
K +V + + K++Y + C EP++RP + L
Sbjct: 271 KFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 317
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + + N ++ + ++APE L + T +SDV++FGV++ E
Sbjct: 194 NVMKIADFGLARDINNIDYYKNTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWE 251
Query: 347 LL 348
+
Sbjct: 252 IF 253
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 85/354 (24%), Positives = 145/354 (40%), Gaps = 74/354 (20%)
Query: 98 RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
RWK +++ GNS ID P +N E E NN Q
Sbjct: 15 RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
+G G G V +A + + L AVK + H E+E +E+ ++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTH-----------GSNLTWHLRMKIA 258
NI++LLG C H ++ E G L L + S L+ + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+ +L + +HRD+ + N+LL + AK+ DFGL+ S N + G
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNA 226
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
+ ++APE + + T +SDV+++G++L E+ +G P P +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGI 270
Query: 374 TDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
SK +V + + K++Y + C EP++RP + L
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 321
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 64 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 180
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
YL E H ++HRD+K SNIL++S KL DFG+S N + GT Y++PE L
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSPERL 237
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ +SD+++ G+ L+E+ +GR P+
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 161 IGEGGRGHVYKA--RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+GEG G V A R E+ +A VK +D D E+ + H+N++ G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVA-VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 218 CIHAETRFLVYEMMQNGSL----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
++L E G L E + P + +H M G+ YLH
Sbjct: 73 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLH---G 122
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYLLEGK 330
+ HRD+K N+LLD N K+SDFGL+ +R K+ GTL YVAPE L +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 331 L-TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ DV++ G+VL +L G P ++ S + Q W
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSX-QEYSDW 220
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 145
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE L
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 202
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ +SD+++ G+ L+E+ +GR P+
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 78/259 (30%), Positives = 119/259 (45%), Gaps = 20/259 (7%)
Query: 179 LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGS 235
+ AVK + D G + E++ L + H++II G C + L V E + GS
Sbjct: 45 MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
L L P H L L A + G+ YLH +HR+L + N+LLD+ K
Sbjct: 105 LRDYL--PRHSIGLAQLLL--FAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVK 157
Query: 296 LSDFGL--SVTAGTQSRNVKISG--TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
+ DFGL +V G + V+ G + + APE L E K SDV++FGV L ELL
Sbjct: 158 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-H 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
+ PT+ ++ A Q+T +L +++ R K +V + C + E
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMT-VLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEA 275
Query: 412 SYRPLITDVLHSLIPLVPT 430
S+RP +LIP++ T
Sbjct: 276 SFRP----TFENLIPILKT 290
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 10 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 70 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 130 PPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
+
Sbjct: 245 IF 246
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 21/274 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG+G G VY A A+++++ + NE+ + + ++ NI++ L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
+ ++V E + GSL T T +IA + + LE+LH ++ V
Sbjct: 88 VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HRD+KS NILL + KL+DFG QS+ ++ GT ++APE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
D+++ G++ +E++ G P +P + ++ T P+L + KL I + +D+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
+ +A +L Q +P L SL PL+
Sbjct: 258 VEKRGSAKELLQHQFLKIAKP-----LSSLTPLI 286
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 38/243 (15%)
Query: 139 TVSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 2 VAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 61
Query: 186 -DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL--- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 62 KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 121
Query: 241 --------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS 290
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 122 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTE 178
Query: 291 SFNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L
Sbjct: 179 DNVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLW 236
Query: 346 ELL 348
E+
Sbjct: 237 EIF 239
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVK--RIDDAGHDAEREFNNEVNWLTKIR 207
AT+ ++ IG G G VYKAR + A+K R+ + EV L ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 208 ---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
H N++ L+ C + T LV+E + P G L +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMR 119
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLG 319
RGL++LH +C +VHRDLK NIL+ S KL+DFGL+ Q + TL
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLW 176
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
Y APE LL+ D+++ G + E+ R+P+
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 10 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 70 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
+
Sbjct: 245 IF 246
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 32/244 (13%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IGEG G V AR AVK +D NEV + +H N++ + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK------IAVDVARGLEYLHEHCN 273
E +++ E +Q G+L +++ +R+ + V + L YLH
Sbjct: 113 VGEELWVLMEFLQGGAL----------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 274 HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGKLT 332
V+HRD+KS +ILL KLSDFG K + GT ++APE +
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 333 DKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDR--SKLPNI--VDPVIR 388
+ D+++ G++++E++ G P SP Q AM +L D KL N V PV+R
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------AMKRLRDSPPPKLKNSHKVSPVLR 272
Query: 389 DTMD 392
D ++
Sbjct: 273 DFLE 276
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G+G G VYKA+ E LAA K I+ + ++ E+ L H I+ LLG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
H +++ E G+++ + G LT + + L +LH + ++HR
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLH---SKRIIHR 133
Query: 280 DLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
DLK+ N+L+ + +L+DFG+S Q R+ I GT ++APE ++ + D
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 192
Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
K+D+++ G+ L+E+ P +++P +
Sbjct: 193 YKADIWSLGITLIEMAQIEPPHHELNPMR 221
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 8/208 (3%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER-EFNNEVNWLTKI 206
E ++F++ + +G G G V+K L+ A K I A R + E+ L +
Sbjct: 21 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
I+ G + E M GSL++ L + + K+++ V +GL
Sbjct: 81 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLT 137
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL 326
YL E H ++HRD+K SNIL++S KL DFG+S N GT Y++PE L
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 194
Query: 327 LEGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ +SD+++ G+ L+E+ +GR P+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 10 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 69
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 70 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARE 129
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 130 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 187 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 244
Query: 347 LL 348
+
Sbjct: 245 IF 246
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 151 ATNNFQESNVIGEG--GRGHVYKARFNEKLLAA-------VKRIDDAGHDAEREFNNEVN 201
+ +FQ +G G GR H+ ++R N + A V R+ H N+E
Sbjct: 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-----NDERL 58
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
L+ + H II + G A+ F++ + ++ G L L N A +V
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF---YAAEV 115
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
LEYLH + +++RDLK NILLD + + K++DFG + + + GT Y+
Sbjct: 116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YXLCGTPDYI 170
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
APE + D ++FG+++ E+L G P
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 39/248 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 51 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 110
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 111 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 170
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 171 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 228 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 347 LL-MGRRP 353
+ +G P
Sbjct: 286 IFTLGGSP 293
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 38/242 (15%)
Query: 140 VSVIEYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E ++ GEG G V K + N AVK +
Sbjct: 2 AGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK 61
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---- 240
DA + +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 62 SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 121
Query: 241 -------HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+ P+H L+ + A VARG+EYL + +HRDL + N+L+
Sbjct: 122 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
K++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E
Sbjct: 179 NVMKIADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWE 236
Query: 347 LL 348
+
Sbjct: 237 IF 238
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 13/221 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
++F+ IG+G G V + N+ K + A+K ++ E N E+ + + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
+++L E F+V +++ G L L H T L ++ L+YL
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---FICELVMALDYL 131
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
N ++HRD+K NILLD + ++DF ++ +++ ++GT Y+APE
Sbjct: 132 Q---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 329 GKLTDKS---DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
K S D ++ GV ELL GRRP S T + +V
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 87/354 (24%), Positives = 146/354 (41%), Gaps = 74/354 (20%)
Query: 98 RWKRLKNTNGNSKQTIDGGKGLSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQE 157
RWK +++ GNS ID P +N E E NN Q
Sbjct: 15 RWKIIESYEGNSYTFID--------PTQLPYN----------------EKWEFPRNNLQF 50
Query: 158 SNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKI-RHQ 209
+G G G V +A + + L AVK + H E+E +E+ ++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--------GPTHG-SNLTWHLR--MKIA 258
NI++LLG C H ++ E G L L P +N T R + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+ +L + +HRD+ + N+LL + AK+ DFGL+ S N + G
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNA 226
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQL 373
+ ++APE + + T +SDV+++G++L E+ +G P P +
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----------------YPGI 270
Query: 374 TDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
SK +V + + K++Y + C EP++RP + L
Sbjct: 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFL 321
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 74.7 bits (182), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+G+G G VYKA+ E LAA K I+ + ++ E+ L H I+ LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
H +++ E G+++ + G LT + + L +LH + ++HR
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLH---SKRIIHR 141
Query: 280 DLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKISGTLGYVAPEYLLEGKLTD---- 333
DLK+ N+L+ + +L+DFG+S Q R+ I GT ++APE ++ + D
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 200
Query: 334 -KSDVYAFGVVLLELLMGRRPVEKMSPTQ 361
K+D+++ G+ L+E+ P +++P +
Sbjct: 201 YKADIWSLGITLIEMAQIEPPHHELNPMR 229
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG+G G VY A A+++++ + NE+ + + ++ NI++ L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
+ ++V E + GSL T T +IA + + LE+LH ++ V
Sbjct: 88 VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HRD+KS NILL + KL+DFG QS+ + GT ++APE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNIVDPVIRDTMDLK 394
D+++ G++ +E++ G P +P + ++ T P+L + KL I + +D+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 395 HLYQVAAVAVLCIQPEPSYRPLITDVLHSLIPLV 428
+ +A +L Q +P L SL PL+
Sbjct: 258 VEKRGSAKELLQHQFLKIAKP-----LSSLTPLI 286
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
+E + L A ++ IGEG G V+KAR N A+KR+ G + R
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
E + L H N++ L C + ET+ LV+E + P G +
Sbjct: 61 EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
+ + RGL++LH +H VVHRDLK NIL+ SS KL+DFGL+ Q
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
+ TL Y APE LL+ D+++ G + E+ R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 144 EYELLEAATNNFQESNVI-----GEGGRGHVY--------KARFNEKLLAAVKRI-DDAG 189
EYEL E ++ GEG G V K + N AVK + DA
Sbjct: 3 EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 190 HDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL-------- 240
+ +E+ + I +H+NII+LLG C +++ E G+L + L
Sbjct: 63 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 241 ---HGPTHG--SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
+ P+H L+ + A VARG+EYL + +HRDL + N+L+ K
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 179
Query: 296 LSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
++DFGL+ + ++ N ++ + ++APE L + T +SDV++FGV+L E+
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
+E + L A ++ IGEG G V+KAR N A+KR+ G + R
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
E + L H N++ L C + ET+ LV+E + P G +
Sbjct: 61 EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
+ + RGL++LH +H VVHRDLK NIL+ SS KL+DFGL+ Q
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
+ TL Y APE LL+ D+++ G + E+ R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 29/250 (11%)
Query: 126 ERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRI 185
E +L K+D + + + EL NF R VY+ R +++ A+K +
Sbjct: 323 EELKDKKLFLKRDNLLIADIEL---GCGNFGSV-------RQGVYRMR-KKQIDVAIKVL 371
Query: 186 DDAGHDAE-REFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT 244
A+ E E + ++ + I+ L+G C AE LV EM G L K L G
Sbjct: 372 KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR 430
Query: 245 HG---SNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL 301
SN+ ++ V+ G++YL E VHR+L + N+LL + AK+SDFGL
Sbjct: 431 EEIPVSNVA-----ELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 302 SVTAGTQSR--NVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEK 356
S G + +G L + APE + K + +SDV+++GV + E L G++P +K
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
Query: 357 MSPTQCQSMV 366
M + + +
Sbjct: 543 MKGPEVMAFI 552
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 143 IEYELLEAATNNFQESNVIGEGGRGHVYKAR--FNEKLLAAVKRID-DAGHDAE-----R 194
+E + L A ++ IGEG G V+KAR N A+KR+ G + R
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHA----ETRF-LVYEMMQNGSLEKQLHGPTHGSNL 249
E + L H N++ L C + ET+ LV+E + P G +
Sbjct: 61 EVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 250 TWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
+ + RGL++LH +H VVHRDLK NIL+ SS KL+DFGL+ Q
Sbjct: 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMS 358
+ TL Y APE LL+ D+++ G + E+ R+P+ + S
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
L +P E +SL + ++++ LEA + F + V+G GG G V+ +
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
L A K+++ + + E L K+ + I+SL Y +T LV +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
M G + ++ + R + + GLE+LH+ +++RDLK N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
N ++SD GL+V Q++ +GT G++APE LL + D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
R P
Sbjct: 384 AARGP 388
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 76/228 (33%), Positives = 107/228 (46%), Gaps = 41/228 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVN--WLTKIRHQN 210
+N + +IG G G VYK +E+ +A VK A + F NE N + + H N
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDERPVA-VKVFSFANR---QNFINEKNIYRVPLMEHDN 68
Query: 211 IISLL--GYCIHAETR---FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
I + + A+ R LV E NGSL K L H S+ W ++A V RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSD--WVSSCRLAHSVTRGL 124
Query: 266 EYLH------EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--------VTAGTQSRN 311
YLH +H + HRDL S N+L+ + +SDFGLS V G + N
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED-N 183
Query: 312 VKIS--GTLGYVAPEYLLEGKLT--------DKSDVYAFGVVLLELLM 349
IS GT+ Y+APE +LEG + + D+YA G++ E+ M
Sbjct: 184 AAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWL 203
+ ++ +Q +G G G V K E+ + +K+ +EV L
Sbjct: 16 FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
++ H NI+ L + +LV E+ + G L ++ S + + MK V
Sbjct: 76 KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLS 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGY 320
G YLH+H +VHRDLK N+LL+S S +A K+ DFGLS + + GT Y
Sbjct: 133 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYY 189
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+APE +L K +K DV++ GV+L LL G P
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
A N+Q +GEG G V Y +K+ L + + A D + E+++L
Sbjct: 5 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 64
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+RH +II L + +V E N + + ++ + + +
Sbjct: 65 LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
EY H H +VHRDLK N+LLD N K++DFGLS T +K S G+ Y APE
Sbjct: 121 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 176
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
++ GKL + DV++ GV+L +L R P + S
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
A N+Q +GEG G V Y +K+ L + + A D + E+++L
Sbjct: 1 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 60
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+RH +II L + +V E N + + ++ + + +
Sbjct: 61 LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 116
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
EY H H +VHRDLK N+LLD N K++DFGLS T +K S G+ Y APE
Sbjct: 117 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 172
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
++ GKL + DV++ GV+L +L R P + S
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 161 IGEGGRGHVY----KARFNEKLLAAVK-------RIDDAGHDAER---EFNNEVNWLTKI 206
+G G G V K +EK + +K R D + E+ E NE++ L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H NII L + +LV E + G L +Q+ MK + G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---QILSGIC 160
Query: 267 YLHEHCNHPVVHRDLKSSNILLD---SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
YLH+ H +VHRD+K NILL+ S N K+ DFGLS + GT Y+AP
Sbjct: 161 YLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
E +L+ K +K DV++ GV++ LL G P
Sbjct: 218 E-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 161 IGEGGRGHVY--------KARFNEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI-RHQN 210
+GEG G V K + N AVK + DA + +E+ + I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 211 IISLLGYCIHAETRFLVYEMMQNGSLEKQL-----------HGPTHG--SNLTWHLRMKI 257
II+LLG C +++ E G+L + L + P+H L+ +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-----VTAGTQSRNV 312
A VARG+EYL + +HRDL + N+L+ K++DFGL+ + ++ N
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
++ + ++APE L + T +SDV++FGV+L E+
Sbjct: 198 RLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
L +P E +SL + ++++ LEA + F + V+G GG G V+ +
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
L A K+++ + + E L K+ + I+SL Y +T LV +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
M G + ++ + R + + GLE+LH+ +++RDLK N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
N ++SD GL+V Q++ +GT G++APE LL + D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
R P
Sbjct: 384 AARGP 388
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
L +P E +SL + ++++ LEA + F + V+G GG G V+ +
Sbjct: 154 LGQAPFQEFLDSLYF------LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
L A K+++ + + E L K+ + I+SL Y +T LV +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
M G + ++ + R + + GLE+LH+ +++RDLK N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
N ++SD GL+V Q++ +GT G++APE LL + D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
R P
Sbjct: 384 AARGP 388
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 140 VSVIEYELLEAATNNFQESNV-----IGEGGRGHVY--------KARFNEKLLAAVKRI- 185
V EYEL E F + +GEG G V K + E + AVK +
Sbjct: 17 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 76
Query: 186 DDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGP- 243
DDA + +E+ + I +H+NII+LLG C +++ G+L + L
Sbjct: 77 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARR 136
Query: 244 ------------THGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSS 291
+T+ + +ARG+EYL + +HRDL + N+L+ +
Sbjct: 137 PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTEN 193
Query: 292 FNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
K++DFGL+ K + + ++APE L + T +SDV++FGV++ E+
Sbjct: 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID ++ ++ EV + + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G+ Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLE---AATNNFQESNVIGEGGRGHVY--KAR 173
LS++P + +S+ ++++ LE N F++ V+G+GG G V + R
Sbjct: 153 LSVAPFADYLDSIYFN------RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 174 FNEKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
K+ A K + E NE L K+ + ++SL + LV +M
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
G L+ ++ H + + A ++ GLE LH +V+RDLK NILLD
Sbjct: 267 NGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLD 320
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM 349
+ ++SD GL+V GT+GY+APE + + T D +A G +L E++
Sbjct: 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 350 GRRPVEK 356
G+ P ++
Sbjct: 381 GQSPFQQ 387
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID ++ ++ EV + + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G+ Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
A N+Q +GEG G V Y +K+ L + + A D + E+++L
Sbjct: 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 69
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+RH +II L + +V E N + + ++ + + +
Sbjct: 70 LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 125
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
EY H H +VHRDLK N+LLD N K++DFGLS T +K S G+ Y APE
Sbjct: 126 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 181
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
++ GKL + DV++ GV+L +L R P + S
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 150 AATNNFQESNVIGEGGRGHV---YKARFNEKL-LAAVKRIDDAGHDAEREFNNEVNWLTK 205
A N+Q +GEG G V Y +K+ L + + A D + E+++L
Sbjct: 11 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRL 70
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+RH +II L + +V E N + + ++ + + +
Sbjct: 71 LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR----DKMSEQEARRFFQQIISAV 126
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPE 324
EY H H +VHRDLK N+LLD N K++DFGLS T +K S G+ Y APE
Sbjct: 127 EYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE 182
Query: 325 YLLEGKLT--DKSDVYAFGVVLLELLMGRRPVEKMS 358
++ GKL + DV++ GV+L +L R P + S
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/247 (27%), Positives = 113/247 (45%), Gaps = 21/247 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLE---AATNNFQESNVIGEGGRGHVY--KAR 173
LS++P + +S+ ++++ LE N F++ V+G+GG G V + R
Sbjct: 153 LSVAPFADYLDSIYFN------RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 174 FNEKLLAAVKRIDDAGHDAEREFN--NEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMM 231
K+ A K + E NE L K+ + ++SL + LV +M
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 232 QNGSLEKQLHGPTHGSNLTWHLRMKI--AVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
G L+ ++ H + + A ++ GLE LH +V+RDLK NILLD
Sbjct: 267 NGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLD 320
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM 349
+ ++SD GL+V GT+GY+APE + + T D +A G +L E++
Sbjct: 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380
Query: 350 GRRPVEK 356
G+ P ++
Sbjct: 381 GQSPFQQ 387
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AV+ ID ++ ++ EV + + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ + G+ Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID ++ ++ EV + + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 105
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNL-TWHLR----MKIAVDVARGLEYLHEHC 272
I+ R E M++ L L G L T HL + RGL+Y+H
Sbjct: 106 -INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 161
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 161 IGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYC 218
G+ +GH++ E+ A A+K + D RE F +E +++H N++ LLG
Sbjct: 22 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 219 IHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDVARGL 265
+ +++ +G L + L P T S L + + +A G+
Sbjct: 82 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVA 322
EYL +H VVH+DL + N+L+ N K+SD GL + +L ++A
Sbjct: 142 EYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
PE ++ GK + SD++++GVVL E+ G +P S M+ +R LP
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-------RNRQVLPC 251
Query: 382 IVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
D P V A+ + C PS RP D+
Sbjct: 252 PDDCPA-----------WVYALMIECWNEFPSRRPRFKDI 280
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 161 IGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYC 218
G+ +GH++ E+ A A+K + D RE F +E +++H N++ LLG
Sbjct: 39 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98
Query: 219 IHAETRFLVYEMMQNGSLEKQL--HGP-----------THGSNLTWHLRMKIAVDVARGL 265
+ +++ +G L + L P T S L + + +A G+
Sbjct: 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL---GYVA 322
EYL +H VVH+DL + N+L+ N K+SD GL + +L ++A
Sbjct: 159 EYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 215
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPN 381
PE ++ GK + SD++++GVVL E+ G +P S M+ +R LP
Sbjct: 216 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-------RNRQVLPC 268
Query: 382 IVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
D P V A+ + C PS RP D+
Sbjct: 269 PDDCPA-----------WVYALMIECWNEFPSRRPRFKDI 297
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 73.2 bits (178), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG+G G VY A A+++++ + NE+ + + ++ NI++ L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
+ ++V E + GSL T T +IA + + LE+LH ++ V
Sbjct: 88 VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HRD+KS NILL + KL+DFG QS+ + GT ++APE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
D+++ G++ +E++ G P +P + ++ T P+L + KL I
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG+G G VY A A+++++ + NE+ + + ++ NI++ L +
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
+ ++V E + GSL T T +IA + + LE+LH ++ V
Sbjct: 89 VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HRD+KS NILL + KL+DFG QS+ + GT ++APE + K
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
D+++ G++ +E++ G P +P + ++ T P+L + KL I
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID ++ ++ EV + + H NI+ L
Sbjct: 16 GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 75
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 76 ETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVH 129
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G+ Y APE L +GK D + D
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 188
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 189 VWSLGVILYTLVSGSLPFD 207
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK----LLAAVKRIDDAGHDAEREFNN--EVNWLT 204
AT+ ++ IG G G VYKAR L +V+ + G + EV L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 205 KIR---HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
++ H N++ L+ C + T LV+E + P G L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKD 124
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG 316
+ RGL++LH +C +VHRDLK NIL+ S KL+DFGL+ Q +
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
TL Y APE LL+ D+++ G + E+ R+P+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
+A + F+ V+G+G G V+ + + + L A+K + A E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
L ++ H I+ L Y E + +L+ + ++ G L +L + ++ ++L
Sbjct: 80 LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 133
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
++A L++LH + +++RDLK NILLD + KL+DFGLS + + + GT+
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
Y+APE + T +D ++FGV++ E+L G P + + +M+ A MPQ
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
+A + F+ V+G+G G V+ + + + L A+K + A E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
L ++ H I+ L Y E + +L+ + ++ G L +L + ++ ++L
Sbjct: 80 LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 133
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
++A L++LH + +++RDLK NILLD + KL+DFGLS + + + GT+
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
Y+APE + T +D ++FGV++ E+L G P + + +M+ A MPQ
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 63/238 (26%), Positives = 116/238 (48%), Gaps = 22/238 (9%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----FNEKLLAAVKRIDDAGHDAEREFNN--EVNW 202
+A + F+ V+G+G G V+ + + + L A+K + A E +
Sbjct: 21 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 203 LTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHLRMKIAV 259
L ++ H I+ L Y E + +L+ + ++ G L +L + ++ ++L
Sbjct: 81 LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-----A 134
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNVKISGTL 318
++A L++LH + +++RDLK NILLD + KL+DFGLS + + + GT+
Sbjct: 135 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA---MPQL 373
Y+APE + T +D ++FGV++ E+L G P + + +M+ A MPQ
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 249
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 86/290 (29%), Positives = 132/290 (45%), Gaps = 60/290 (20%)
Query: 160 VIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYC 218
V G G V+KA+ NE + + I D + E+ EV L ++H+NI+ +G
Sbjct: 31 VKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEY--EVYSLPGMKHENILQFIG-- 85
Query: 219 IHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
AE R +L+ + GSL L ++W+ IA +ARGL YLHE
Sbjct: 86 --AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE 139
Query: 271 HC------NHPVV-HRDLKSSNILLDSSFNAKLSDFGLSVT--AGTQSRNVKIS-GTLGY 320
+ P + HRD+KS N+LL ++ A ++DFGL++ AG + + GT Y
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 321 VAPEYLLEGKLTDKS------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLT 374
+APE +LEG + + D+YA G+VL EL R P + +P
Sbjct: 200 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWEL--ASRCTAADGPVD-----EYMLPFEE 251
Query: 375 DRSKLPNIVD-----------PVIRDTMDLKHLYQVAAVAVLCIQPEPSY 413
+ + P++ D PV+RD KH A +A+LC E +
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQ-KH----AGMAMLCETIEECW 296
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AV+ ID ++ ++ EV + + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G+ Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 196 VWSLGVILYTLVSGSLPFD 214
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 77/316 (24%), Positives = 135/316 (42%), Gaps = 61/316 (19%)
Query: 146 ELLEAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNN 198
E E NN Q +G G G V +A + + L AVK + H E+E +
Sbjct: 24 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 199 EVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSL-------EKQLHGPT------ 244
E+ ++ + +H+NI++LLG C H ++ E G L + + GP+
Sbjct: 84 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 245 -------HGSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKL 296
G L + + VA+G+ +L ++C +HRD+ + N+LL + AK+
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKI 199
Query: 297 SDFGLSVTAGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGR 351
DFGL+ S N + G + ++APE + + T +SDV+++G++L E+ +G
Sbjct: 200 GDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 258
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVD---PVIRDTMDLKHLYQVAAVAVLCIQ 408
P P + SK +V + + K++Y + C
Sbjct: 259 NP----------------YPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQA---CWA 299
Query: 409 PEPSYRPLITDVLHSL 424
EP++RP + L
Sbjct: 300 LEPTHRPTFQQICSFL 315
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 20/245 (8%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEA---ATNNFQESNVIGEGGRGHVYKARFN 175
L +P E +S K + ++++ LEA + F + V+G GG G V+ +
Sbjct: 154 LGQAPFQEFLDS------KYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK 207
Query: 176 EK-LLAAVKRIDDAGHDAEREFNN---EVNWLTKIRHQNIISLLGYCIHAETRF-LVYEM 230
L A K+++ + + E L K+ + I+SL Y +T LV +
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 231 MQNGSLEKQLHGPTHGSNLTWHLR-MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
M G + ++ + R + + GLE+LH+ +++RDLK N+LLD
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 290 SSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
N ++SD GL+V Q++ +GT G++APE LL + D +A GV L E++
Sbjct: 324 DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 349 MGRRP 353
R P
Sbjct: 384 AARGP 388
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 120
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+
Sbjct: 121 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
K+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 228
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 229 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 265
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 161 IGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+GEG G VYKA E + A+K++ +E E++ + + +++ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
++V E GS+ + LT I +GLEYLH +HR
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHR 149
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
D+K+ NILL++ +AKL+DFG++ +T RN I GT ++APE + E +D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVADI 208
Query: 338 YAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
++ G+ +E+ G+ P + P + M+
Sbjct: 209 WSLGITAIEMAEGKPPYADIHPMRAIFMI 237
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFN-NEVNWLTKIRHQNIISLLGYC 218
IGEG G V A N K+ A+K+I H + E+ L + RH+NII +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI-NDI 93
Query: 219 IHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 94 IRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 89 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 144
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+
Sbjct: 145 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 196
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
K+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 197 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 252
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 253 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 289
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 72.4 bits (176), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID + ++ EV + + H NI+ L
Sbjct: 24 GKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 84 ETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVH 137
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD N K++DFG S ++ G+ Y APE L +GK D + D
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 196
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 85
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 86 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+V+G G V A + +KL+A +A E NE+ L KI+H NI++L
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+L+ +++ G L EK + S L + V ++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ +VHRDLK N+L LD +SDFGLS S GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
+ D ++ GV+ LL G P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
IG G G K R V + D G E E +EVN L +++H NI+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
I T ++V E + G L + G L +++ + L+ H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
H V+HRDLK +N+ LD N KL DFGL+ + K GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
+KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
IG G G K R V + D G E E +EVN L +++H NI+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
I T ++V E + G L + G L +++ + L+ H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
H V+HRDLK +N+ LD N KL DFGL+ + K GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
+KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 71 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 126
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+ R
Sbjct: 127 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 178
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 179 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 234
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 235 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 271
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 146
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV 312
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+
Sbjct: 147 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198
Query: 313 KI-SGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
K+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 254
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 255 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 291
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 90 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 89 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 67 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 122
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+ R
Sbjct: 123 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 230
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 231 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 267
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL------EKQLHGPTHGSNLTWH 252
E++ + HQ+++ G+ + F+V E+ + SL K L P ++
Sbjct: 67 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYY 122
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRN 311
LR + G +YLH + V+HRDLK N+ L+ K+ DFGL+ R
Sbjct: 123 LR-----QIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 174
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE L + + + DV++ G ++ LL+G+ P E T C +
Sbjct: 175 KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE----TSCLKETYLRIK 230
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
+ + +P ++PV A++ +Q +P+ RP I ++L+
Sbjct: 231 K--NEYSIPKHINPV------------AASLIQKMLQTDPTARPTINELLN 267
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L AVK ID ++ ++ EV + H NI+ L
Sbjct: 23 GKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVI 82
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +LV E G + L HG R K + ++Y H+ +VH
Sbjct: 83 ETEKTLYLVXEYASGGEVFDYL--VAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S ++ G Y APE L +GK D + D
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 195
Query: 337 VYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
V++ GV+L L+ G P + + + + V
Sbjct: 196 VWSLGVILYTLVSGSLPFDGQNLKELRERV 225
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 87
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 88 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 143
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 83
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 84 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 55/158 (34%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
EV L + H NI+ L + +LV E + G L ++ H I
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI---IHRMKFNEVDAAVII 142
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKIS 315
V G+ YLH+H +VHRDLK N+LL+S K+ DFGLS Q + +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT Y+APE +L K +K DV++ GV+L LL G P
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 90
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 91 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 146
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 91
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 92 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 147
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 82
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 83 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 138
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 90 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 89 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 93
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 94 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 149
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 85
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 86 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 141
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 83
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 84 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 139
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 72.0 bits (175), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 92
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 152 TNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
++ +Q +G G G V K E+ + +K+ +EV L ++
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
H NI+ L + +LV E+ + G L ++ S + + MK V G Y
Sbjct: 63 HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTY 119
Query: 268 LHEHCNHPVVHRDLKSSNILLDS-SFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
LH+H +VHRDLK N+LL+S S +A K+ DFGLS + + GT Y+APE
Sbjct: 120 LHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE 176
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+L K +K DV++ GV+L LL G P
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCGYPP 204
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 108
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 109 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 161
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 23/273 (8%)
Query: 154 NFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI---DDAGHDAEREFNNEVNWLTKIRHQ 209
NF+ IG G VY+A + + A+K++ D A + E++ L ++ H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYL 268
N+I I +V E+ G L + + H + K V + LE++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV-KISGTLGYVAPEYLL 327
H + V+HRD+K +N+ + ++ KL D GL +++ + GT Y++PE +
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 328 EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVI 387
E KSD+++ G +L E+ SP M +++ + ++ P + P
Sbjct: 210 ENGYNFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSD 261
Query: 388 RDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDV 420
+ +L+ L +CI P+P RP +T V
Sbjct: 262 HYSEELRQLVN------MCINPDPEKRPDVTYV 288
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+V+G G V A + +KL+A +A E NE+ L KI+H NI++L
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+L+ +++ G L EK + S L + V ++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ +VHRDLK N+L LD +SDFGLS S GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
+ D ++ GV+ LL G P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+V+G G V A + +KL+A +A E NE+ L KI+H NI++L
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+L+ +++ G L EK + S L + V ++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ +VHRDLK N+L LD +SDFGLS S GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
+ D ++ GV+ LL G P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 92
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 93
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 94 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 146
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 71.6 bits (174), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L + RH+NII +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGI-ND 88
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 89 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L A+K ID + ++ EV + + H NI+ L
Sbjct: 21 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 80
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +L+ E G + L HG R K + ++Y H+ +VH
Sbjct: 81 ETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 134
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S + G+ Y APE L +GK D + D
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE-LFQGKKYDGPEVD 193
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 194 VWSLGVILYTLVSGSLPFD 212
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
N++ ++G G R ++K E AVK ID G AE RE E
Sbjct: 4 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
V+ L K+ H NII L FLV+++M+ G L L S M+
Sbjct: 61 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
++V L L+ +VHRDLK NILLD N KL+DFG S + ++ GT
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 174
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
Y+APE ++E + D + D+++ GV++ LL G P
Sbjct: 175 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/244 (26%), Positives = 119/244 (48%), Gaps = 34/244 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKAR----------FNEKLL--AAVKRIDDAGHDAEREF 196
+A ++F+ V+G+G G V+ R + K+L A +K D ER+
Sbjct: 24 KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGS--NLTWHL 253
+VN H ++ L Y E + +L+ + ++ G L +L + ++ ++L
Sbjct: 84 LADVN------HPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 136
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-GTQSRNV 312
++A GL++LH + +++RDLK NILLD + KL+DFGLS A + +
Sbjct: 137 -----AELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY 188
Query: 313 KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA--- 369
GT+ Y+APE + + +D +++GV++ E+L G P + + +++ A
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLG 248
Query: 370 MPQL 373
MPQ
Sbjct: 249 MPQF 252
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
+ ++GEG G VY+ + EK+ AVK D D + +F +E + + H +I+
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
L+G I E +++ E+ G L L + ++L + ++ + + + YL E
Sbjct: 73 KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 128
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
N VHRD+ NIL+ S KL DFGLS + K S T + +++PE +
Sbjct: 129 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 185
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
+ T SDV+ F V + E+L G++P + ++ + DR P++ PV+
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 240
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
M C +PS RP T+++ SL
Sbjct: 241 TLM------------TRCWDYDPSDRPRFTELVCSL 264
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
+ ++GEG G VY+ + EK+ AVK D D + +F +E + + H +I+
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
L+G I E +++ E+ G L L + ++L + ++ + + + YL E
Sbjct: 89 KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 144
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
N VHRD+ NIL+ S KL DFGLS + K S T + +++PE +
Sbjct: 145 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 201
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
+ T SDV+ F V + E+L G++P + ++ + DR P++ PV+
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 256
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
M C +PS RP T+++ SL
Sbjct: 257 TLM------------TRCWDYDPSDRPRFTELVCSL 280
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 165 GRGHVYKARFNEKLLA----AVKRIDDAGHDAE--REFNNEVNWLTKIRHQNIISLLGYC 218
G+G+ K + +L A+K ID + ++ EV + + H NI+ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 219 IHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVH 278
+T +L+ E G + L HG R K + ++Y H+ +VH
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 137
Query: 279 RDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD--KSD 336
RDLK+ N+LLD+ N K++DFG S + G Y APE L +GK D + D
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE-LFQGKKYDGPEVD 196
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV+L L+ G P +
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 9/197 (4%)
Query: 160 VIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAERE---FNNEVNWLTKIRHQNIISLLG 216
IG G G K R V + D G E E +EVN L +++H NI+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 217 YCIHAE--TRFLVYEMMQNGSLEKQL-HGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
I T ++V E + G L + G L +++ + L+ H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 274 --HPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
H V+HRDLK +N+ LD N KL DFGL+ K GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 331 LTDKSDVYAFGVVLLEL 347
+KSD+++ G +L EL
Sbjct: 193 YNEKSDIWSLGCLLYEL 209
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 33/276 (11%)
Query: 158 SNVIGEGGRGHVYKARFN----EKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNII 212
+ ++GEG G VY+ + EK+ AVK D D + +F +E + + H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 213 SLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
L+G I E +++ E+ G L L + ++L + ++ + + + YL E
Sbjct: 77 KLIGI-IEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAYL-ESI 132
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAPEYLLEG 329
N VHRD+ NIL+ S KL DFGLS + K S T + +++PE +
Sbjct: 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFR 189
Query: 330 KLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIR 388
+ T SDV+ F V + E+L G++P + ++ + DR P++ PV+
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-----EKGDRLPKPDLCPPVLY 244
Query: 389 DTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
M C +PS RP T+++ SL
Sbjct: 245 TLM------------TRCWDYDPSDRPRFTELVCSL 268
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG+G G VY A A+++++ + NE+ + + ++ NI++ L +
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV---DVARGLEYLHEHCNHPV 276
+ ++V E + GSL T T +IA + + LE+LH ++ V
Sbjct: 89 VGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HR++KS NILL + KL+DFG QS+ + GT ++APE + K
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 336 DVYAFGVVLLELLMGRRPVEKMSPTQCQSMV-TWAMPQLTDRSKLPNI 382
D+++ G++ +E++ G P +P + ++ T P+L + KL I
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+++I H +R E+ L + RH+NII
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIG---- 89
Query: 218 CIHAETRFLVYEMMQN-----GSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
I+ R E M++ +E L+ +L+ + RGL+Y+H
Sbjct: 90 -INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--- 145
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLLE 328
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKI 206
++ V+G G G V+K + + K+ +K I+D +G + + + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H +I+ LLG C + + LV + + GSL H H L L + V +A+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAP 323
YL EH +VHR+L + N+LL S +++DFG++ + + S + ++A
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL 348
E + GK T +SDV+++GV + EL+
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELM 211
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
D + E+ L RH +II L F+V E + G L + HG
Sbjct: 53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEE 110
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
R ++ + ++Y H H VVHRDLK N+LLD+ NAK++DFGLS
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMV- 366
G+ Y APE ++ G+L + D+++ GV+L LL G P ++ PT + +
Sbjct: 167 LRDSCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225
Query: 367 -TWAMPQLTDRSKLPNI-----VDPVIRDTM 391
+ +P+ +RS + VDP+ R T+
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPLKRATI 256
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A + AVK + + A H R +E+ L I H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-----------HGSNLTWHLRMKIAVD 260
+LLG C +V E + G+L L + LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT--- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQLT 374
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEG 267
Query: 375 DRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 268 TRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L RH+NII +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGI-ND 90
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 91 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
D + E+ L RH +II L F+V E + G L + HG
Sbjct: 53 DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEE 110
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
R ++ + ++Y H H VVHRDLK N+LLD+ NAK++DFGLS
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMV- 366
G+ Y APE ++ G+L + D+++ GV+L LL G P ++ PT + +
Sbjct: 167 LRTSCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225
Query: 367 -TWAMPQLTDRSKLPNI-----VDPVIRDTM 391
+ +P+ +RS + VDP+ R T+
Sbjct: 226 GVFYIPEYLNRSVATLLMHMLQVDPLKRATI 256
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
N++ ++G G R ++K E AVK ID G AE RE E
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
V+ L K+ H NII L FLV+++M+ G L L S M+
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
++V L L+ +VHRDLK NILLD N KL+DFG S + ++ GT
Sbjct: 134 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
Y+APE ++E + D + D+++ GV++ LL G P
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 9/167 (5%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
D + E+ L RH +II L F+V E + G L + L
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLD 114
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
++ + G++Y H H VVHRDLK N+LLD+ NAK++DFGLS
Sbjct: 115 EKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
Query: 311 NVKISGTLGYVAPEYLLEGKLT--DKSDVYAFGVVLLELLMGRRPVE 355
G+ Y APE ++ G+L + D+++ GV+L LL G P +
Sbjct: 172 LRXSCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 45/288 (15%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A + AVK + + A H R +E+ L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQL---------HGPTHGSNLTWHLRMKIAVDVA 262
+LLG C +V E + G+L L + + LT + + VA
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LG 319
+G+E+L + +HRDL + NILL K+ DFGL+ V+ L
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQLTDR 376
++APE + + T +SDV++FGV+L E+ +G P K+ C+ + + R
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEGTR 265
Query: 377 SKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ P+ P + TM + C EPS RP ++++ L
Sbjct: 266 MRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 301
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 159 NVIGEGGRGHVYKA--RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+V+G G V A + +KL+A A E NE+ L KI+H NI++L
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 217 YCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+L+ +++ G L EK + S L + V ++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQ--------VLDAVKYLH-- 133
Query: 272 CNHPVVHRDLKSSNIL---LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ +VHRDLK N+L LD +SDFGLS S GT GYVAPE L +
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
+ D ++ GV+ LL G P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 158 SNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+IG+G G VY R++ ++ + I+ D + F EV + RH+N++ +G
Sbjct: 38 GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLR--MKIAVDVARGLEYLHEHCNHP 275
C+ ++ + + + L+ + + + +IA ++ +G+ YLH
Sbjct: 98 CMSPPHLAIITSLCKG----RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGTQSRNVKI-SGTLGYVAPEYLL-- 327
++H+DLKS N+ D+ ++DFGL + AG + ++I +G L ++APE +
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 328 -----EGKL--TDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAM 370
E KL + SDV+A G + EL P + TQ + W M
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIWQM 255
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKI 206
++ V+G G G V+K + + K+ +K I+D +G + + + + + +
Sbjct: 31 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
H +I+ LLG C + + LV + + GSL H H L L + V +A+G+
Sbjct: 91 DHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMY 147
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LGYVAP 323
YL EH +VHR+L + N+LL S +++DFG++ + + S + ++A
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL 348
E + GK T +SDV+++GV + EL+
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELM 229
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 27/269 (10%)
Query: 161 IGEGGRG--HVYKARFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+G G G H+ + R + L +K I+ D + E+ L + H NII +
Sbjct: 30 LGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 218 CIHAETRFLVYEMMQNGSL-EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
++V E + G L E+ + G L+ ++ + L Y H + V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHV 145
Query: 277 VHRDLKSSNILL-DSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD 333
VH+DLK NIL D+S ++ K+ DFGL+ + + +GT Y+APE + + +T
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTF 204
Query: 334 KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
K D+++ GVV+ LL G P S + Q T+ P + P+ +DL
Sbjct: 205 KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR------PLTPQAVDL 258
Query: 394 KHLYQVAAVAVLCIQPEPSYRPLITDVLH 422
L Q+ + +P RP VLH
Sbjct: 259 --LKQM-------LTKDPERRPSAAQVLH 278
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 77 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 153 NNFQESNVIGEGG----RGHVYKARFNEKLLAAVKRIDDAG---HDAE-----REFN-NE 199
N++ ++G G R ++K E AVK ID G AE RE E
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 200 VNWLTKIR-HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
V+ L K+ H NII L FLV+++M+ G L L S M+
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
++V L L+ +VHRDLK NILLD N KL+DFG S + + GT
Sbjct: 134 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTP 187
Query: 319 GYVAPEYLLEGKLTD-------KSDVYAFGVVLLELLMGRRP 353
Y+APE ++E + D + D+++ GV++ LL G P
Sbjct: 188 SYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 127
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQ 211
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 45 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 105 IG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 158
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 219 SASDVWMFGVCMWEILMHGVKPFQ 242
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNI 211
+++ IGEG G V+KA+ E + A+KR+ DD E+ L +++H+NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
+ L +H++ + LV+E + L+K + +L + + +GL + H
Sbjct: 64 VRLHD-VLHSDKKLTLVFEFC-DQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEG 329
+ V+HRDLK N+L++ + KL+DFGL+ G R TL Y P+ L
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 330 KLTDKS-DVYAFGVVLLELLMGRRPV 354
KL S D+++ G + EL RP+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPL 202
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G V A N K+ A+K+I H +R E+ L RH+NII +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGI-ND 90
Query: 218 CIHAET------RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I A T ++V ++M E L+ +L+ + RGL+Y+H
Sbjct: 91 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 143
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+LL+++ + K+ DFGL+ A + + T Y APE +L
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEK-LLAAVK--RIDDAGHDAEREFN-NEVNWLTKI 206
+NF+ V+G+G G V AR E L AVK + D D + E E L+
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 207 RHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
R+ ++ L C R F V E + G L + A ++ L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF---YAAEIISAL 137
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKISGTLGYVA 322
+LH + +++RDLK N+LLD + KL+DFG+ + G + GT Y+A
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIA 192
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
PE L E D +A GV+L E+L G P E
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 82 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 135
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQ 219
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 70.1 bits (170), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 160 VIGEGGRGHVY--KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
V+G G V+ K R KL A +K I + + NE+ L KI+H+NI++L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFA-LKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 218 CIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+LV +++ G L E+ ++ S + V ++YLHE+
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--------LVIQQVLSAVKYLHEN- 125
Query: 273 NHPVVHRDLKSSNIL-LDSSFNAKL--SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEG 329
+VHRDLK N+L L N+K+ +DFGLS + GT GYVAPE L +
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPEVLAQK 182
Query: 330 KLTDKSDVYAFGVVLLELLMGRRP 353
+ D ++ GV+ LL G P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 154 NFQESNVIGEGGRGHVYKARFNEK----LLAAVKR----IDDAGHDAEREFNNEVNWLTK 205
+F+ ++G+G G V+ A F + + A+K+ +DD D E +
Sbjct: 19 DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD---DVECTMVEKRVLSLA 75
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + + E F V E + G L + H +L+ A ++ GL
Sbjct: 76 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLS--RATFYAAEIILGL 132
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPE 324
++LH + +V+RDLK NILLD + K++DFG+ ++ + GT Y+APE
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRPV 354
LL K D ++FGV+L E+L+G+ P
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 19 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 79 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 132
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 193 SASDVWMFGVCMWEILMHGVKPFQ 216
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 13/210 (6%)
Query: 150 AATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR 207
++++ F++ +G G VYK + A+K + D+ E++ + +++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 208 HQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSN---LTWHLRMKIAVDVAR 263
H+NI+ L IH E + LV+E M N L+K + T G+ L +L + +
Sbjct: 62 HENIVRLYD-VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVA 322
GL + HE+ ++HRDLK N+L++ KL DFGL+ G TL Y A
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 323 PEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
P+ L+ + S D+++ G +L E++ G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT------------HGSNLTWHLRMKIAV 259
+LLG C +V E + G+L L + LT + +
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT-- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 318 -LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQL 373
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KE 266
Query: 374 TDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 267 GTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
H +II+L+ + FLV+++M+ G L L T L+ I + + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSF 215
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYL- 326
LH + +VHRDLK NILLD + +LSDFG S + ++ GT GY+APE L
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 327 -----LEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ D++A GV+L LL G P
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N L A+K + D+ RE F E + + H +I+ L
Sbjct: 20 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 80 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 133
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQ 217
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N + A+K + D+ RE F E + + H +I+ L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L + +L + A ++ L YL +
Sbjct: 77 IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N + A+K + D+ RE F E + + H +I+ L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L +L + A ++ L YL +
Sbjct: 77 IGV-ITENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ S+ KL DFGLS + T + K + ++APE + + T
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 69.3 bits (168), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRIDD---AGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+GEG G V A + + A+K I D E+++L +RH +II L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
I T ++ G L + +T + + +EY H H +
Sbjct: 77 -VITTPTDIVMVIEYAGGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCH---RHKI 129
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLT--D 333
VHRDLK N+LLD + N K++DFGLS T +K S G+ Y APE ++ GKL
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPE-VINGKLYAGP 187
Query: 334 KSDVYAFGVVLLELLMGRRPVE 355
+ DV++ G+VL +L+GR P +
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFD 209
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 78/261 (29%), Positives = 125/261 (47%), Gaps = 54/261 (20%)
Query: 135 GKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDA--- 188
G+ D + +YEL++ +G+G G V+K+ R E + AVK+I DA
Sbjct: 1 GRVDRHVLRKYELVKK----------LGKGAYGIVWKSIDRRTGE--VVAVKKIFDAFQN 48
Query: 189 GHDAEREFNNEVNWLTKIR-HQNIISLLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTH 245
DA+R F E+ LT++ H+NI++LL R +LV++ M E LH
Sbjct: 49 STDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIR 102
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--- 302
+ L + + + + ++YLH + ++HRD+K SNILL++ + K++DFGLS
Sbjct: 103 ANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159
Query: 303 VTAGTQSRNVKIS-------------------GTLGYVAPEYLL-EGKLTDKSDVYAFGV 342
V + N+ +S T Y APE LL K T D+++ G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGC 219
Query: 343 VLLELLMGRRPVEKMSPTQCQ 363
+L E+L G +P+ S T Q
Sbjct: 220 ILGEILCG-KPIFPGSSTMNQ 239
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 179 LAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF--LVYEMMQNGS 235
+ AVK + + G + E+ L + H++I+ G C + LV E + GS
Sbjct: 40 MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 99
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
L L P H L L A + G+ YLH +HR L + N+LLD+ K
Sbjct: 100 LRDYL--PRHCVGLAQLLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVK 152
Query: 296 LSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-- 349
+ DFGL+ V G + V+ G + + APE L E K SDV++FGV L ELL
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYC 212
Query: 350 --GRRPVEKMSP----TQCQSMVTWAMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAV 402
+ P K + TQ Q M + +L +R +LP R ++ HL +
Sbjct: 213 DSNQSPHTKFTELIGHTQGQ-MTVLRLTELLERGERLPR----PDRCPCEIYHLMKN--- 264
Query: 403 AVLCIQPEPSYRPLITDVLHSLIPLVPT 430
C + E S+RP +L+P++ T
Sbjct: 265 ---CWETEASFRP----TFQNLVPILQT 285
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 68.9 bits (167), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
+++FQ +++GEG G V A + A+K+I+ D A R E+ L +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
+NII++ I F ++ E+MQ LH L+
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
R ++ LH V+HRDLK SN+L++S+ + K+ DFGL S G QS
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
V+ T Y APE +L K + DV++ G +L EL + RRP+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 79/268 (29%), Positives = 119/268 (44%), Gaps = 38/268 (14%)
Query: 179 LAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF--LVYEMMQNGS 235
+ AVK + + G + E+ L + H++I+ G C + LV E + GS
Sbjct: 39 MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 98
Query: 236 LEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAK 295
L L P H L L A + G+ YLH +HR L + N+LLD+ K
Sbjct: 99 LRDYL--PRHCVGLAQLLL--FAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVK 151
Query: 296 LSDFGLS--VTAGTQSRNVKISGT--LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-- 349
+ DFGL+ V G + V+ G + + APE L E K SDV++FGV L ELL
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYC 211
Query: 350 --GRRPVEKMSP----TQCQSMVTWAMPQLTDR-SKLPNIVDPVIRDTMDLKHLYQVAAV 402
+ P K + TQ Q M + +L +R +LP R ++ HL +
Sbjct: 212 DSNQSPHTKFTELIGHTQGQ-MTVLRLTELLERGERLPR----PDRCPCEIYHLMKN--- 263
Query: 403 AVLCIQPEPSYRPLITDVLHSLIPLVPT 430
C + E S+RP +L+P++ T
Sbjct: 264 ---CWETEASFRP----TFQNLVPILQT 284
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 68.9 bits (167), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+G+G G V++ ++ + +A D+ E E N V +RH NI+ +
Sbjct: 15 CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNILGFIAS 70
Query: 218 CIHAETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
+ + +L+ ++GSL L T L HL +++AV A GL +LH
Sbjct: 71 DMTSRNSSTQLWLITHYHEHGSLYDFLQRQT----LEPHLALRLAVSAACGLAHLHVEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
+ HRD KS N+L+ S+ ++D GL+V S + I GT Y+AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTDK------SDVYAFGVVLLELLMGRRPV 354
E L E TD +D++AFG+VL E+ RR +
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARF-----NEKLLAAVKRI-DDAGHDAEREFNNEVNWLTKI 206
++ V+G G G VYK + N K+ A+K + ++ A +E +E + +
Sbjct: 17 TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+ LLG C+ + + LV ++M G L H + L + + +A+G+
Sbjct: 77 GSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISG---TLGYVAP 323
YL + +VHRDL + N+L+ S + K++DFGL+ G + ++A
Sbjct: 134 YLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE 355
E +L + T +SDV+++GV + EL+ G +P +
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 265
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 266 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 305
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 213 SLLGYCIHAETRFLVY-EMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 256
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 257 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 296
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 38/280 (13%)
Query: 112 TIDGGKG-LSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVY 170
+ DGG G L + + L G + V + +ELL+ V+G G G V+
Sbjct: 22 SADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----------VLGTGAYGKVF 71
Query: 171 KAR----------FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
R + K+L + A E L IR + L Y
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129
Query: 221 AETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
ET+ L+ + + G L L + T H ++ LE+LH+ +++R
Sbjct: 130 TETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYR 183
Query: 280 DLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT-DKS- 335
D+K NILLDS+ + L+DFGLS A R GT+ Y+AP+ + G DK+
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 336 DVYAFGVVLLELLMGRRPV----EKMSPTQCQSMVTWAMP 371
D ++ GV++ ELL G P EK S + + + P
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 155 FQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQNI 211
+ + IGEG G V A + K A+K+I H +R E+ L + RH+N+
Sbjct: 45 YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENV 103
Query: 212 ISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
I + + + + +E L+ L+ + RGL+Y+H
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH-- 161
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN----VKISGTLGYVAPEYLL 327
+ V+HRDLK SN+L++++ + K+ DFGL+ A + + + T Y APE +L
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 328 EGKLTDKS-DVYAFGVVLLELLMGR 351
K KS D+++ G +L E+L R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 302
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 303 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 342
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 161 IGEGGRGHVYKA-RFNEKLLAAVKRI------DDAGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A F A + + + A H R +E+ L I H N++
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQLHGPT-------------HGSNLTWHLRMKIA 258
+LLG C +V E + G+L L + LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT- 317
VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 318 --LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMPQ 372
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ + +
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------K 267
Query: 373 LTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P+ P + TM + C EPS RP ++++ L
Sbjct: 268 EGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 307
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 68.6 bits (166), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 193 EREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGS 247
E NE+ L KI+H+NI++L +LV +++ G L EK + S
Sbjct: 64 ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS 123
Query: 248 NLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVT 304
L +R V + YLH +VHRDLK N+L D +SDFGLS
Sbjct: 124 TL---IRQ-----VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM 172
Query: 305 AGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
G GT GYVAPE L + + D ++ GV+ LL G P
Sbjct: 173 EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 68.2 bits (165), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 45/133 (33%), Positives = 69/133 (51%), Gaps = 7/133 (5%)
Query: 222 ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDL 281
E F V E + G L + H +L+ A ++ GL++LH + +V+RDL
Sbjct: 91 ENLFFVMEYLNGGDLMYHIQS-CHKFDLS--RATFYAAEIILGLQFLH---SKGIVYRDL 144
Query: 282 KSSNILLDSSFNAKLSDFGLSVTAGT-QSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAF 340
K NILLD + K++DFG+ ++ GT Y+APE LL K D ++F
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSF 204
Query: 341 GVVLLELLMGRRP 353
GV+L E+L+G+ P
Sbjct: 205 GVLLYEMLIGQSP 217
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 160 VIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISL 214
IGEG G V++ + N + A+K + D+ RE F E + + H +I+ L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 215 LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+G I +++ E+ G L L +L + A ++ L YL +
Sbjct: 77 IGV-ITENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLE---SK 130
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLT 332
VHRD+ + N+L+ ++ KL DFGLS + T + K + ++APE + + T
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 333 DKSDVYAFGVVLLELLM-GRRPVE 355
SDV+ FGV + E+LM G +P +
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQ 214
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
+A + + S +G G G V K F K A+K I + +A+ N
Sbjct: 6 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQN 210
+ Q + G G V+KA+ +A D +ERE + ++H+N
Sbjct: 15 GSLQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPG----MKHEN 70
Query: 211 IISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
++ I AE R +L+ GSL L G + +TW+ +A ++
Sbjct: 71 LLQF----IAAEKRGSNLEVELWLITAFHDKGSLTDYLKG----NIITWNELCHVAETMS 122
Query: 263 RGLEYLHEH---CNH-----PVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKI 314
RGL YLHE C + HRD KS N+LL S A L+DFGL+V
Sbjct: 123 RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDT 182
Query: 315 SGTLG---YVAPEYLLEGKLTDKS------DVYAFGVVLLELL 348
G +G Y+APE +LEG + + D+YA G+VL EL+
Sbjct: 183 HGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELV 224
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q+ IG G +G V A F+ L AVK++ + A+R + E+ L + H+
Sbjct: 24 YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
NIISLL +T +LV E+M + +L + +H +++ L +
Sbjct: 82 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC----- 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TA T T Y AP
Sbjct: 136 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAP 192
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMG 350
E +L + D+++ G ++ EL+ G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
+A + + S +G G G V K F K A+K I + +A+ N
Sbjct: 6 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
+A + + S +G G G V K F K A+K I + +A+ N
Sbjct: 6 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 65 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 124 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + + V R D A + F E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 71 HPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
+ L + H++ ++HRD+K +NI++ ++ K+ DFG++ + + ++ + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 161 IGEGGRGHVYKA------RFNEKLLAAVKRIDD-AGHDAEREFNNEVNWLTKIRHQ-NII 212
+G G G V +A + AVK + + A H R +E+ L I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 213 SLLGYCIHAETRFLV-YEMMQNGSLEKQL---------HGPTHGSNLTWHLRMKIAVDVA 262
+LLG C +V E + G+L L + + LT + + VA
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT---LG 319
+G+E+L + +HRDL + NILL K+ DFGL+ V+ L
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 320 YVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKMSPTQCQSMVTWAMPQLTDRSK 378
++APE + + T +SDV++FGV+L E+ +G P + + + + T R +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV---KIDEEFXRRLKEGT-RMR 267
Query: 379 LPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
P+ P + TM + C EPS RP ++++ L
Sbjct: 268 APDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 301
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 152 TNNFQESNVIGEGGRGHVY----KARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
++ ++ V+G+G G V K E + + + + EV L ++
Sbjct: 31 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
H NI+ L + +LV E+ G L ++ S + +I V G+ Y
Sbjct: 91 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITY 147
Query: 268 LHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
+H++ +VHRDLK N+LL+S N ++ DFGLS + GT Y+APE
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 325 YLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+L G +K DV++ GV+L LL G P
Sbjct: 205 -VLHGTYDEKCDVWSTGVILYILLSGCPP 232
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
+A + + S +G G G V K F K A+K I + +A+ N
Sbjct: 5 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 63
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 64 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 123 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD 191
++DT ++ E + IGEG G V++ + N + A+K + D
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 192 AERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+ RE F E + + H +I+ L+G I +++ E+ G L L +L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ--VRKFSLD 489
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQ 308
+ A ++ L YL + VHRD+ + N+L+ S+ KL DFGLS + T
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVE 355
+ K + ++APE + + T SDV+ FGV + E+LM G +P +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEKLL--AAVKRIDD------AGHDAEREFN--N 198
+A + + S +G G G V K F K A+K I + +A+ N
Sbjct: 12 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 70
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 71 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 130 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK-LLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQNI 211
+++ IGEG G V+KA+ E + A+KR+ DD E+ L +++H+NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 212 ISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHE 270
+ L +H++ + LV+E + L+K + +L + + +GL + H
Sbjct: 64 VRLHD-VLHSDKKLTLVFEFC-DQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 271 HCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEG 329
+ V+HRDLK N+L++ + KL++FGL+ G R TL Y P+ L
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 330 KLTDKS-DVYAFGVVLLELLMGRRPV 354
KL S D+++ G + EL RP+
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPL 202
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 155 FQESNVIGEGGRGHVYKAR----------FNEKLLAA---VKRIDDAGH-DAEREFNNEV 200
F+ V+G+GG G V++ R F K+L V+ D H AER
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIA 258
N L +++H I+ L+ +L+ E + G L QL G ++L
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL----- 127
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKIS 315
+++ L +LH+ +++RDLK NI+L+ + KL+DFGL S+ GT +
Sbjct: 128 AEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FC 182
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT+ Y+APE L+ D ++ G ++ ++L G P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + AVK + D D F E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 71 HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV----KISGTL 318
+ L + H++ ++HRD+K +NIL+ ++ K+ DFG++ +V + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + + V R D A + F E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 71 HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
+ L + H++ ++HRD+K +NI++ ++ K+ DFG++ + + ++ + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 69/243 (28%), Positives = 114/243 (46%), Gaps = 33/243 (13%)
Query: 119 LSLSPILERFNSLRLAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARFNEKL 178
+S S + +F S+ +A TV +Q+ IG G +G V A F+ L
Sbjct: 1 MSKSKVDNQFYSVEVADSTFTV-----------LKRYQQLKPIGSGAQGIVCAA-FDTVL 48
Query: 179 --LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISLLGYCIHAETR------FLV 227
AVK++ + A+R + E+ L + H+NIISLL +T +LV
Sbjct: 49 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 228 YEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNIL 287
E+M + +L + +H +++ L + G+++LH + ++HRDLK SNI+
Sbjct: 108 MELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH---SAGIIHRDLKPSNIV 158
Query: 288 LDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLEL 347
+ S K+ DFGL+ TA T T Y APE +L D+++ G ++ EL
Sbjct: 159 VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 348 LMG 350
+ G
Sbjct: 219 VKG 221
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
EV L ++ H NI+ L + +LV E+ G L ++ S + +I
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
V G+ Y+H++ +VHRDLK N+LL+S N ++ DFGLS +
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT Y+APE +L G +K DV++ GV+L LL G P
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 44/231 (19%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
++F+E V+G+G G V KAR + A+K+I H E+ +EV L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 209 Q-------------NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--HGSNLTWHL 253
Q N + + T F+ E +NG+L +H + W L
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-------- 305
+I L Y+H + ++HRDLK NI +D S N K+ DFGL+
Sbjct: 122 FRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 306 -------GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
G+ GT YVA E L G +K D+Y+ G++ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
++N+ +G+G V + L +I + + R+F E K++H
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
NI+ L +LV++++ G L ++ + S+ + IA
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 118
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
Y H ++ +VHR+LK N+LL S KL+DFGL++ +GT GY
Sbjct: 119 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 172
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
++PE L + + D++A GV+L LL+G P
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 136 KKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKARF----NEKLLAAVKRIDDAGHD 191
++DT ++ E + IGEG G V++ + N + A+K + D
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 192 AERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+ RE F E + + H +I+ L+G I +++ E+ G L L +L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ--VRKFSLD 489
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQ 308
+ A ++ L YL + VHRD+ + N+L+ ++ KL DFGLS + T
Sbjct: 490 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTY 546
Query: 309 SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVE 355
+ K + ++APE + + T SDV+ FGV + E+LM G +P +
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
+++FQ +++GEG G V A + A+K+I+ D A R E+ L +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
+NII++ I F ++ E+MQ LH L+
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
R ++ LH V+HRDLK SN+L++S+ + K+ DFGL S G QS
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ T Y APE +L K + DV++ G +L EL + RRP+
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
++N+ +G+G V + L +I + + R+F E K++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
NI+ L +LV++++ G L ++ + S+ + IA
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
Y H ++ +VHR+LK N+LL S KL+DFGL++ +GT GY
Sbjct: 120 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
++PE L + + D++A GV+L LL+G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 155 FQESNVIGEGGRGHVYKAR----------FNEKLLAA---VKRIDDAGH-DAEREFNNEV 200
F+ V+G+GG G V++ R F K+L V+ D H AER
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER------ 72
Query: 201 NWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH--GPTHGSNLTWHLRMKIA 258
N L +++H I+ L+ +L+ E + G L QL G ++L
Sbjct: 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL----- 127
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL---SVTAGTQSRNVKIS 315
+++ L +LH+ +++RDLK NI+L+ + KL+DFGL S+ GT +
Sbjct: 128 AEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX--FC 182
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT+ Y+APE L+ D ++ G ++ ++L G P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRID--DAGHDAEREFNNEVNWLTKIRH 208
+++FQ +++GEG G V A + A+K+I+ D A R E+ L +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 209 QNIISLLGYCIHAETRF-------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
+NII++ I F ++ E+MQ LH L+
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQT-----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 262 ARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----------SVTAGTQSR 310
R ++ LH V+HRDLK SN+L++S+ + K+ DFGL S G QS
Sbjct: 122 LRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 311 NVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELLMGRRPV 354
+ T Y APE +L K + DV++ G +L EL + RRP+
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
++N+ +G+G V + L +I + + R+F E K++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
NI+ L +LV++++ G L ++ + S+ + IA
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 119
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
Y H ++ +VHR+LK N+LL S KL+DFGL++ +GT GY
Sbjct: 120 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
++PE L + + D++A GV+L LL+G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + AVK + D D F E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 71 HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
+ L + H++ ++HRD+K +NI++ ++ K+ DFG++ + + ++ + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR---FNEKLLAAVKRIDDAGHDA-EREFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + + V R D A + F E +
Sbjct: 28 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 88 HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 143
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
+ L + H++ ++HRD+K +NI++ ++ K+ DFG++ + + ++ + GT
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 20/221 (9%)
Query: 152 TNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRI-DDAGHDAE--REFNNEVNWLTKIR 207
++ ++ ++G GG V+ AR + AVK + D D F E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 208 HQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
H I+++ AET ++V E + +L +H T G +T +++ D
Sbjct: 71 HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVH--TEGP-MTPKRAIEVIADAC 126
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSV----TAGTQSRNVKISGTL 318
+ L + H++ ++HRD+K +NI++ ++ K+ DFG++ + + ++ + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP 359
Y++PE + +SDVY+ G VL E+L G P SP
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 152 TNNFQESNVIGEGG-----------RGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNNE 199
T+ +Q IG+G GH Y A+ N K L+A ++ E
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDH---------QKLERE 53
Query: 200 VNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
++H NI+ L +LV++++ G L + + + S
Sbjct: 54 ARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------A 103
Query: 260 DVARGLEYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRN 311
D + ++ + E HC+ VVHRDLK N+LL S KL+DFGL++ G Q
Sbjct: 104 DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW 163
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+GT GY++PE L + D++A GV+L LL+G P
Sbjct: 164 FGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
+ +G+GG Y+ + K + A K + + H E+ + E+ +
Sbjct: 26 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 84
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
+ +++ G+ + ++V E+ + SL +LH + +R I +G
Sbjct: 85 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 138
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
++YLH N+ V+HRDLK N+ L+ + K+ DFGL+ R + GT Y+AP
Sbjct: 139 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
E L + + + D+++ G +L LL+G+ P E T C + + + +P +
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 249
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+PV +A+ + +P+ RP + ++L
Sbjct: 250 NPV------------ASALIRRMLHADPTLRPSVAELL 275
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
EV L ++ H NI+ L + +LV E+ G L ++ S + +I
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 156
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
V G+ Y+H++ +VHRDLK N+LL+S N ++ DFGLS +
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT Y+APE +L G +K DV++ GV+L LL G P
Sbjct: 214 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 250
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
EV L ++ H NI+ L + +LV E+ G L ++ S + +I
Sbjct: 99 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 155
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
V G+ Y+H++ +VHRDLK N+LL+S N ++ DFGLS +
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT Y+APE +L G +K DV++ GV+L LL G P
Sbjct: 213 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 249
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
+ +G+GG Y+ + K + A K + + H E+ + E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
+ +++ G+ + ++V E+ + SL +LH + +R I +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
++YLH N+ V+HRDLK N+ L+ + K+ DFGL+ R + GT Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
E L + + + D+++ G +L LL+G+ P E T C + + + +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+PV +A+ + +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
+ +G+GG Y+ + K + A K + + H E+ + E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
+ +++ G+ + ++V E+ + SL +LH + +R I +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
++YLH N+ V+HRDLK N+ L+ + K+ DFGL+ R + GT Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
E L + + + D+++ G +L LL+G+ P E T C + + + +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+PV +A+ + +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 45/126 (35%), Positives = 64/126 (50%), Gaps = 8/126 (6%)
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS 315
KI + + L +L E N ++HRD+K SNILLD S N KL DFG+S + +
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 316 GTLGYVAPEYLLEGKLTD----KSDVYAFGVVLLELLMGRRPVEKMSPT--QCQSMVTWA 369
G Y+APE + +SDV++ G+ L EL GR P K + Q +V
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 370 MPQLTD 375
PQL++
Sbjct: 247 PPQLSN 252
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAG---HDAEREFNNEVNWLTK 205
A ++F VIG+G G V AR E++ AVK + E+ +E N L K
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 206 -IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
++H ++ L A+ + V + + G L L L R A ++A
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARF-YAAEIASA 151
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-SVTAGTQSRNVKISGTLGYVAP 323
L YLH +V+RDLK NILLDS + L+DFGL S GT Y+AP
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
E L + D + G VL E+L G P
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 66.6 bits (161), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/278 (22%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 153 NNFQESNVIGEGGRGHVYK-ARFNEKLLAAVKRIDDA----GHDAEREFNNEVNWLTKIR 207
+ +G+GG Y+ + K + A K + + H E+ + E+ +
Sbjct: 42 KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLD 100
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHG---SNLTWHLRMKIAVDVARG 264
+ +++ G+ + ++V E+ + SL +LH + +R I +G
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ-SRNVKISGTLGYVAP 323
++YLH N+ V+HRDLK N+ L+ + K+ DFGL+ R + GT Y+AP
Sbjct: 155 VQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIV 383
E L + + + D+++ G +L LL+G+ P E T C + + + +P +
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE----TSCLKETYIRIKK--NEYSVPRHI 265
Query: 384 DPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVL 421
+PV +A+ + +P+ RP + ++L
Sbjct: 266 NPV------------ASALIRRMLHADPTLRPSVAELL 291
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK--------LLAAVKRIDDAGHDAEREFN--N 198
+A + + S +G G G V K F K +++ K + +A+ N
Sbjct: 131 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 189
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 249 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKARFNEK--------LLAAVKRIDDAGHDAEREFN--N 198
+A + + S +G G G V K F K +++ K + +A+ N
Sbjct: 145 KALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVET 203
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHL---RM 255
E+ L K+ H II + + AE ++V E+M+ G L ++ G T L +M
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNV 312
+AV +YLHE+ ++HRDLK N+LL S K++DFG S G S
Sbjct: 263 LLAV------QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 313 KISGTLGYVAPEYLLE---GKLTDKSDVYAFGVVLLELLMGRRP 353
+ GT Y+APE L+ D ++ GV+L L G P
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 36/265 (13%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+ E G ++K R+ ++ V ++ D R+FN E L H N++ +LG C
Sbjct: 18 LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 220 H--AETRFLVYEMMQNGSLEKQLHGPTHGSNLT--WHLRMKIAVDVARGLEYLHEHCNHP 275
A L+ M GSL LH G+N +K A+D+ARG+ +L H P
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFL--HTLEP 132
Query: 276 VVHRD-LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
++ R L S ++++D A++S + + + R +VAPE L+ K D
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY----APAWVAPEA-LQKKPEDT 187
Query: 334 ---KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
+D+++F V+L EL+ P +S + V A+ L R +P + P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV--ALEGL--RPTIPPGISP----- 238
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRP 415
V+ + +C+ +P+ RP
Sbjct: 239 -------HVSKLMKICMNEDPAKRP 256
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
+ +++W+ +H N L+G C E+R F V E + G L H
Sbjct: 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 107
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
H R + +++ L YLHE +++RDLK N+LLDS + KL+D+G+ G +
Sbjct: 108 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 162
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ GT Y+APE L D +A GV++ E++ GR P +
Sbjct: 163 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
+F+ ++GEG V AR +I + H + N+V ++T R ++++
Sbjct: 37 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVT--RERDVM 91
Query: 213 SLLG--------YCIHAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
S L +C + + + +NG L K + GS R A ++
Sbjct: 92 SRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVS 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGY 320
LEYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT Y
Sbjct: 149 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
V+PE L E SD++A G ++ +L+ G P
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 66.2 bits (160), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
+ +++W+ +H N L+G C E+R F V E + G L H
Sbjct: 61 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 118
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
H R + +++ L YLHE +++RDLK N+LLDS + KL+D+G+ G +
Sbjct: 119 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 173
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ GT Y+APE L D +A GV++ E++ GR P +
Sbjct: 174 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
+ +++W+ +H N L+G C E+R F V E + G L H
Sbjct: 46 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 103
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
H R + +++ L YLHE +++RDLK N+LLDS + KL+D+G+ G +
Sbjct: 104 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 158
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ GT Y+APE L D +A GV++ E++ GR P +
Sbjct: 159 PGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 157 ESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIIS 213
+ +V+GEG V AVK I+ GH R F EV L + + H+N++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
L+ + + +LV+E M+ GS+ +H H + L + + DVA L++LH N
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---N 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNVKIS--------GTLGYVA 322
+ HRDLK NIL + K+ DFGL IS G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQC 362
PE + E + DK D+++ GV+L LL G P + C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 197 NNEVNWLTKIRH-----QNIISLLGY--CIHAETR-FLVYEMMQNGSLEKQLHGPTHGSN 248
+ +++W+ +H N L+G C E+R F V E + G L H
Sbjct: 93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 150
Query: 249 LTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ 308
H R + +++ L YLHE +++RDLK N+LLDS + KL+D+G+ G +
Sbjct: 151 PEEHARF-YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM-CKEGLR 205
Query: 309 SRNV--KISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ GT Y+APE L D +A GV++ E++ GR P +
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNN---EVNWLTKIRH 208
++N+ +G+G V + L +I + + R+F E K++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 209 QNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVAR 263
NI+ L +LV++++ G L ++ + S+ + IA
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA----- 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGY 320
Y H ++ +VHR+LK N+LL S KL+DFGL++ +GT GY
Sbjct: 143 ---YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 321 VAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
++PE L + + D++A GV+L LL+G P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 10 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 66
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 67 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 123
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 211
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 65.9 bits (159), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E + SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAET 223
G G Y A+F +K +R+ + RE EVN L +IRH NII+L +
Sbjct: 35 GTGKEYAAKFIKK-----RRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 89
Query: 224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 90 VVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 143
Query: 284 SNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
NI LLD + KL DFG++ + AG + +N I GT +VAPE + L ++D+
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADM 201
Query: 338 YAFGVVLLELLMGRRP 353
++ GV+ LL G P
Sbjct: 202 WSIGVITYILLSGASP 217
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 199 EVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIA 258
EV L ++ H NI L + +LV E+ G L ++ S + +I
Sbjct: 76 EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKIS 315
V G+ Y H++ +VHRDLK N+LL+S N ++ DFGLS +
Sbjct: 133 RQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT Y+APE +L G +K DV++ GV+L LL G P
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 9 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 65
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 66 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 122
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 210
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 7 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 63
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 64 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 120
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 208
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQN 210
+F+ +G GG G V++A+ + A+KRI + RE EV L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 211 IISLLGYCIHAET---------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIA 258
I+ + T + +Y MQ +L+ ++G + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQ---------- 308
+ +A +E+LH + ++HRDLK SNI K+ DFGL VTA Q
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL-VTAMDQDEEEQTVLTP 180
Query: 309 ----SRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELL 348
+R+ GT Y++PE + + K D+++ G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 64
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 121
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 65.5 bits (158), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/195 (32%), Positives = 94/195 (48%), Gaps = 18/195 (9%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETR 224
G G Y A+F +K + R + + ERE VN L +IRH NII+L +
Sbjct: 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIERE----VNILREIRHPNIITLHDIFENKTDV 83
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 84 VLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPE 137
Query: 285 NI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVY 338
NI LLD + KL DFG++ + AG + +N I GT +VAPE + L ++D++
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 339 AFGVVLLELLMGRRP 353
+ GV+ LL G P
Sbjct: 196 SIGVITYILLSGASP 210
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 89
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 90 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 146
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 203
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 65.1 bits (157), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 89
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 90 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 146
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 147 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 203
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 14 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 70
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 71 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 127
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 128 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 184
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 215
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 35 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 91
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 92 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 148
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 149 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 205
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 236
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 65.1 bits (157), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 86
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 143
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVS 200
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 161 IGEGGRGHVYK---ARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL--- 214
+G GG G+V + E++ R + + + ER + E+ + K+ H N++S
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 80
Query: 215 ---LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
L + L E + G L K L+ + L + D++ L YLHE+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 272 CNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
++HRDLK NI+L K+ D G + + GTL Y+APE L +
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K T D ++FG + E + G RP
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 161 IGEGGRGHVYK---ARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL--- 214
+G GG G+V + E++ R + + + ER + E+ + K+ H N++S
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 81
Query: 215 ---LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
L + L E + G L K L+ + L + D++ L YLHE+
Sbjct: 82 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 272 CNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
++HRDLK NI+L K+ D G + + GTL Y+APE L +
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 198
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K T D ++FG + E + G RP
Sbjct: 199 KKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 85
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 86 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 142
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 199
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
++H NI+ L +LV++++ G L + + + S D + +
Sbjct: 87 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 136
Query: 266 EYLHEHCNH----PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
+ E NH +VHRDLK N+LL S KL+DFGL++ G Q +GT
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GY++PE L + D++A GV+L LL+G P
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 85
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 86 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 142
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 143 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 199
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 64.7 bits (156), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 165 GRGHVYKARFNEKLLAAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAET 223
G G Y A+F +K +R+ + RE EVN L +IRH NII+L +
Sbjct: 49 GTGKEYAAKFIKK-----RRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 103
Query: 224 RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKS 283
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 104 VVLILELVSGGELFDFL---AEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 157
Query: 284 SNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDV 337
NI LLD + KL DFG++ + AG + +N I GT +VAPE + L ++D+
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYEPLGLEADM 215
Query: 338 YAFGVVLLELLMGRRP 353
++ GV+ LL G P
Sbjct: 216 WSIGVITYILLSGASP 231
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 259 VDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS--- 315
++ LEYLH ++HRDLK NILL+ + +++DFG + +S+ + +
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 316 GTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GT YV+PE L E SD++A G ++ +L+ G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
++H NI+ L +LV++++ G L + + + S D + +
Sbjct: 60 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 109
Query: 266 EYLHEHCNHP----VVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
+ + E NH +VHRDLK N+LL S KL+DFGL++ G Q +GT
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GY++PE L + D++A GV+L LL+G P
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
++H NI+ L +LV++++ G L + + + S D + +
Sbjct: 60 LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----------ADASHCI 109
Query: 266 EYLHEHCNH----PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
+ + E NH +VHRDLK N+LL S KL+DFGL++ G Q +GT
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GY++PE L + D++A GV+L LL+G P
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 158 SNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIISL 214
S ++GEG V A AVK I+ AGH R F EV L + + ++NI+ L
Sbjct: 18 SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILEL 76
Query: 215 LGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
+ + +TRF LV+E +Q GS+ + H ++ DVA L++LH
Sbjct: 77 IEF-FEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRDVAAALDFLH---T 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGL--------SVTAGTQSRNVKISGTLGYVA 322
+ HRDLK NIL +S K+ DF L S T T G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRP 353
PE + + DK D+++ GVVL +L G P
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR----- 207
+F+ ++GEG V AR +I + H + N+V ++T+ R
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---ENKVPYVTRERDVMSR 88
Query: 208 --HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
H + L E + +NG L K + GS R A ++ L
Sbjct: 89 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTA-EIVSAL 145
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVA 322
EYLH ++HRDLK NILL+ + +++DFG + +S+ + + GT YV+
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE L E SD++A G ++ +L+ G P
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 44/231 (19%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
++F+E V+G+G G V KAR + A+K+I H E+ +EV L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNH 61
Query: 209 Q-------------NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT--HGSNLTWHL 253
Q N + + T F+ E +N +L +H + W L
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA-------- 305
+I L Y+H + ++HRDLK NI +D S N K+ DFGL+
Sbjct: 122 FRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 306 -------GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
G+ GT YVA E L G +K D+Y+ G++ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK----LLAAVKRIDD---AGHDAEREFNNEVNWLTK 205
F ++G+G G V +A+ ++ + AVK + A D E EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKE 81
Query: 206 IRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSN---LTWHLRMK 256
H ++ L+G + + + ++ M++G L L G N L ++
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQSRNVKI 314
VD+A G+EYL + +HRDL + N +L ++DFGLS + +G R
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 315 SG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
S + ++A E L + T SDV+AFGV + E++ G+ P
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 130
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLX---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 84 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 77 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 77 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMV 213
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 130
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 24/228 (10%)
Query: 135 GKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDD--AGHD 191
G KD +++Y ++ IG GG V A + A+K +D G D
Sbjct: 1 GPKDYDELLKY---------YELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSD 51
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTW 251
R E+ L +RHQ+I L A F+V E G L + L+
Sbjct: 52 LPR-IKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYI---ISQDRLSE 107
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSR 310
+ + + Y+H + HRDLK N+L D KL DFGL G +
Sbjct: 108 EETRVVFRQIVSAVAYVH---SQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDY 164
Query: 311 NVK-ISGTLGYVAPEYLLEGK--LTDKSDVYAFGVVLLELLMGRRPVE 355
+++ G+L Y APE L++GK L ++DV++ G++L L+ G P +
Sbjct: 165 HLQTCCGSLAYAAPE-LIQGKSYLGSEADVWSMGILLYVLMCGFLPFD 211
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
IGEG G VYKA+ N A+K+I +D G + E++ L +++H NI+ L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
IH + R LV+E + L+K L G L + + G+ Y H +
Sbjct: 68 -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
V+HRDLK N+L++ K++DFGL+ G R TL Y AP+ L+ K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
D+++ G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 25 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 81
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 82 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 136
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 137 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMV 218
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 206 IRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
++H NI+ L +L+++++ G L + + + S D + +
Sbjct: 78 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADASHCI 127
Query: 266 EYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVKISGT 317
+ + E HC+ VVHRDLK N+LL S KL+DFGL++ G Q +GT
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 318 LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
GY++PE L + D++A GV+L LL+G P
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
IGEG G VYKA+ N A+K+I +D G + E++ L +++H NI+ L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
IH + R LV+E + L+K L G L + + G+ Y H +
Sbjct: 68 -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
V+HRDLK N+L++ K++DFGL+ G R TL Y AP+ L+ K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
D+++ G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI----DDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
IGEG G VYKA+ N A+K+I +D G + E++ L +++H NI+ L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHSNIVKLYD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
IH + R LV+E + L+K L G L + + G+ Y H +
Sbjct: 68 -VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLL-EGKLTD 333
V+HRDLK N+L++ K++DFGL+ G R TL Y AP+ L+ K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 334 KSDVYAFGVVLLELLMG 350
D+++ G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 84 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMV 220
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/237 (26%), Positives = 111/237 (46%), Gaps = 15/237 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE---FNNEVNWL 203
E ++ + +G G G V K R + AVKRI + E++ + +++
Sbjct: 46 FEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 105
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVA 262
T + ++ G ++ E+M + SL+K G + + KIAV +
Sbjct: 106 T-VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
+ LE+LH + V+HRD+K SN+L+++ K+ DFG+S +G Y+A
Sbjct: 164 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 323 PEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKM-SP-TQCQSMVTWAMPQL 373
PE L + + KSD+++ G+ ++EL + R P + +P Q + +V PQL
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 278
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+G+G G V++ + + +A D+ E E N V +RH+NI+ +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
+ H+ T+ +L+ + GSL L T + ++I + +A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
+ HRDLKS NIL+ + ++D GL+V + + + GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
E L E D + D++AFG+VL E+ RR V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 176 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV 257
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 16/224 (7%)
Query: 133 LAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD 191
LA K V++ E+E L+ F + ++ E G Y + +K + K D+ H
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHT 195
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLT 250
E L RH ++ L Y R V E G L L S
Sbjct: 196 L-----TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 249
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
++ L+YLH N VV+RDLK N++LD + K++DFGL
Sbjct: 250 ARF---YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 311 NVK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+K GT Y+APE L + D + GVV+ E++ GR P
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+G+G G V++ + + +A D+ E E N V +RH+NI+ +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
+ H+ T+ +L+ + GSL L T + ++I + +A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 126
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
+ HRDLKS NIL+ + ++D GL+V + + + GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
E L E D + D++AFG+VL E+ RR V
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 221
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + + A+K++ + A+R + E+ + + H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NIISLL +T +LV E+M + +L + + +++ L +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 176 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV 257
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 157 ESNVIGEGGRGHVYKA-RFNEKLLAAVKRID-DAGHDAEREFNNEVNWLTKIR-HQNIIS 213
+ +V+GEG V AVK I+ GH R F EV L + + H+N++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR-EVEMLYQCQGHRNVLE 75
Query: 214 LLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCN 273
L+ + + +LV+E M+ GS+ +H H + L + + DVA L++LH N
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---N 129
Query: 274 HPVVHRDLKSSNILLDSSFN---AKLSDFGLSVTAGTQSRNVKIS--------GTLGYVA 322
+ HRDLK NIL + K+ DF L IS G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 323 PE----YLLEGKLTDK-SDVYAFGVVLLELLMGRRPVEKMSPTQC 362
PE + E + DK D+++ GV+L LL G P + C
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC 234
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 160 VIGEGGRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
+G+G G V++ + + +A D+ E E N V +RH+NI+ +
Sbjct: 44 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 99
Query: 218 CI---HAETR-FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH---- 269
+ H+ T+ +L+ + GSL L T + ++I + +A GL +LH
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC----LRIVLSIASGLAHLHIEIF 155
Query: 270 -EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAP 323
+ HRDLKS NIL+ + ++D GL+V + + + GT Y+AP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 324 EYLLEGKLTD------KSDVYAFGVVLLELLMGRRPV 354
E L E D + D++AFG+VL E+ RR V
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV 250
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 63.2 bits (152), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 92/224 (41%), Gaps = 16/224 (7%)
Query: 133 LAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHD 191
LA K V++ E+E L+ F + ++ E G Y + +K + K D+ H
Sbjct: 141 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK--DEVAHT 198
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLT 250
E L RH ++ L Y R V E G L L S
Sbjct: 199 L-----TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 252
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
++ L+YLH N VV+RDLK N++LD + K++DFGL
Sbjct: 253 ARF---YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 307
Query: 311 NVK-ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+K GT Y+APE L + D + GVV+ E++ GR P
Sbjct: 308 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 15/237 (6%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAERE---FNNEVNWL 203
+E ++ + +G G G V K R + AVKRI + E++ + +++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 204 TKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPT-HGSNLTWHLRMKIAVDVA 262
T + ++ G ++ E+M + SL+K G + + KIAV +
Sbjct: 62 T-VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
+ LE+LH + V+HRD+K SN+L+++ K+ DFG+S +G Y+A
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177
Query: 323 PEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP--TQCQSMVTWAMPQL 373
PE L + + KSD+++ G+ ++EL + R P + Q + +V PQL
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVVAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 62.8 bits (151), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ GV++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 28 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 84
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 85 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 139
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT V T Y A
Sbjct: 140 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 119
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 120 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 175
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
+ + + APE L + SD + FGV L E+ G+ P ++ +Q
Sbjct: 176 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ +L P + V V C +P RP + L
Sbjct: 236 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 425 IPLVPTDL 432
+ PTD+
Sbjct: 280 LEAQPTDM 287
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 151 ATNNFQESNVIGEGGRGHVYKARFNEKLLAA---------VKRIDDAGHDAEREFNNEVN 201
T +E + E G+G R K+LA K++ H ++ E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH---QKLEREAR 62
Query: 202 WLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
++H NI+ L +L+++++ G L + + + S D
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE----------ADA 112
Query: 262 ARGLEYLHE---HCNH-PVVHRDLKSSNILLDSSFNA---KLSDFGLSV-TAGTQSRNVK 313
+ ++ + E HC+ VVHR+LK N+LL S KL+DFGL++ G Q
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 314 ISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+GT GY++PE L + D++A GV+L LL+G P
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 119
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 120 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 175
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
+ + + APE L + SD + FGV L E+ G+ P ++ +Q
Sbjct: 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ +L P + V V C +P RP + L
Sbjct: 236 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 279
Query: 425 IPLVPTDL 432
+ PTD+
Sbjct: 280 LEAQPTDM 287
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 62.0 bits (149), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 15/163 (9%)
Query: 198 NEVNWLTKIRHQNIISLLGYC--IHAETRFLVYEMMQNGS-LEKQLHGPTHGSNLTWHLR 254
E+ L K+ H N++ L+ + + ++V+E++ G +E P ++ +
Sbjct: 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-AGTQSRNVK 313
D+ +G+EYLH ++HRD+K SN+L+ + K++DFG+S G+ +
Sbjct: 145 -----DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 314 ISGTLGYVAPEYLLEGK--LTDKS-DVYAFGVVLLELLMGRRP 353
GT ++APE L E + + K+ DV+A GV L + G+ P
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 29/248 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 57 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 113
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 114 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 169
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
+ + + APE L + SD + FGV L E+ G+ P ++ +Q
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 229
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ +L P + V V C +P RP + L
Sbjct: 230 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 273
Query: 425 IPLVPTDL 432
+ PTD+
Sbjct: 274 LEAQPTDM 281
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 67/125 (53%), Gaps = 18/125 (14%)
Query: 244 THGSNLTWHL----RMK------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN 293
+G +L +H+ R K A ++A GL +L + +++RDLK N++LDS +
Sbjct: 103 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 159
Query: 294 AKLSDFGL---SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
K++DFG+ ++ G ++ GT Y+APE + D +AFGV+L E+L G
Sbjct: 160 IKIADFGMCKENIWDGVTTKX--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
Query: 351 RRPVE 355
+ P E
Sbjct: 218 QAPFE 222
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 37/125 (29%), Positives = 68/125 (54%), Gaps = 18/125 (14%)
Query: 244 THGSNLTWHLR----------MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN 293
+G +L +H++ + A +++ GL +LH+ +++RDLK N++LDS +
Sbjct: 102 VNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGH 158
Query: 294 AKLSDFGLS---VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMG 350
K++DFG+ + G +R + GT Y+APE + D +A+GV+L E+L G
Sbjct: 159 IKIADFGMCKEHMMDGVTTR--EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 216
Query: 351 RRPVE 355
+ P +
Sbjct: 217 QPPFD 221
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 61.6 bits (148), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 61.6 bits (148), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
E N +G G G V +A + + + AVK + + H ERE +E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
L+ + H NI++LLG C ++ E G L L P
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
L + + VA+G+ +L ++C +HRDL + NILL K+ DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 194
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
S N + G + ++APE + T +SDV+++G+ L EL +G P M
Sbjct: 195 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
E N +G G G V +A + + + AVK + + H ERE +E+
Sbjct: 37 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
L+ + H NI++LLG C ++ E G L L P
Sbjct: 97 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
L + + VA+G+ +L ++C +HRDL + NILL K+ DFGL+
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 212
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
S N + G + ++APE + T +SDV+++G+ L EL +G P M
Sbjct: 213 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 269
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
E N +G G G V +A + + + AVK + + H ERE +E+
Sbjct: 35 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
L+ + H NI++LLG C ++ E G L L P
Sbjct: 95 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
L + + VA+G+ +L ++C +HRDL + NILL K+ DFGL+
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 210
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
S N + G + ++APE + T +SDV+++G+ L EL +G P M
Sbjct: 211 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 267
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
E N +G G G V +A + + + AVK + + H ERE +E+
Sbjct: 42 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
L+ + H NI++LLG C ++ E G L L P
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
L + + VA+G+ +L ++C +HRDL + NILL K+ DFGL+
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 217
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
S N + G + ++APE + T +SDV+++G+ L EL +G P M
Sbjct: 218 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 41 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 96
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 97 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 148
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
++ L+YLH N VV+RDLK N++LD + K++DFGL +K G
Sbjct: 114 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 171
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
T Y+APE L + D + GVV+ E++ GR P
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 40/124 (32%), Positives = 67/124 (54%), Gaps = 18/124 (14%)
Query: 245 HGSNLTWHL----RMK------IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA 294
+G +L +H+ R K A ++A GL +L + +++RDLK N++LDS +
Sbjct: 425 NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 481
Query: 295 KLSDFGL---SVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGR 351
K++DFG+ ++ G ++ GT Y+APE + D +AFGV+L E+L G+
Sbjct: 482 KIADFGMCKENIWDGVTTKX--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
Query: 352 RPVE 355
P E
Sbjct: 540 APFE 543
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
++ L+YLH N VV+RDLK N++LD + K++DFGL +K G
Sbjct: 116 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 173
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
T Y+APE L + D + GVV+ E++ GR P
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 29/247 (11%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRPVEKMSPTQCQS 364
+ + + APE L + SD + FGV L E+ G+ P ++ +Q
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225
Query: 365 MVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ +L P + V V C +P RP + L
Sbjct: 226 KIDKEGERLPRPEDCPQ----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 425 IPLVPTD 431
+ PTD
Sbjct: 270 LEAQPTD 276
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
N+I LL A + +LV +M N ++ Q H L +
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ-------- 133
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
+ RGL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWY 188
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
APE +L +++ D+++ G ++ ELL GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
++ L+YLH N VV+RDLK N++LD + K++DFGL +K G
Sbjct: 115 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCG 172
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
T Y+APE L + D + GVV+ E++ GR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + IG G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 29 YQNLSPIGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVD 260
N+I LL A + +LV +M N ++ Q H L +
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQ-------- 133
Query: 261 VARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGY 320
+ RGL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWY 188
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
APE +L +++ D+++ G ++ ELL GR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 36 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 28 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 83
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 84 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 135
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 136 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 195
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 196 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
+ VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ +
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 307
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ R + P+ P + TM + C EPS RP ++++ L
Sbjct: 308 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 348
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA------RFNEKLLAAVKRIDDAGHDAERE-FNNEVN 201
E N +G G G V +A + + + AVK + + H ERE +E+
Sbjct: 42 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 202 WLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH-----------GPT----H 245
L+ + H NI++LLG C ++ E G L L P
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 246 GSNLTWHLRMKIAVDVARGLEYL-HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
L + + VA+G+ +L ++C +HRDL + NILL K+ DFGL+
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARH 217
Query: 305 AGTQSRNVKISGT----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVEKM 357
S N + G + ++APE + T +SDV+++G+ L EL +G P M
Sbjct: 218 IKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGXVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 20 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
++ LEYLH + VV+RD+K N++LD + K++DFGL + +K G
Sbjct: 116 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 172
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
T Y+APE L + D + GVV+ E++ GR P
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 36/265 (13%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+ E G ++K R+ ++ V ++ D R+FN E L H N++ +LG C
Sbjct: 18 LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 220 H--AETRFLVYEMMQNGSLEKQLHGPTHGSNLT--WHLRMKIAVDVARGLEYLHEHCNHP 275
A L+ GSL LH G+N +K A+D ARG +L H P
Sbjct: 78 SPPAPHPTLITHWXPYGSLYNVLH---EGTNFVVDQSQAVKFALDXARGXAFL--HTLEP 132
Query: 276 VVHRD-LKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTD- 333
++ R L S ++ +D A++S + + + R +VAPE L+ K D
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY----APAWVAPE-ALQKKPEDT 187
Query: 334 ---KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDT 390
+D ++F V+L EL+ P +S + V A+ L R +P + P
Sbjct: 188 NRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKV--ALEGL--RPTIPPGISP----- 238
Query: 391 MDLKHLYQVAAVAVLCIQPEPSYRP 415
V+ + +C +P+ RP
Sbjct: 239 -------HVSKLXKICXNEDPAKRP 256
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISG 316
++ LEYLH + VV+RD+K N++LD + K++DFGL + +K G
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCG 167
Query: 317 TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
T Y+APE L + D + GVV+ E++ GR P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKVVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLLYQMLV---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDA--EREFNNEVNWLTKIRHQ 209
+++ IGEG G V+K R + + A+K+ ++ D ++ E+ L +++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 210 NIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLH 269
N+++LL LV+E + L + + + HL I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLL- 327
+H +HRD+K NIL+ KL DFG + + G T Y +PE L+
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 328 EGKLTDKSDVYAFGVVLLELLMG 350
+ + DV+A G V ELL G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 21 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 79 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 188
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 22 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 79
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 80 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 134
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 189
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 190 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 21 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 78
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 79 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 188
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 189 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
+ VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 309
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ R + P+ P + TM + C EPS RP ++++ L
Sbjct: 310 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 350
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 31 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 8 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 63
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 64 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 115
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 116 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 175
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 176 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 60.8 bits (146), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 2 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 57
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 58 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 109
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
F + ++ E G Y + K + K D+ H E L RH +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ L Y R V E G L L + T ++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
+ VV+RD+K N++LD + K++DFGL + +K GT Y+APE L +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
D + GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 26 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 13/200 (6%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEK-LLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
+FQ + +G G G V+K R E L AVKR R + L ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEK 112
Query: 212 ISLLGYCIHAETRF----LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
+ C+ E + ++Y + Q H G++L D L +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
LH + +VH D+K +NI L KL DFGL V GT G Y+APE LL
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LL 228
Query: 328 EGKLTDKSDVYAFGVVLLEL 347
+G +DV++ G+ +LE+
Sbjct: 229 QGSYGTAADVFSLGLTILEV 248
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 29 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
F + ++ E G Y + K + K D+ H E L RH +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ L Y R V E G L L + T ++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
+ VV+RD+K N++LD + K++DFGL + +K GT Y+APE L +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
D + GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 161 IGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
IG G G R K L AVK I+ G + E+ +RH NI+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 220 HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHR 279
++ E G L +++ S + + G+ Y H + + HR
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ---QLLSGVSYCH---SMQICHR 140
Query: 280 DLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SD 336
DLK N LLD S K+ DFG S ++ S+ GT Y+APE LL + K +D
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200
Query: 337 VYAFGVVLLELLMGRRPVE 355
V++ GV L +L+G P E
Sbjct: 201 VWSCGVTLYVMLVGAYPFE 219
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 23 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 80
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 81 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 135
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 190
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 191 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 29 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 152 TNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHDAER--EFNNEVNWLTKIRH 208
++F+E V+G+G G V KAR + A+K+I H E+ +EV L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI---RHTEEKLSTILSEVXLLASLNH 61
Query: 209 QNIISLLGYCIH-------------AETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRM 255
Q ++ + T F+ E +N +L +H + R+
Sbjct: 62 QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 256 KIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---------- 305
+ L Y+H + ++HR+LK NI +D S N K+ DFGL+
Sbjct: 122 --FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 306 -----GTQSRNVKISGTLGYVAPEYLL-EGKLTDKSDVYAFGVVLLELL 348
G+ GT YVA E L G +K D Y+ G++ E +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
F + ++ E G Y + K + K D+ H E L RH +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ L Y R V E G L L + T ++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
+ VV+RD+K N++LD + K++DFGL + +K GT Y+APE L +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
D + GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 47 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 214
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 3 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 58
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 59 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 110
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 111 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 170
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 171 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 29 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 86
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 87 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 196
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 197 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
F + ++ E G Y + K + K D+ H E L RH +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 67
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ L Y R V E G L L + T ++ LEYLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 122
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
+ VV+RD+K N++LD + K++DFGL + +K GT Y+APE L +
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
D + GVV+ E++ GR P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 26 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 31 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 16/203 (7%)
Query: 153 NNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNII 212
F + ++ E G Y + K + K D+ H E L RH +
Sbjct: 19 GTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTV-----TESRVLQNTRHP-FL 70
Query: 213 SLLGYCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ L Y R V E G L L + T ++ LEYLH
Sbjct: 71 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH-- 125
Query: 272 CNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVK-ISGTLGYVAPEYLLEGK 330
+ VV+RD+K N++LD + K++DFGL + +K GT Y+APE L +
Sbjct: 126 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 331 LTDKSDVYAFGVVLLELLMGRRP 353
D + GVV+ E++ GR P
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLP 207
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
+G G G V Y AR +K+ AVK++ A R + E+ L ++H+N+I L
Sbjct: 28 VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
L A + +LV +M N ++ Q H L + L RGL
Sbjct: 85 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL--------LRGL 136
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
+Y+H + ++HRDLK SN+ ++ ++ DFGL+ A + T Y APE
Sbjct: 137 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY--VATRWYRAPEI 191
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
+L +++ D+++ G ++ ELL G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 30 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 31 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 139 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 35 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 93 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 202
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
+ VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ +
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 316
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ R + P+ P + TM + C EPS RP ++++ L
Sbjct: 317 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 357
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 37/261 (14%)
Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
+K +D A + F + ++K+ H++++ G C+ + LV E ++ GSL+ L
Sbjct: 45 LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK 104
Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFN-------- 293
+ N+ W ++++A +A + +L E+ ++H ++ + NILL +
Sbjct: 105 KNKNCINILW--KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 294 AKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLM-GR 351
KLSD G+S+T + + + +V PE + K L +D ++FG L E+ G
Sbjct: 160 IKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
+P+ + + + DR +LP ++A + C+ EP
Sbjct: 217 KPLSALDSQR-------KLQFYEDRHQLP------------APKAAELANLINNCMDYEP 257
Query: 412 SYRPLITDVLHSLIPLVPTDL 432
+RP ++ L L DL
Sbjct: 258 DHRPSFRAIIRDLNSLFTPDL 278
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 43 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 210
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 150 AATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQ 209
A T QES IG+G G V++ ++ + +A +I + + E+ +RH+
Sbjct: 5 ARTIVLQES--IGKGRFGEVWRGKWRGEEVAV--KIFSSREERSWFREAEIYQTVMLRHE 60
Query: 210 NIISLLGYCIHAETR--------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV 261
NI LG+ I A+ + +LV + ++GSL L+ T +T +K+A+
Sbjct: 61 NI---LGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 112
Query: 262 ARGLEYLH-----EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS- 315
A GL +LH + HRDLKS NIL+ + ++D GL+V + + + I+
Sbjct: 113 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 172
Query: 316 ----GTLGYVAPEYLLEG------KLTDKSDVYAFGVVLLEL 347
GT Y+APE L + + ++D+YA G+V E+
Sbjct: 173 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
+G G G V Y AR +K+ AVK++ A R + E+ L ++H+N+I L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
L A + +LV +M N ++ Q H L + L RGL
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL--------LRGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
+Y+H + ++HRDLK SN+ ++ ++ DFGL+ A + T Y APE
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEI 199
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
+L +++ D+++ G ++ ELL G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 36 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 36 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 93
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 94 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 148
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 203
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 204 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 44 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
+ VA+G+E+L + +HRDL + NILL K+ DFGL+ V+
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
L ++APE + + T +SDV++FGV+L E+ +G P K+ C+ +
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------ 314
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
+ R + P+ P + TM + C EPS RP ++++ L
Sbjct: 315 KEGTRMRAPDYTTPEMYQTM------------LDCWHGEPSQRPTFSELVEHL 355
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISG-----TLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
+ + + APE L + SD + FGV L E+ G+ P
Sbjct: 166 DHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 31 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 88
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVATRWYRAP 198
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 35 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 92
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 93 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 147
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLA--RHTDDEMTGYVATRWYRAP 202
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 203 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 72/262 (27%), Positives = 107/262 (40%), Gaps = 47/262 (17%)
Query: 161 IGEGGRGHVYKARFNEKLL--AAVKRIDDAGHDAERE-FNNEVNWLTKIRHQNIISLLG- 216
IG G VYK E + A + D +ER+ F E L ++H NI+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 217 --------YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI---------AV 259
CI LV E+ +G+L+ T+ R K+
Sbjct: 94 WESTVKGKKCI-----VLVTELXTSGTLK------------TYLKRFKVXKIKVLRSWCR 136
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLSVTAGTQSRNVKISGTL 318
+ +GL++LH P++HRDLK NI + + + K+ D GL+ T S + GT
Sbjct: 137 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTP 194
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPV-EKMSPTQCQSMVTWAM-PQLTDR 376
+ APE E K + DVYAFG LE P E + Q VT + P D+
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 377 SKLP---NIVDPVIRDTMDLKH 395
+P I++ IR D ++
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERY 275
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 26 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
L AVK I+ G + E+ +RH NI+ + +V E G L +
Sbjct: 45 LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 103
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
++ S + + G+ Y H V HRDLK N LLD S K+
Sbjct: 104 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 157
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
DFG S ++ S+ GT Y+APE LL+ + K +DV++ GV L +L+G P E
Sbjct: 158 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 217
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMG 350
PE +L + D+++ G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHA-ETRFLVY-EMMQNGSLEKQLHGPTHGSNLTWHLRMKIA----VDVARGL 265
+ L + + E + +VY ++ + E H S L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
Y+H + + HRD+K N+LLD KL DFG + NV + Y APE
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 325 YLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ T DV++ G VL ELL+G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 26 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 83
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 84 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA--RHTDDEMTGYVATRWYRAP 193
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 194 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKSQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGL--CRHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 30 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 195 EFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK-QLHGPTHGSNLTWHL 253
+F NE+ +T I+++ ++ G + + +++YE M+N S+ K + N T +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 254 RMK----IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQS 309
++ I V Y+H N + HRD+K SNIL+D + KLSDFG S
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGES--EYMVD 204
Query: 310 RNVKIS-GTLGYVAPEYLLEGKLTD--KSDVYAFGVVLLELLMGRRP 353
+ +K S GT ++ PE+ + K D+++ G+ L + P
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 60.1 bits (144), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 47 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 104
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMXGYVATRWYRAP 214
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 215 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 30 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIH 220
IG+G G V+ ++ + +A ++ +A E+ +RH+NI+ + I
Sbjct: 45 IGKGRYGEVWMGKWRGEKVAV--KVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 221 AETR----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC---- 272
+L+ + +NGSL L T L +K+A GL +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 273 -NHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-----GTLGYVAPEYL 326
+ HRDLKS NIL+ + ++D GL+V + + V I GT Y+ PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 327 LEGKLTDK------SDVYAFGVVLLELLMGRRPV 354
E + +D+Y+FG++L E+ RR V
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 57 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 113
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 114 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 169
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
+ + + APE L + SD + FGV L E+ G+ P
Sbjct: 170 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 191 DAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLT 250
+A +F EVN + + H+N+I L G + + +V E+ GSL +L H +
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--KHQGHFL 109
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSR 310
+ AV VA G+ YL + +HRDL + N+LL + K+ DFGL + A Q+
Sbjct: 110 LGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL-MRALPQND 165
Query: 311 NVKISGT-----LGYVAPEYLLEGKLTDKSDVYAFGVVLLELLM-GRRP 353
+ + + APE L + SD + FGV L E+ G+ P
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 161 IGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
+G G G V Y AR +K+ AVK++ A R + E+ L ++H+N+I L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 215 LGYCIHAET------RFLVYEMMQ---NGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
L A + +LV +M N ++ Q H L + L RGL
Sbjct: 93 LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL--------LRGL 144
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEY 325
+Y+H + ++HRDLK SN+ ++ ++ DFGL+ A + T Y APE
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY--VATRWYRAPEI 199
Query: 326 LLEGKLTDKS-DVYAFGVVLLELLMGR 351
+L +++ D+++ G ++ ELL G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 59/261 (22%), Positives = 114/261 (43%), Gaps = 37/261 (14%)
Query: 182 VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLH 241
+K +D A + F + ++K+ H++++ G C + LV E ++ GSL+ L
Sbjct: 45 LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK 104
Query: 242 GPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA------- 294
+ N+ W ++++A +A + +L E+ ++H ++ + NILL +
Sbjct: 105 KNKNCINILW--KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 295 -KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLM-GR 351
KLSD G+S+T + + + +V PE + K L +D ++FG L E+ G
Sbjct: 160 IKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEP 411
+P+ + + + DR +LP ++A + C+ EP
Sbjct: 217 KPLSALDSQR-------KLQFYEDRHQLP------------APKAAELANLINNCMDYEP 257
Query: 412 SYRPLITDVLHSLIPLVPTDL 432
+RP ++ L L DL
Sbjct: 258 DHRPSFRAIIRDLNSLFTPDL 278
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
L AVK I+ G + E+ +RH NI+ + +V E G L +
Sbjct: 46 LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
++ S + + G+ Y H V HRDLK N LLD S K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
+DFG S + S+ GT Y+APE LL+ + K +DV++ GV L +L+G P E
Sbjct: 159 ADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ D+GL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNE 199
EYE++E IG G G V AR A+K+I +A +A+R E
Sbjct: 56 EYEIIE----------TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 104
Query: 200 VNWLTKIRHQNIIS----LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSN-LTWH 252
+ L +H NII+ L + E + ++V ++M E LH H S LT
Sbjct: 105 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-----ESDLHQIIHSSQPLTLE 159
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGT 307
+ RGL+Y+H + V+HRDLK SN+L++ + K+ DFG+ + A
Sbjct: 160 HVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 308 QSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRR 352
Q + T Y APE +L + T D+++ G + E+L R+
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 159 NVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
N IG G G V A + ++ A K+I + F E+ + + H NII L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+LV E+ G L +++ H +I DV + Y H+ V
Sbjct: 75 FEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 128
Query: 278 HRDLKSSNILL--DSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
HRDLK N L DS + KL DFGL+ GT YV+P+ +LEG +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPE 187
Query: 335 SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
D ++ GV++ LL G P +PT + M+
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFS--APTDXEVML 217
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 20 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ + LT + + R
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKR---IDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
IGEG G + E V + I E EV L ++H NI+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPT-----HGSNLTWHLRMKIAVDVARGLEYLHEHC 272
+ ++V + + G L K+++ L W +++ +A L+++H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVH--- 142
Query: 273 NHPVVHRDLKSSNILLDSSFNAKLSDFGLS-VTAGTQSRNVKISGTLGYVAPEYLLEGKL 331
+ ++HRD+KS NI L +L DFG++ V T GT Y++PE
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 332 TDKSDVYAFGVVLLELLMGRRPVEKMS 358
+KSD++A G VL EL + E S
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGS 229
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 144 EYELLEAATNNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGH---DAEREFNNE 199
EYE++E IG G G V AR A+K+I +A +A+R E
Sbjct: 55 EYEIIE----------TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 103
Query: 200 VNWLTKIRHQNIIS----LLGYCIHAETR--FLVYEMMQNGSLEKQLHGPTHGSN-LTWH 252
+ L +H NII+ L + E + ++V ++M E LH H S LT
Sbjct: 104 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-----ESDLHQIIHSSQPLTLE 158
Query: 253 LRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGL-----SVTAGT 307
+ RGL+Y+H + V+HRDLK SN+L++ + K+ DFG+ + A
Sbjct: 159 HVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 308 QSRNVKISGTLGYVAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRR 352
Q + T Y APE +L + T D+++ G + E+L R+
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 20 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 58.9 bits (141), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 13/212 (6%)
Query: 159 NVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGY 217
N IG G G V A + ++ A K+I + F E+ + + H NII L
Sbjct: 32 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 218 CIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVV 277
+LV E+ G L +++ H +I DV + Y H+ V
Sbjct: 92 FEDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 145
Query: 278 HRDLKSSNILL--DSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
HRDLK N L DS + KL DFGL+ GT YV+P+ +LEG +
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPE 204
Query: 335 SDVYAFGVVLLELLMGRRPVEKMSPTQCQSMV 366
D ++ GV++ LL G P +PT + M+
Sbjct: 205 CDEWSAGVMMYVLLCGYPPFS--APTDXEVML 234
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMAGFVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 161 IGEG--GRGHVYKARFNEKLLAA--VKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
IG G G + + + + +L+A ++R + + +RE N +RH NI+
Sbjct: 27 IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPV 276
+ +V E G L +++ S + + G+ Y H V
Sbjct: 83 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QV 136
Query: 277 VHRDLKSSNILLDSSFNA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK 334
HRDLK N LLD S K+ DFG S ++ S+ GT Y+APE LL+ + K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 335 -SDVYAFGVVLLELLMGRRPVE 355
+DV++ GV L +L+G P E
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFE 218
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 22 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 77 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 132
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 133 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 29 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 84 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 139
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 140 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 40 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 95 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 150
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 151 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 41/134 (30%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
G + + KIAV + + LE+LH + V+HRD+K SN+L+++ K DFG+S
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL 187
Query: 306 GTQSRNVKISGTLGYVAPEY----LLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSP-- 359
+G Y APE L + + KSD+++ G+ +EL + R P +
Sbjct: 188 VDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPF 247
Query: 360 TQCQSMVTWAMPQL 373
Q + +V PQL
Sbjct: 248 QQLKQVVEEPSPQL 261
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 34 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 89 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 144
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 145 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 25 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 80 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 135
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 136 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 58.5 bits (140), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 143
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 144 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 78/287 (27%), Positives = 118/287 (41%), Gaps = 63/287 (21%)
Query: 160 VIGEGGRGHVYKARFNE-KLLAAVKRIDDAG------HDAEREFNNEVNWLTKIRHQNII 212
IG+G G V A N+ + + A+K ++ D ER EV + K+ H NI
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEVRLMKKLHHPNIA 91
Query: 213 SLLGYCIHAETRF--LVYEMMQNGSL-------------------------------EKQ 239
L Y ++ + ++ LV E+ G L E+
Sbjct: 92 RL--YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 240 LHGPTHG--SNLTWHLRMKIAVDVAR----GLEYLHEHCNHPVVHRDLKSSNILL--DSS 291
++G HG +L + R K+ ++ R L YLH N + HRD+K N L + S
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 292 FNAKLSDFGLS-----VTAGTQSRNVKISGTLGYVAPEYL--LEGKLTDKSDVYAFGVVL 344
F KL DFGLS + G +GT +VAPE L K D ++ GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTM 391
LLMG P ++ S V +L + N++ P+ RD +
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVL--NKKLCFENPNYNVLSPLARDLL 311
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 20 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 77
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 33 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 88 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 143
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 144 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 58.5 bits (140), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 18/212 (8%)
Query: 149 EAATNNFQESNVIGEGGRGHVY--KARFNEK--LLAAVKRIDDAGHDAEREFNNEVNWLT 204
+A ++ F+ + +G G VY K + +K L +K+ D ++ E+ L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLL 103
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
++ H NII L LV E++ G L ++ + S +K +
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---QILEA 160
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDS---SFNAKLSDFGLSVTAGTQSRNVKISGTLGYV 321
+ YLHE+ +VHRDLK N+L + K++DFGLS Q + GT GY
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 322 APEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
APE L + D+++ G++ LL G P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 43 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 100
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 155
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 210
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 211 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 86
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 87 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 140
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 198
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 199 MWSIGVITYILLSGASP 215
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 44 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 49 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 159
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 160 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 58.2 bits (139), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 86
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 87 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 140
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 141 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 198
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 199 MWSIGVITYILLSGASP 215
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 26 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 81 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 136
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 137 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 160 VIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR-HQNIISLLGY 217
V+ EGG VY+A+ A+KR+ + R EV ++ K+ H NI+ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---F 91
Query: 218 CIHA----------ETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
C A + FL+ + G L + L L+ +KI R +++
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 268 LHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA--------GTQSR-----NVKI 314
+H P++HRDLK N+LL + KL DFG + T Q R +
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 315 SGTLGYVAPEYL---LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ T Y PE + + +K D++A G +L L + P E
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 165
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 166 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 20 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 77 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 131
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 132 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMV 213
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 57 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 167
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 168 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 165
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 166 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 44 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 101
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMXGXVATRWYRAP 211
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 31 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 87
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 88 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 142
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 143 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMV 224
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 59 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 169
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 170 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 48/265 (18%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
+F+ VIG G G V K + +K+ A +KR + A ER+ N +
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 202 WLTKIRH-----QNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMK 256
W+T + + N+ ++ Y + + L+ E +L P + + M
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLL------SKFEDRL--PEEMARF-YLAEMV 185
Query: 257 IAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT---AGTQSRNVK 313
IA+D L Y VHRD+K NIL+D + + +L+DFG + GT +V
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 314 ISGTLGYVAPEYLL-----EGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTW 368
+ GT Y++PE L +G+ + D ++ GV + E+L G P S + +
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM- 294
Query: 369 AMPQLTDRSKLPNIVDPVIRDTMDL 393
+R + P V V + DL
Sbjct: 295 ---NHKERFQFPTQVTDVSENAKDL 316
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 16/175 (9%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
++V E M G + L S H R A + EYLH + +++RDLK
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEP--HARF-YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 285 NILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVL 344
N+L+D K++DFG + + R + GT Y+APE +L D +A GV++
Sbjct: 171 NLLIDQQGYIKVADFGFA--KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
E+ G P P Q + ++ + + P+ ++D L++L QV
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKI------VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 16/175 (9%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
++V E M G + L S H R A + EYLH + +++RDLK
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEP--HARF-YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 285 NILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVL 344
N+L+D K++DFG + + R + GT Y+APE +L D +A GV++
Sbjct: 171 NLLIDQQGYIKVADFGFA--KRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 345 LELLMGRRPVEKMSPTQCQSMVTWAMPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
E+ G P P Q + ++ + + P+ ++D L++L QV
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKI------VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 161 IGEGGRGHVYKARFNEKL---LAAVKRID-DAGHDAEREFNNEVNWLTKIRHQNIISLLG 216
+GEG VYK + KL L A+K I + A EV+ L ++H NI++L
Sbjct: 10 LGEGTYATVYKGK--SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 217 YCIHAETRF-LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHP 275
IH E LV+E + + L++ L G+ + H + RGL Y H
Sbjct: 68 -IIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 276 VVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS-GTLGYVAPEYLLEGKLTDK 334
V+HRDLK N+L++ KL+DFGL+ ++ TL Y P+ LL TD
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS--TDY 178
Query: 335 S---DVYAFGVVLLELLMGR 351
S D++ G + E+ GR
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 30 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 87
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 88 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 142
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 197
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 198 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ FGL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL 240
AVK ID + D E + + +H NII+L + +LV E+M+ G L ++
Sbjct: 56 AVKVIDKSKRDPSEEIEILLRY---GQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI 112
Query: 241 HGPTHGSNLTWHLRMKIAVD---------VARGLEYLHEHCNHPVVHRDLKSSNIL-LDS 290
LR K + + + +EYLH + VVHRDLK SNIL +D
Sbjct: 113 ------------LRQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDE 157
Query: 291 SFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLLE 346
S N ++ DFG + ++ + T +VAPE L + D+++ G++L
Sbjct: 158 SGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYT 217
Query: 347 LLMGRRP 353
+L G P
Sbjct: 218 MLAGYTP 224
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 34 YQNLAPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 91
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 92 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y AP
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 201
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 202 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARFNE--KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + +L+A K + D +R N E+ + K+ H NI
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 210
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + HRD+K N+LLD KL DFG + NV
Sbjct: 211 ----FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 277 VHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKIS---GTLGYVAPEYLLEGKLTD 333
HRD+K NIL+ + A L DFG++ +A T + ++ GTL Y APE E T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 334 KSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQ-LTDRSKLPNIVDPVI 387
++D+YA VL E L G P + + + + A+P+ T R +P D VI
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTVRPGIPVAFDAVI 269
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFGL+ + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
AVK ID + +R+ + E+ L + +H NII+L + +LV E+M+ G L +
Sbjct: 56 AVKVIDKS----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 240 LHGPTHGSNLTWHLRMKIAVD---------VARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
+ LR K + + + +EYLH + VVHRDLK SNIL +D
Sbjct: 112 I------------LRQKFFSEREASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVD 156
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
S N ++ DFG + ++ + T +VAPE L + D+++ G++L
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 346 ELLMGRRP 353
+L G P
Sbjct: 217 TMLAGYTP 224
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ D GL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K R + D ERE V+ L +I+H N+I+L +
Sbjct: 32 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSILKEIQHPNVITLHEVYENKT 87
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +LT + + G+ YLH + + H DLK
Sbjct: 88 DVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLK 141
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + K+ DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYEPLGLEAD 199
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 200 MWSIGVITYILLSGASP 216
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D K++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
L AVK I+ G + E+ +RH NI+ + +V E G L +
Sbjct: 46 LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
++ S + + G+ Y H V HRDLK N LLD S K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
FG S ++ S+ GT Y+APE LL+ + K +DV++ GV L +L+G P E
Sbjct: 159 CAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D K++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKR--VKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 27/173 (15%)
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGT 317
+ VARG+E+L + +HRDL + NILL + K+ DFGL+ V+ T
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 318 ---LGYVAPEYLLEGKLTDKSDVYAFGVVLLELL-MGRRPVE--KMSPTQCQSMVTWAMP 371
L ++APE + + + KSDV+++GV+L E+ +G P +M C S + M
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC-SRLREGM- 319
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQVAAVAVLCIQPEPSYRPLITDVLHSL 424
R + P P I YQ + + C +P RP +++ L
Sbjct: 320 ----RMRAPEYSTPEI---------YQ---IMLDCWHRDPKERPRFAELVEKL 356
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + + ERE V+ L ++ H N+I+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ D GL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + + ERE V+ L ++ H N+I+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 10/180 (5%)
Query: 179 LAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEK 238
L AVK I+ G + E+ +RH NI+ + +V E G L +
Sbjct: 46 LVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 239 QLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA--KL 296
++ S + + G+ Y H V HRDLK N LLD S K+
Sbjct: 105 RICNAGRFSEDEARFFFQ---QLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKI 158
Query: 297 SDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDK-SDVYAFGVVLLELLMGRRPVE 355
FG S ++ S+ GT Y+APE LL+ + K +DV++ GV L +L+G P E
Sbjct: 159 CAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFE 218
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + + ERE V+ L ++ H N+I+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEK--LLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K L AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ D GL+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + + ERE V+ L ++ H N+I+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + L A+K++ + F N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR--------------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 317 TLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + + ERE V+ L ++ H N+I+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSILRQVLHHNVITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 20 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 80 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + +V GT+ Y+ PE +
Sbjct: 126 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 229
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 230 ISKLHAIIDP 239
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + L A+K++ + F N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 154 NFQESNVIGEGGRGHVYKARF-NEKLLAAVKRIDDAGHDAEREFNN-EVNWLTKIRHQNI 211
++ ++ VIG G G VY+A+ + L A+K++ + F N E+ + K+ H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLDHCNI 75
Query: 212 ISLLGYCIHAETR----FL----------VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKI 257
+ L + + + +L VY + ++ S KQ + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL---- 131
Query: 258 AVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISG 316
R L Y+H + + HRD+K N+LLD KL DFG + NV
Sbjct: 132 ----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 317 TLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
+ Y APE + T DV++ G VL ELL+G+
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 71/268 (26%), Positives = 110/268 (41%), Gaps = 54/268 (20%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
+F+ VIG G G V K + E++ A +KR + A ER+ N +
Sbjct: 75 DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 202 WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWHL 253
W+T L Y E +LV + G L E +L P + +
Sbjct: 135 WITA---------LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL--PEDMARF-YIG 182
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSR 310
M +A+D L Y VHRD+K N+LLD + + +L+DFG + GT
Sbjct: 183 EMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 233
Query: 311 NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
+V + GT Y++PE L GK + D ++ GV + E+L G P S +
Sbjct: 234 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
+ +R + P+ V V + DL
Sbjct: 293 IM----NHEERFQFPSHVTDVSEEAKDL 316
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 96 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + +V GT+ Y+ PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 245
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 246 ISKLHAIIDP 255
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 71/268 (26%), Positives = 110/268 (41%), Gaps = 54/268 (20%)
Query: 154 NFQESNVIGEGGRGHV--YKARFNEKLLAA--------VKRIDDAGHDAEREF--NNEVN 201
+F+ VIG G G V K + E++ A +KR + A ER+ N +
Sbjct: 91 DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 202 WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSL-------EKQLHGPTHGSNLTWHL 253
W+T L Y E +LV + G L E +L P + +
Sbjct: 151 WITA---------LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL--PEDMARF-YIG 198
Query: 254 RMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA---GTQSR 310
M +A+D L Y VHRD+K N+LLD + + +L+DFG + GT
Sbjct: 199 EMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQS 249
Query: 311 NVKISGTLGYVAPEYLLE-----GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSM 365
+V + GT Y++PE L GK + D ++ GV + E+L G P S +
Sbjct: 250 SVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 308
Query: 366 VTWAMPQLTDRSKLPNIVDPVIRDTMDL 393
+ +R + P+ V V + DL
Sbjct: 309 IM----NHEERFQFPSHVTDVSEEAKDL 332
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 150 AATNNFQESNVIGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKI 206
+ + ++ +GEG G VYKA NE + R++ EV+ L ++
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 207 RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLE 266
+H+NII L H L++E +N L+K + +++ + + G+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVN 146
Query: 267 YLHEHCNHPVVHRDLKSSNILLDSSFNA-----KLSDFGLSVTAGTQSRNVKIS-GTLGY 320
+ H + +HRDLK N+LL S + K+ DFGL+ G R TL Y
Sbjct: 147 FCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 321 VAPEYLLEGKLTDKS-DVYAFGVVLLELLM 349
PE LL + S D+++ + E+LM
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
++GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D K++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 163 EGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCIHAE 222
E G Y A+F +K + R + ERE V+ L ++ H NII+L +
Sbjct: 33 EKSTGLEYAAKFIKKRQSRASRRGVCREEIERE----VSILRQVLHPNIITLHDVYENRT 88
Query: 223 TRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLK 282
L+ E++ G L L +L+ + G+ YLH + H DLK
Sbjct: 89 DVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLK 142
Query: 283 SSNI-LLDSSF---NAKLSDFGLS--VTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSD 336
NI LLD + + KL DFGL+ + G + +N I GT +VAPE + L ++D
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVNYEPLGLEAD 200
Query: 337 VYAFGVVLLELLMGRRP 353
+++ GV+ LL G P
Sbjct: 201 MWSIGVITYILLSGASP 217
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + + VK S GT+ Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 274 ISKLHAIIDP 283
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 4 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAV 259
L K+ +I LL + ++ L+ E M+ ++ T L L
Sbjct: 64 LLKKVSSGFSGVIRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELARSFFW 121
Query: 260 DVARGLEYLHEHCNHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTL 318
V + + H N V+HRD+K NIL+D + KL DFG S + GT
Sbjct: 122 QVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTR 177
Query: 319 GYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------KMSPTQCQS 364
Y PE++ + +S V++ G++L +++ G P E + ++CQ
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 237
Query: 365 MVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
++ W + + +DR I + P ++D + + + A + + + P PS
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPGPS 284
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 16 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 76 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + +V GT+ Y+ PE +
Sbjct: 122 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 225
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 226 ISKLHAIIDP 235
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D +++DFGL+ + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 155 FQESNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRH 208
+Q IG G +G V Y A + A+K++ + A+R + E+ + + H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 209 QNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVA 262
+NII LL ++ ++V E+M + +L + + +++ L +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLC---- 137
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
G+++LH + ++HRDLK SNI++ S K+ DFGL+ TAGT T Y A
Sbjct: 138 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELL 348
PE +L + D+++ G ++ E++
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMV 219
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 77 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + +V GT+ Y+ PE +
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 227 ISKLHAIIDP 236
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 129 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFA--KRVKGRT 182
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 237
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 238 -VSGKVRFPSHFSSDLKDL--LRNLLQV 262
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + + VK S GT+ Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 274 ISKLHAIIDP 283
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 155 FQESNVIGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQN 210
+Q + +G G G V + L AVK++ A+R + E+ L ++H+N
Sbjct: 53 YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 111
Query: 211 IISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+I LL A + +LV +M L+ LT + + RG
Sbjct: 112 VIGLLDVFTPATSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPE 324
L+Y+H + ++HRDLK SN+ ++ K+ DFGL+ T T Y APE
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAPE 221
Query: 325 YLLEGKLTDKS-DVYAFGVVLLELLMGR 351
+L + + D+++ G ++ ELL GR
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 135 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 188
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 243
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 244 -VSGKVRFPSHFSSDLKDL--LRNLLQV 268
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 149 EAATNNF---QESNVIGEGGRGHVYKARFNEKLLA-AVKRIDDAGHDAEREFNNEVNWLT 204
+ A N+F ++ ++G G G V+K L A K I G + E NE++ +
Sbjct: 82 QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 205 KIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
++ H N+I L LV E + G L ++ ++ NLT + + G
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEG 199
Query: 265 LEYLHEHCNHPVVHRDLKSSNILL--DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVA 322
+ ++H+ ++H DLK NIL + K+ DFGL+ + + GT ++A
Sbjct: 200 IRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLA 256
Query: 323 PEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
PE + ++ +D+++ GV+ LL G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 137 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 190
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 245
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 246 -VSGKVRFPSHFSSDLKDL--LRNLLQV 270
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 128 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 181
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 236
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 237 -VSGKVRFPSHFSSDLKDL--LRNLLQV 261
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 143 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 196
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 251
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 252 -VSGKVRFPSHFSSDLKDL--LRNLLQV 276
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 135 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 188
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 243
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 244 -VSGKVRFPSHFSSDLKDL--LRNLLQV 268
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT 216
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 271
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 272 -VSGKVRFPSHFSSDLKDL--LRNLLQV 296
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 55.5 bits (132), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRT 216
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 271
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 272 -VSGKVRFPSHFSSDLKDL--LRNLLQV 296
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 55.1 bits (131), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 96 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNV---KISGTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ V GT+ Y+ PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 245
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 246 ISKLHAIIDP 255
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 55.1 bits (131), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKL--LAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQ 209
+Q + +G G G V A F+ K AVK++ A+R + E+ L ++H+
Sbjct: 24 YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 81
Query: 210 NIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
N+I LL A + +LV +M L+ LT + + R
Sbjct: 82 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
GL+Y+H + ++HRDLK SN+ ++ K+ DF L+ T T Y AP
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLA--RHTDDEMTGYVATRWYRAP 191
Query: 324 EYLLEGKLTDKS-DVYAFGVVLLELLMGR 351
E +L +++ D+++ G ++ ELL GR
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
+G G G V A R EK+ A+K++ A+R + E+ L ++H+N+I L
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 106
Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
L A + +LV MQ L+K + G + + + +GL+Y+
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GMEFSEEKIQYLVYQMLKGLKYI 160
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
H + VVHRDLK N+ ++ K+ DFGL+ A + + T Y APE +L
Sbjct: 161 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 215
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
+++ D+++ G ++ E+L G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 55.1 bits (131), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
AVK ID + +R+ E+ L + +H NII+L + ++V E+M+ G L +
Sbjct: 51 AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 240 LHGPTHGSNLTWHLRMK---------IAVDVARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
+ LR K + + + +EYLH VVHRDLK SNIL +D
Sbjct: 107 I------------LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
S N ++ DFG + ++ + T +VAPE L D+++ GV+L
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 346 ELLMGRRP 353
+L G P
Sbjct: 212 TMLTGYTP 219
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 161 IGEGGRGHVYKA---RFNEKLLAAVKRIDDAGHD---AEREFNNEVNWLTKIRHQNIISL 214
+G G G V A R EK+ A+K++ A+R + E+ L ++H+N+I L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKV--AIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 215 LGYCIHAETR------FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
L A + +LV MQ L+K + G + + + +GL+Y+
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYI 142
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
H + VVHRDLK N+ ++ K+ DFGL+ A + + T Y APE +L
Sbjct: 143 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILS 197
Query: 329 GKLTDKS-DVYAFGVVLLELLMGR 351
+++ D+++ G ++ E+L G+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 15/205 (7%)
Query: 155 FQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL 214
+ VIG G G V++A+ E A+K++ +R N E+ + ++H N++ L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 215 LGYCIHAETRF------LVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYL 268
+ + LV E + H + L + R L Y+
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 269 HEHCNHPVVHRDLKSSNILLDSSFNA-KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLL 327
H + HRD+K N+LLD KL DFG + NV + Y APE +
Sbjct: 158 HSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIF 214
Query: 328 EG-KLTDKSDVYAFGVVLLELLMGR 351
T D+++ G V+ EL+ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 161 IGEGGRGHVYKAR-FNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISLLGYCI 219
+GEGG +V ++ A+KRI E E + H NI+ L+ YC+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 220 H----AETRFLVYEMMQNGSLEKQLHG-PTHGSNLTWHLRMKIAVDVARGLEYLHEHCNH 274
+L+ + G+L ++ G+ LT + + + + RGLE +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--- 153
Query: 275 PVVHRDLKSSNILLDSSFNAKLSDFG------LSVTAGTQSRNVK----ISGTLGYVAPE 324
HRDLK +NILL L D G + V Q+ ++ T+ Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 325 YL---LEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
+ +++DV++ G VL ++ G P +
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)
Query: 255 MKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSF---NAKLSDFGLSVTAGTQSRN 311
+++ + G+ YLH++ +VH DLK NILL S + + K+ DFG+S G
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
+I GT Y+APE L +T +D++ G++ LL P
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE +L D +A GV++ ++ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
PS
Sbjct: 284 PS 285
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
PS
Sbjct: 284 PS 285
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
PS
Sbjct: 311 PS 312
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
PS
Sbjct: 311 PS 312
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 77/333 (23%), Positives = 137/333 (41%), Gaps = 64/333 (19%)
Query: 123 PILERFNSL---RLAGKKD--TVSVIEYELLEAATNNFQESNVIGEGGRGHVYKA-RFNE 176
P+L + NSL R A D + + E + +Q ++G GG G VY R ++
Sbjct: 16 PLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 75
Query: 177 KLLAAVKRIDDAGHDAEREFNN------EVNWLTKIRH--QNIISLLGYCIHAETRFLVY 228
L A+K ++ E N EV L K+ +I LL + ++ L+
Sbjct: 76 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 135
Query: 229 E-----------MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHC-NHPV 276
E + + G+L+++L + W + + HC N V
Sbjct: 136 ERPEPVQDLFDFITERGALQEEL-----ARSFFWQVLEAV------------RHCHNCGV 178
Query: 277 VHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKS 335
+HRD+K NIL+D + KL DFG S + GT Y PE++ + +S
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRS 237
Query: 336 -DVYAFGVVLLELLMGRRPVE-------------KMSPTQCQSMVTWAMP-QLTDRSKLP 380
V++ G++L +++ G P E + +CQ ++ W + + +DR
Sbjct: 238 AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSDRPTFE 297
Query: 381 NIVD-PVIRDTMDLKHLYQVAAVAVLCIQPEPS 412
I + P ++D + + + A + + + P PS
Sbjct: 298 EIQNHPWMQDVLLPQ---ETAEIHLHSLSPGPS 327
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 158 SNVIGEGGRGHVYKARFNEKL-LAAVKRIDDAGH----DAE-REFNNEVNWLTKIRHQNI 211
S+++G+G +V++ R + L A+K ++ D + REF EV L K+ H+NI
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF--EV--LKKLNHKNI 69
Query: 212 ISLLGYCIHAET----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
+ L + I ET + L+ E GSL L P++ L + + DV G+ +
Sbjct: 70 VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 268 LHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
L E+ +VHR++K NI+ D KL+DFG + + V + GT Y+ P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHP 184
Query: 324 EYLL--------EGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + K D+++ GV G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 4 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 64 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 118
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 119 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 165
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 166 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 225
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 226 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 282
Query: 411 PS 412
PS
Sbjct: 283 PS 284
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 19 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 79 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 133
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 134 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 180
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 241 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 297
Query: 411 PS 412
PS
Sbjct: 298 PS 299
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
H NI+ L FLV E++ G L +++ H S M+ V + +
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSH 121
Query: 268 LHEHCNHPVVHRDLKSSNILL---DSSFNAKLSDFGLSVTAGTQSRNVKISG-TLGYVAP 323
+H+ VVHRDLK N+L + + K+ DFG + ++ +K TL Y AP
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 324 EYLLEGKLTDKSDVYAFGVVLLELLMGRRPVE 355
E L + + D+++ GV+L +L G+ P +
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
L+ KDT++ I L +++ VIG G G V R + KLL+ +
Sbjct: 56 LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
KR D A ER+ N W+ + L Y + ++V E M G L
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 164
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
+ + W R A +V L+ +H + +HRD+K N+LLD S + KL+DF
Sbjct: 165 MS--NYDVPEKWA-RFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 217
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
G + + R GT Y++PE L +G + D ++ GV L E+L+G P
Sbjct: 218 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 254 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
PS
Sbjct: 311 PS 312
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 242 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
PS
Sbjct: 299 PS 300
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 153
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 154 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 200
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 260
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 317
Query: 411 PS 412
PS
Sbjct: 318 PS 319
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 20/168 (11%)
Query: 192 AEREFNNEVNWLTKIRHQNIISLLGYCIHAETR------FLVYEMMQNGSLEKQLHGPTH 245
A+R + E+ L +RH+N+I LL ET +LV M L K +
Sbjct: 68 AKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKL 125
Query: 246 GSNLTWHLRMKIAV-DVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT 304
G + R++ V + +GL Y+H ++HRDLK N+ ++ K+ DFGL+
Sbjct: 126 GED-----RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 305 AGTQSRNVKISGTLGYVAPEYLLEG-KLTDKSDVYAFGVVLLELLMGR 351
A ++ + T Y APE +L + T D+++ G ++ E++ G+
Sbjct: 178 ADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 47 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 161
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 162 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 208
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 209 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 268
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 269 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 325
Query: 411 PS 412
PS
Sbjct: 326 PS 327
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 255 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
PS
Sbjct: 312 PS 313
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 119
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 120 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 166
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 167 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 226
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 227 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 283
Query: 411 PS 412
PS
Sbjct: 284 PS 285
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 158 SNVIGEGGRGHVYKARFNEKL-LAAVKRIDDAGH----DAE-REFNNEVNWLTKIRHQNI 211
S+++G+G +V++ R + L A+K ++ D + REF EV L K+ H+NI
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF--EV--LKKLNHKNI 69
Query: 212 ISLLGYCIHAET----RFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEY 267
+ L + I ET + L+ E GSL L P++ L + + DV G+ +
Sbjct: 70 VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 268 LHEHCNHPVVHRDLKSSNILL----DSSFNAKLSDFGLSVTAGTQSRNVKISGTLGYVAP 323
L E+ +VHR++K NI+ D KL+DFG + + V + GT Y+ P
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 324 EYL--------LEGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + K D+++ GV G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 50/273 (18%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE-----------REF 196
L A + + I G G V +E + A+KR+ + D +
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLH------GPTH 245
E+ L H NI+ L +H E +LV E+M+ L + +H P H
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
+H+ + GL LHE VVHRDL NILL + + + DF L+
Sbjct: 136 IQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 306 GTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR------------- 351
+ Y APE +++ K T D+++ G V+ E+ +
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTD--RSKLPNI 382
+ VE + + + +V ++ P D R+ L N+
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ ++CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 255 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
PS
Sbjct: 312 PS 313
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 50/273 (18%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKARFNEKLLAAVKRIDDAGHDAE-----------REF 196
L A + + I G G V +E + A+KR+ + D +
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 197 NNEVNWLTKIRHQNIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLH------GPTH 245
E+ L H NI+ L +H E +LV E+M+ L + +H P H
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTA 305
+H+ + GL LHE VVHRDL NILL + + + DF L+
Sbjct: 136 IQYFMYHILL--------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 306 GTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGR------------- 351
+ Y APE +++ K T D+++ G V+ E+ +
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 352 RPVEKMSPTQCQSMVTWAMPQLTD--RSKLPNI 382
+ VE + + + +V ++ P D R+ L N+
Sbjct: 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
L+ KDT++ I L +++ VIG G G V R + KLL+ +
Sbjct: 51 LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
KR D A ER+ N W+ + L Y + ++V E M G L
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
+ + W R A +V L+ +H + +HRD+K N+LLD S + KL+DF
Sbjct: 160 MS--NYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
G + + R GT Y++PE L +G + D ++ GV L E+L+G P
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+++D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+APE ++ D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 67/240 (27%), Positives = 103/240 (42%), Gaps = 37/240 (15%)
Query: 133 LAGKKDTVSVIEYELLEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---V 182
L+ KDT++ I L +++ VIG G G V R + KLL+ +
Sbjct: 56 LSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 113
Query: 183 KRIDDAGHDAEREFNNEVN--WLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLEKQ 239
KR D A ER+ N W+ + L Y + ++V E M G L
Sbjct: 114 KRSDSAFFWEERDIMAFANSPWVVQ---------LFYAFQDDRYLYMVMEYMPGGDLVNL 164
Query: 240 LHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDF 299
+ + W R A +V L+ +H + +HRD+K N+LLD S + KL+DF
Sbjct: 165 MS--NYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 217
Query: 300 GLSVTAGTQS--RNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
G + + R GT Y++PE L +G + D ++ GV L E+L+G P
Sbjct: 218 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 155 FQESNVIGEGGRGHVYKA-------RFNEKLLAAVKRIDDAGHDAEREFNNEVNWLTKIR 207
++ VIG+G V + +F K++ K G E + E + ++
Sbjct: 26 YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE-DLKREASICHMLK 84
Query: 208 HQNIISLLGYCIHAETRFLVYEMMQNGSL-----EKQLHGPTHGSNLTWHLRMKIAVDVA 262
H +I+ LL ++V+E M L ++ G + + H +I
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---- 140
Query: 263 RGLEYLHEHCNHPVVHRDLKSSNILLDSSFNA---KLSDFGLSVTAGTQSRNVKIS-GTL 318
L Y H ++ ++HRD+K N+LL S N+ KL DFG+++ G GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTP 197
Query: 319 GYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRP 353
++APE + DV+ GV+L LL G P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 55/250 (22%)
Query: 161 IGEGGRGHVYKARFNEKLLAAVKRI--DDAGHDAEREFNNEVNWLTKIRHQN--IISLLG 216
IG GG V++ +K + A+K + ++A + + NE+ +L K++ + II L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 217 YCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDV-------ARGLEYLH 269
Y I T +Y +M+ G+++ L L+ K ++D LE +H
Sbjct: 124 YEI---TDQYIYMVMECGNID-----------LNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 270 EHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN-VKIS--GTLGYVAPEYL 326
H +VH DLK +N L+ KL DFG++ + + VK S G + Y+ PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 327 LEGKLTDKS-----------DVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQLTD 375
+ + ++ DV++ G +L + G+ P +++ +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 376 RSKLPNIVDP 385
SKL I+DP
Sbjct: 274 ISKLHAIIDP 283
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 27 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 87 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 141
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 142 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 188
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 189 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 248
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 249 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 305
Query: 411 PS 412
PS
Sbjct: 306 PS 307
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 19 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 79 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 133
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 134 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 180
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 181 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 240
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 241 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 297
Query: 411 PS 412
PS
Sbjct: 298 PS 299
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 146
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 147 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 193
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 194 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 253
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 254 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 310
Query: 411 PS 412
PS
Sbjct: 311 PS 312
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 255 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
PS
Sbjct: 312 PS 313
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 147
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 148 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 194
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 195 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQV 254
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 255 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 311
Query: 411 PS 412
PS
Sbjct: 312 PS 313
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 242 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
PS
Sbjct: 299 PS 300
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 109/233 (46%), Gaps = 44/233 (18%)
Query: 153 NNFQESNVIGEGGRGHVYKARFN-EKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQ 209
+ ++ ++IG G GHV +A EK + A+K+I D + E+ L ++ H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 210 NIISLLGYCIHAETR-----FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
+++ +L I + ++V E+ + +K P + + L H++ + ++ G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL--HIKT-LLYNLLVG 168
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAG------------------ 306
++Y+H + ++HRDLK +N L++ + K+ DFGL+ T
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 307 -----TQSRNVK--ISG---TLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
++N+K ++G T Y APE LL+ T+ DV++ G + ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 52 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 166
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 167 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 213
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 214 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 273
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + +DR I + P ++D + + + A + + + P
Sbjct: 274 FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 330
Query: 411 PS 412
PS
Sbjct: 331 PS 332
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT Y+AP +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 53.5 bits (127), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 31/258 (12%)
Query: 161 IGEGGRGHVYKARFNE-KLLAAVKRIDDAGHDAEREFNNEVNWLTKIRHQNIISL----- 214
+G GG G V+ A N+ A+K+I + + E+ + ++ H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 215 ---------LGYCIHAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGL 265
+G + ++V E M+ GP L H R+ + RGL
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL----LEEHARL-FMYQLLRGL 133
Query: 266 EYLHEHCNHPVVHRDLKSSNILLDS-SFNAKLSDFGLS-VTAGTQSRNVKISGTL---GY 320
+Y+H + V+HRDLK +N+ +++ K+ DFGL+ + S +S L Y
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190
Query: 321 VAPEYLLE-GKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMPQL--TDRS 377
+P LL T D++A G + E+L G+ + ++ ++P + DR
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 378 KLPNIVDPVIRDTMDLKH 395
+L +++ IR+ M H
Sbjct: 251 ELLSVIPVYIRNDMTEPH 268
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 56/281 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 3 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 202 WLTKIR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 63 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 117
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 118 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 164
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 165 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 224
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
+ ++CQ ++ W + + +DR I + P ++D +
Sbjct: 225 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 265
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 53.1 bits (126), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 18/150 (12%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLS--VTAGTQS 309
H R A + EYLH + +++RDLK N+L+D +++DFG + V T +
Sbjct: 163 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT 218
Query: 310 RNVKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWA 369
+ GT Y+APE +L D +A GV++ E+ G P P Q +
Sbjct: 219 ----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--- 271
Query: 370 MPQLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 272 ---VSGKVRFPSHFSSDLKDL--LRNLLQV 296
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 149 EAATNNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVN 201
E + +Q ++G GG G VY R ++ L A+K ++ E N EV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 202 WLTKIRH--QNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSN 248
L K+ +I LL + ++ L+ E + + G+L+++L +
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS 134
Query: 249 LTWHLRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAG 306
W + + HC N V+HRD+K NIL+D + KL DFG S
Sbjct: 135 FFWQVLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALL 181
Query: 307 TQSRNVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE---------- 355
+ GT Y PE++ + +S V++ G++L +++ G P E
Sbjct: 182 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 241
Query: 356 ---KMSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTMDLKHLYQVAAVAVLCIQPE 410
+ +CQ ++ W + + DR I + P ++D + + + A + + + P
Sbjct: 242 FFRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQ---ETAEIHLHSLSPG 298
Query: 411 PS 412
PS
Sbjct: 299 PS 300
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 28/133 (21%)
Query: 230 MMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLD 289
M + SLE + HG + + I + +A +E+LH + ++HRDLK SNI
Sbjct: 152 MNRRCSLEDREHG----------VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFT 198
Query: 290 SSFNAKLSDFGLSVTAGTQSRNVKIS--------------GTLGYVAPEYLLEGKLTDKS 335
K+ DFGL VTA Q + GT Y++PE + + K
Sbjct: 199 MDDVVKVGDFGL-VTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 336 DVYAFGVVLLELL 348
D+++ G++L ELL
Sbjct: 258 DIFSLGLILFELL 270
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 52.8 bits (125), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
+ +Q ++G GG G VY R ++ L A+K ++ E N EV L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
+ +I LL + ++ L+ E + + G+L+++L + W
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
+ + HC N V+HRD+K NIL+D + KL DFG S +
Sbjct: 119 VLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
GT Y PE++ + +S V++ G++L +++ G P E +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
++CQ ++ W + + +DR I + P ++D +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 64/277 (23%), Positives = 116/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
+ +Q ++G GG G VY R ++ L A+K ++ E N EV L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
+ +I LL + ++ L+ E + + G+L+++L + W
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
+ + HC N V+HRD+K NIL+D + KL DFG S +
Sbjct: 119 VLEAV------------RHCHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
GT Y PE++ + +S V++ G++L +++ G P E +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
++CQ ++ W + + +DR I + P ++D +
Sbjct: 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHD--AEREFNNEVNWLTKIRHQ 209
+N++ ++IG G G+VY A N A+K+++ D + E+ L +++
Sbjct: 28 DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 210 NIISLLGYCI-----HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARG 264
II L I + ++V E+ + L+K P LT I ++ G
Sbjct: 88 YIIRLHDLIIPEDLLKFDELYIVLEI-ADSDLKKLFKTPIF---LTEQHVKTILYNLLLG 143
Query: 265 LEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT-------------------- 304
+++HE ++HRDLK +N LL+ + K+ DFGL+ T
Sbjct: 144 EKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENE 200
Query: 305 -AGTQSRNVKIS-----GTLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
G ++N+K T Y APE LL+ T+ D+++ G + ELL
Sbjct: 201 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 14/148 (9%)
Query: 252 HLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVTAGTQSRN 311
H R A + EYLH + +++RDLK N+L+D +++DFG + + R
Sbjct: 142 HARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFA--KRVKGRT 195
Query: 312 VKISGTLGYVAPEYLLEGKLTDKSDVYAFGVVLLELLMGRRPVEKMSPTQCQSMVTWAMP 371
+ GT +APE +L D +A GV++ E+ G P P Q +
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----- 250
Query: 372 QLTDRSKLPNIVDPVIRDTMDLKHLYQV 399
++ + + P+ ++D L++L QV
Sbjct: 251 -VSGKVRFPSHFSSDLKDL--LRNLLQV 275
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 56/277 (20%)
Query: 153 NNFQESNVIGEGGRGHVYKA-RFNEKLLAAVKRIDDAGHDAEREFNN------EVNWLTK 205
+ +Q ++G GG G VY R ++ L A+K ++ E N EV L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 206 IR--HQNIISLLGYCIHAETRFLVYE-----------MMQNGSLEKQLHGPTHGSNLTWH 252
+ +I LL + ++ L+ E + + G+L+++L + W
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARSFFWQ 118
Query: 253 LRMKIAVDVARGLEYLHEHC-NHPVVHRDLKSSNILLD-SSFNAKLSDFGLSVTAGTQSR 310
+ + HC N V+HRD+K NIL+D + KL DFG S +
Sbjct: 119 VLEAV------------RHCHNXGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTV 165
Query: 311 NVKISGTLGYVAPEYLLEGKLTDKS-DVYAFGVVLLELLMGRRPVE-------------K 356
GT Y PE++ + +S V++ G++L +++ G P E +
Sbjct: 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 225
Query: 357 MSPTQCQSMVTWAMP-QLTDRSKLPNIVD-PVIRDTM 391
+CQ ++ W + + +DR I + P ++D +
Sbjct: 226 RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 52.0 bits (123), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 190 HDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---HGPTH 245
H++++E E+ ++ +RH +++L ++YE M G L +++ H
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSV 303
++R V +GL ++HE+ VH DLK NI+ + S KL DFGL+
Sbjct: 254 EDEAVEYMRQ-----VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRP 353
+ +GT + APE + EGK + +D+++ GV+ LL G P
Sbjct: 306 HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 190 HDAERE-FNNEVNWLTKIRHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQL---HGPTH 245
H++++E E+ ++ +RH +++L ++YE M G L +++ H
Sbjct: 88 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 147
Query: 246 GSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDS--SFNAKLSDFGLSV 303
++R V +GL ++HE+ VH DLK NI+ + S KL DFGL+
Sbjct: 148 EDEAVEYMRQ-----VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 304 TAGTQSRNVKISGTLGYVAPEYLLEGK-LTDKSDVYAFGVVLLELLMGRRP 353
+ +GT + APE + EGK + +D+++ GV+ LL G P
Sbjct: 200 HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSP 249
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 34/188 (18%)
Query: 181 AVKRIDDAGHDAEREFNNEVNWLTKI-RHQNIISLLGYCIHAETRFLVYEMMQNGSLEKQ 239
AVK ID + +R+ E+ L + +H NII+L + ++V E+ + G L +
Sbjct: 51 AVKIIDKS----KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 240 LHGPTHGSNLTWHLRMK---------IAVDVARGLEYLHEHCNHPVVHRDLKSSNIL-LD 289
+ LR K + + + +EYLH VVHRDLK SNIL +D
Sbjct: 107 I------------LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVD 151
Query: 290 SSFNA---KLSDFGLSVTAGTQSRNVKISG-TLGYVAPEYLLEGKLTDKSDVYAFGVVLL 345
S N ++ DFG + ++ + T +VAPE L D+++ GV+L
Sbjct: 152 ESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 346 ELLMGRRP 353
L G P
Sbjct: 212 TXLTGYTP 219
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
++ E M+ G L ++ T +I D+ +++LH +H + HRD+K
Sbjct: 83 LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 138
Query: 285 NILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG 341
N+L S KL+DFG + TQ+ T YVAPE L K D+++ G
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 197
Query: 342 VVLLELLMGRRP 353
V++ LL G P
Sbjct: 198 VIMYILLCGFPP 209
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/245 (25%), Positives = 102/245 (41%), Gaps = 35/245 (14%)
Query: 122 SPILERFNSLRLAGKKDTVSVIEYELLEA-ATNNFQESNVIGEGGRGHVYKARFNEKLLA 180
PI+ R +RL ++D ++E+L+ F E V+ G VY + K
Sbjct: 47 EPIVVRLKEVRL--QRD-----DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-D 98
Query: 181 AVKRIDDAGHDAEREF--NNEVNWLTKIRHQNIISLLGYCIHAETR-FLVYEMMQNGSLE 237
+KR + + ER+ N + W+T+ L + E +LV E G L
Sbjct: 99 MLKRGEVSCFREERDVLVNGDRRWITQ---------LHFAFQDENYLYLVMEYYVGGDLL 149
Query: 238 KQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLS 297
L G + + ++ ++ +H VHRD+K NILLD + +L+
Sbjct: 150 TLLS--KFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA 204
Query: 298 DFG--LSVTAGTQSRNVKISGTLGYVAPEYL-------LEGKLTDKSDVYAFGVVLLELL 348
DFG L + A R++ GT Y++PE L G + D +A GV E+
Sbjct: 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 349 MGRRP 353
G+ P
Sbjct: 265 YGQTP 269
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 148 LEAATNNFQESNVIGEGGRGHVYKAR-------FNEKLLAA---VKRIDDAGHDAEREFN 197
L+ ++ VIG G G V R + KLL+ +KR D A ER+
Sbjct: 70 LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 198 NEVN--WLTKIRHQNIISLLGYCIHAETRFL--VYEMMQNGSLEKQLHG---PTHGSNLT 250
N W+ ++ +C + ++L V E M G L + P +
Sbjct: 130 AFANSPWVVQL----------FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF- 178
Query: 251 WHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT---AGT 307
+V L+ +H + ++HRD+K N+LLD + KL+DFG + G
Sbjct: 179 ------YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 229
Query: 308 QSRNVKISGTLGYVAPEYLL----EGKLTDKSDVYAFGVVLLELLMGRRP 353
+ + GT Y++PE L +G + D ++ GV L E+L+G P
Sbjct: 230 VHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 8/132 (6%)
Query: 225 FLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEHCNHPVVHRDLKSS 284
++ E M+ G L ++ T +I D+ +++LH +H + HRD+K
Sbjct: 102 LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPE 157
Query: 285 NILLDSSFNA---KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLEGKLTDKSDVYAFG 341
N+L S KL+DFG + TQ+ T YVAPE L K D+++ G
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKET-TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 342 VVLLELLMGRRP 353
V++ LL G P
Sbjct: 217 VIMYILLCGFPP 228
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 153 NNFQESNVIGEGGRGHVYKA--RFNEKLLA--AVKRIDDAGHDAEREFNNEVNWLTKIRH 208
+N+ ++IG G G+VY A + EK +A V R+ + D +R E+ L +++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKS 84
Query: 209 QNIISLLGYCI-----HAETRFLVYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVAR 263
II L I + ++V E+ + L+K P LT I ++
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF---LTEEHIKTILYNLLL 140
Query: 264 GLEYLHEHCNHPVVHRDLKSSNILLDSSFNAKLSDFGLSVT------------------A 305
G ++HE ++HRDLK +N LL+ + K+ DFGL+ T
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 306 GTQSRNVKIS-----GTLGYVAPEY-LLEGKLTDKSDVYAFGVVLLELL 348
G ++N+K T Y APE LL+ T D+++ G + ELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G ++ R EK A+K + D A RE E++W ++ H I
Sbjct: 21 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 75
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ + T +I + ++YLH
Sbjct: 76 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 132
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + + T YVAPE L
Sbjct: 133 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGP 191
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 192 EKYDKSCDMWSLGVIMYILLCGYPP 216
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G ++ R EK A+K + D A RE E++W ++ H I
Sbjct: 27 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 81
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ T +I + ++YLH
Sbjct: 82 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 138
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + T YVAPE L
Sbjct: 139 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 197
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 198 EKYDKSCDMWSLGVIMYILLCGYPP 222
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G ++ R EK A+K + D A RE E++W ++ H I
Sbjct: 29 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 83
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ T +I + ++YLH
Sbjct: 84 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 140
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + T YVAPE L
Sbjct: 141 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 199
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 200 EKYDKSCDMWSLGVIMYILLCGYPP 224
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G ++ R EK A+K + D A RE E++W ++ H I
Sbjct: 28 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 82
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ T +I + ++YLH
Sbjct: 83 DVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH-- 139
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + T YVAPE L
Sbjct: 140 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 198
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 199 EKYDKSCDMWSLGVIMYILLCGYPP 223
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRG---HVYKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G ++ R EK A+K + D A RE E++W ++ H I
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 77
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ + T +I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 134
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + T YVAPE L
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 193
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 194 EKYDKSCDMWSLGVIMYILLCGYPP 218
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 158 SNVIGEGGRGHV---YKARFNEKLLAAVKRIDDAGHDAEREFNNEVNW-LTKIRHQNIIS 213
S V+G G G V + R EK A+K + D A RE E++W ++ H I
Sbjct: 22 SQVLGLGINGKVLQIFNKRTQEKF--ALKMLQDCP-KARREV--ELHWRASQCPHIVRIV 76
Query: 214 LLGYCIHAETRFL--VYEMMQNGSLEKQLHGPTHGSNLTWHLRMKIAVDVARGLEYLHEH 271
+ ++A + L V E + G L ++ + T +I + ++YLH
Sbjct: 77 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 133
Query: 272 CNHPVVHRDLKSSNILLDSSF-NA--KLSDFGLSVTAGTQSRNVKISGTLGYVAPEYLLE 328
+ + HRD+K N+L S NA KL+DFG + + + T YVAPE L
Sbjct: 134 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 192
Query: 329 GKLTDKSDVYAFGVVLLELLMGRRP 353
K D+++ GV++ LL G P
Sbjct: 193 EKYDKSCDMWSLGVIMYILLCGYPP 217
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.136 0.403
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 12,519,340
Number of Sequences: 62578
Number of extensions: 502521
Number of successful extensions: 3574
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 892
Number of HSP's successfully gapped in prelim test: 199
Number of HSP's that attempted gapping in prelim test: 1101
Number of HSP's gapped (non-prelim): 1121
length of query: 439
length of database: 14,973,337
effective HSP length: 102
effective length of query: 337
effective length of database: 8,590,381
effective search space: 2894958397
effective search space used: 2894958397
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)